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 LIST OF ABBREVIATIONS 
 
Nanofiltration 
Am Membrane active area (m-2) Lt Threshold permeability         
(L h-1 m-2 bar-1) 
Afree Membrane area unoccupied by 
surface crystals (m-2) 
ms Weight of the scaling on the 
membrane surface (mg) 
Aoc Membrane area occupied by surface 
crystals (m-2) 
ΔP Transmembrane pressure (bar) 
Cm Concentration on the membrane 
surface 
Rf Total fouling resistance  (m-1) 
Cb Solute concentration in bulk Rm Intrinsic hydraulic membrane 
resistance (m-1) 
Cp Solute concentration in permeate Rrf Resistance due to reversible 
fouling (m-1) 
CP Concentration polarization degree Rif Resistance due to irreversible 
fouling (m-1) 
D Solute diffusivity (m2 s-1 ) Rir Residual irreversible fouling 
resistance after rinsing (m-1) 
J Permeate flux (L h-1 m-2) Rt Threshold irreversible fouling 
resistance (m-1) 
Jlim Limiting flux (L h-1 m-2) Robs Observed ion rejection 
Jcritical Critical flux (L h-1 m-2) S Supersaturation ratio (mol2 L-2) 
k Solute mass transfer coefficient    
(m s-1) 
Sm Supersaturation ratio on 
membrane surface (mol2 L-2) 
Ksp Thermodynamic solubility product 
(mol2L-2) 
Scritical Critical supersaturation ratio 
(mol2 L-2) 
Lp Pure permeability (L h-1 m-2 bar-1) µp Viscosity of permeate (Pa·s) 
Lpf Pure water permeability after filtration 
(L h-1 m-2 bar-1) 
δ Boundary layer thickness (m s-1)
Lb Permeability combining colloidal 
silica and organics fouling and scaling 
(L h-1 m-2 bar-1) 
β Area occupied per unit mass    
(m2 mg-1) 
 LIST OF ABBREVIATIONS 
 
Electrochemical oxidation 
C0      Initial concentration 
A       E electrode surface (m2) 
F       Faraday constant (C mol-1) 
ilim      Limiting current density (A m-2) 
Ilim        Limiting current intensity (A)  
ilim,ne-    Limiting current density of directly electron transfer (A m-2), 
ilim,·OH   Limiting current density corresponding to the total mineralization of the organics 
(A m-2) 
i·OH     Part of current density used to generate ·OH 
kd      Mass transfer coefficient (m s-1) 
km      Constant rate of mineralization (m s-1) 
r       Specific electrochemical reaction rate (mol m-2 s-1) 
V      Volume of solution (m3) 
Φ      Flow rate (m3 s-1) 
α       Ratio of applied current density and the initial liming current density 
γ       Equivalent number of exchanged electrons  
Γ       Reaction rate of organic on the electrode  (mol m-2 s-1) 
Γe-      Electrochemical reaction rate by electrons transfer   (mol m-2 s-1) 
Γ·R      Rate of electron transfer and the rate of reaction with ·OH  (mol m-2 s-1) 
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 General introduction 
 
General introduction 
It has been reported that micropollutants such as pharmaceuticals are widespread in the 
aquatic environment. Because of their limited biodegradability, micropollutants are 
incompletely eliminated in wastewater treatment plants, whatever the process used: activated 
sludge treatment or even membrane bioreactor (MBR) process which exhibits good 
purification performances. As a consequence, refractory pharmaceuticals remain in treated 
wastewater and are continuously discharged into aquatic systems. Considering their 
persistence and potential long-term toxicity, even at low concentrations, additional treatments 
are required to prevent their occurrence in aquatic ecosystems and limit the risk for exposed 
organisms. The difficulty in removing these contaminants from waters comes from their 
resistance to biological degradation, their small size or their extreme dilution. Within the 
framework of the conservation of the environment and the water resource, it seems necessary 
besides limiting the discharges of micropollutants, developing new technologies allowing the 
purification of waters.   
In recent works, nanofiltration (NF) and reverse osmosis (RO) have been investigated 
for the rejection of pharmaceuticals in synthetic solution and surface water. Both techniques 
are considered really efficient to provide pharmaceutical-free treated water. However, they are 
only separation techniques, and their major drawback is to produce a concentrate stream which 
contains the pollutants in higher concentration and could be as consequence more toxic than 
the influent.  In this case, concentrate stream cannot be discharged into the environment and 
its further treatment is necessary.  
Electrochemical oxidation (EO) is a promising process for pollutants elimination in 
particular using a boron doped diamond (BDD) anode. The use of BDD anode allows the 
production of electrogenerated hydroxyl radicals from water discharge. Because the action of 
hydroxyl radicals is located close to the anode, there are transfer limitations in dilute solution. 
The coupling of electrochemical oxidation with the preconcentration step by nanofiltration 
renders it economically viable. 
 
The objective of this project was to evaluate the performances of the coupling of 
nanofiltration and electrochemical oxidation as tertiary treatment of wastewater after 
membrane bioreactor treatment. Considering that the hospital wastewater is one of the main 
sources of micropollutants, especially pharmaceuticals, the study focused on the tertiary 
treatment of the secondary effluent of a MBR system which was fed directly from a hospital’s 
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sanitary collection system (Toulouse, France).  
More precisely, this Thesis focused on the effect of this complex water matrix containing 
a mixture of organics, inorganics, pharmaceuticals and numerous other components on the 
behavior of both processes, nanofiltration and electrochemical oxidation, during the treatment 
in operating conditions as comparable as possible to real ones.  
 
In nanofiltration process, the monitoring of permeate flux is a particularly important way 
to control fouling and as a consequence process productivity. Numerous studies have been 
dedicated in one hand to develop procedures to identify and/or predict critical flux and limiting 
flux in synthetic solutions; in another hand to observe flux behaviors in a complex matrix. The 
key point is to implement the procedures developed in synthetic solutions to the case of a real 
complex matrix in order to be able to predict and possibly control fouling from the flux 
behaviors as a function of the water matrix properties such as pH, organics and salt 
concentrations.  
Concerning the process selectivity, pharmaceuticals rejection by a nanofiltration 
membrane results from the complex combination of numerous mechanisms (steric exclusion, 
electrostatic and hydrophobic interactions…) which is not well understood mainly due to the 
specific properties of pharmaceutical molecules. Superimposed to that difficulty in predicting 
pharmaceuticals rejection by a certain membrane, it should be taken into account again the 
complexity of real water matrixes and its impact on pharmaceuticals rejection not only directly 
by modifying solute-membrane interactions, but also indirectly through the type of fouling 
generated during the filtration. 
 
Hospital wastewater as well as numerous wastewater contain a lots of inorganic ions, the 
main part being retained in the membrane concentrate. Thanks to the presence of these salts, 
the concentrate is sufficiently conductive and no addition of electrolyte is required for further 
treatment by electrochemical process. However, the presence of chloride ions raises questions: 
numerous studies indicate the oxidation of organics in presence of chlorides may cause 
halogenated organic compounds. Moreover, the use of an anode at high oxygen overvoltage, 
such as BDD, can lead to the formation of perchlorate. Both types of compounds are very toxic 
for the environment. Nevertheless, very few information are given on the ability of the 
electrochemical process to control the production of such compounds. A specific study will be 
devoted to propose conditions allowing limiting the formation of such undesired species.  
 
The manuscript is outlined as follows: 
A literature review will be the subject of the first chapter of this manuscript. It will report 
the general principles of membrane filtration and electrochemical oxidation process and the 
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current state of knowledge on the elimination of pharmaceuticals by using these technologies. 
The second chapter will be devoted to the description of the experimental techniques and 
methods. It will present the solutions used as well as analytical methods. It will describe in 
detail the experimental set-up used in this study.  
Chapter III will present the investigations on the fouling mechanisms during the 
nanofiltration step and their association with the process productivity (critical and limiting 
fluxes) and selectivity (pharmaceuticals rejection). A method allowing to control the 
productivity will be proposed considering the fouling mechanism expected as a function of the 
water matrix properties.  
The electrochemical oxidation of pharmaceuticals will be reported in chapter IV. The 
impact of the simultaneous presence of organics and inorganics on pharmaceuticals 
degradation will be investigated with a specific focus on the formation of by-products in 
presence of chlorine ions in synthetic solution.  A numerical model giving the temporal 
concentration of pharmaceutical compounds during the electrolysis will be proposed. Finally 
the application of electrochemical oxidation to the nanofiltration concentrate will be 
demonstrated. 
Chapter V will describe the efficiency of the coupling process and the main associated 
impact parameters through the monitoring of the toxicity.   
Finally, chapter VI will give general conclusions and recommendations for a future work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
  General introduction 
 
   
 
 
 
 
 
 
 
 
Chapter  I 
 
Background on the tertiary treatment of 
wastewater 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
   
 
Contents 
 
I.1 Occurrence of pharmaceuticals in wastewater: Towards a new tertiary treatment ........ 5 
I.1.1 Threats of pharmaceuticals in aquatic systems ........................................................ 5 
I.1.2 Source of pharmaceuticals and their pass-through from conventional wastewater 
treatment plants ................................................................................................................ 6 
I.1.3 Tertiary treatment for the elimination of pharmaceuticals in wastewater ............... 7 
I.1.3.1 Membrane process for production of high quality water ................................. 8 
I.1.3.2 Electrochemical oxidation for elimination of pharmaceuticals ........................ 9 
I.1.3.3 Combining NF and electrochemical oxidation as tertiary treatment of MBR 
effluent ....................................................................................................................... 11 
I.2 Nanofiltration................................................................................................................ 12 
I.2.1 General Presentation of the process ................................................................... 12 
I.2.1.1 Cross-flow filtration ....................................................................................... 12 
I.2.1.2 Continuous mode and batch filtration process ............................................... 13 
I.2.2 Fouling mechanisms in nanofiltration ................................................................... 14 
I.2.2.1 Concentration polarization ............................................................................. 14 
I.2.2.2 Colloidal organics fouling .............................................................................. 16 
I.2.2.3 Inorganic fouling or scaling ............................................................................ 17 
I.2.3 Critical flux and Limiting flux ............................................................................... 21 
I.2.4 Factors affecting the rejection of pharmaceuticals during NF treatment .............. 23 
I.3 Electrochemical oxidation ............................................................................................ 25 
I.3.1 BDD anode ............................................................................................................ 26 
I.3.2 Hydroxyl radicals .................................................................................................. 26 
I.3.3 Theoretical model for oxidation of organic compounds on BDD ......................... 28 
I.3.4 Long-term sustainability of electrochemical oxidation treatment ......................... 31 
I.4 Main problem need to be addressed during the research .......................................... 32 
References .......................................................................................................................... 34 
   
 5 
Chapter I Background on the tertiary treatment of wastewater
I.1 Occurrence of pharmaceuticals in wastewater: Towards a 
new tertiary treatment  
I.1.1 Threats of pharmaceuticals in aquatic systems 
   It has been reported that micropollutants such as pharmaceuticals are widespread in the 
aquatic environment. Numbers of reports about the occurrence of pharmaceuticals in 
aquatic systems have been accumulated these decades [1–6]. By the early 2000s, 
pharmaceuticals and hormones have been detected in rivers [1], seawater [2], wastewater 
[3] in Europe, China [2], United States [3]. The concentrations of them were in the range 
of ng L-1 to even µg L-1. To give precise and recent examples, micrograms per liter of 
ofloxacin, norfloxacin, ciprofloxacin and trimethoprim were commonly detected in water 
samples from three gorge reservoirs in Chongqing region in China [4]. Antibiotics were 
detected quite frequently in ng L−1 range, up to μg L−1 in surface waters of six investigated 
rivers including freshwater, estuarine and marine samples [5,7]. Corre et al. reported that 
around 3000 pharmaceuticals were available in the aquatic system in the United States and 
Europe [6].  
Even if pharmaceuticals occur at trace level in aquatic system they still pose severe 
threats not only to drinking water, but also long-term toxicity to eco-system in which 
pharmaceuticals could have detrimental interaction to aquatic organisms and humans being 
through water cycle. 
Accumulation of pharmaceuticals in the aquatic system increases the risk of the 
appearance of them into drinking water. Heberer [8] began to track some persistent 
pharmaceutical compounds from municipal sewage to drinking water and sub-ng L-1 of 
pharmaceuticals have been found in drinking water. Fifty eight pharmaceutically active 
compounds were analyzed in 10 bottled of mineral drinking water brands produced in Spain. 
Nicotine was detected in concentrations in the ng L-1 range in half of them [9]. Bruce et al. 
[10] reported that 15 active pharmaceutical ingredients and four metabolites were detected 
in 19 drinking water treatment plants across the United States; these authors mentioned that 
safe long-term exposure to mixtures of compounds, particularly for sensitive population 
groups, had to be clarified, even if the adverse health effects from targeted pharmaceuticals 
were not expected at these concentrations. Johnson et al. [11] showed that cytotoxic drugs 
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such as 5-fluorouracil posed a risk to aquatic organisms and to humans through water cycle. 
The exposure of the pregnant woman, or more specifically her fetus, to these drugs via 
drinking water should be minimized. Kümmerer and Al-Ahmad [12] reported the additional 
risk of cancer due to the presence of cyclophosphamide and ifosfamide into the aquatic 
environment cannot be fully excluded, especially with respect to children. 
Presence of pharmaceuticals in the environment could be mixed with other organic 
compounds and microorganisms. Some researches cared about the mixture effect which 
could be even worse [11,13]. It is generally accepted that mixtures with components 
exhibiting the same mode of action act according to the model of concentration addition 
[13]. Some other researches believed the pharmaceuticals exposure promotes the evolution 
of antibiotic-resistant bacteria [14].  
Long-term effect on aquatic environment should also be taken into account as shown 
in the review paper of Ankley et al. [13]. For example, Ethinyl estradiol (EE) was present 
at extremely low environmental concentrations in sea, but this level was high enough to 
cause biological responses in fishes. 
Special attentions should be taken to the exposure of pharmaceuticals in aquatic 
ecosystems even at low concentrations, considering their persistence, long-term toxicity as 
well as the potential endangerment through drinking water of certain people groups such 
as pregnant women and children. The elimination of pharmaceuticals from the source is 
required to prevent the escape of them into aquatic system and limit the risks previously 
mentioned. 
I.1.2 Source of pharmaceuticals and their pass-through from 
conventional wastewater treatment plants  
It was reported that one of the sources of pharmaceuticals is domestic sewerage 
network: excreted by people taking them, or disposed as unused drugs [15]. Another 
important source is hospital wastewater in which the concentration of target 
pharmaceuticals is higher than in the municipal wastewater [16]. For example, 
ciprofloxacin was detected at concentrations ranging from 0.8 µg L-1 in municipal 
wastewater to 13.7 µg L-1 in hospital effluent. As a consequence, pharmaceuticals in 
hospital wastewater are likely to pose the highest environmental risk compared to the 
influent and effluent of wastewater treatment plants [17]. Chang et al. [4] believed that 
hospitals, nurseries and slaughter houses are the main sources of antibiotics in rivers. 
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The removal of pharmaceuticals in conventional wastewater treatment plants (WWTP) 
is applied with activated sludge process. Although WWTP is effective in removing several 
pharmaceuticals, some refractory pharmaceuticals were still detected in WWTP effluents 
and discharged into aquatic system through the treatment plants [3,5,14,16,18]. Clara et al. 
investigated that antiepileptic pharmaceuticals like carbamazepine were not affected during 
the treatment [18]. Ciprofloxacin, sulfamethoxazole, trimethoprim, tetracycline, and 
clindamycin were detected in the treatment effluents at concentrations in the μg L-1 range 
[19]. Buerge et al. found that there is no difference in concentrations of cyclophosphamide 
and ifosfamide between influent and effluent in two Swiss sewage treatment plants 
indicating the absence of any elimination [20]. Ciprofloxacin, sulfamethoxazole, and 
clindamycin were found as far as 100 meters in the receiving stream from the discharge 
point of WWTP, which indicates the spread of these drugs in aquatic system through the 
WWTP [19]. Moreover, the pharmaceuticals spreading into the aquatic environment could 
persist for a long time due to their low environmental degradability. Kümmerer et al. [21] 
reported only a few of pharmaceutical compounds were partially biodegraded under test 
conditions in aquatic systems. Most of them were persistent. Johnson et al. [11] raised that 
many pharmaceuticals could be extremely persistent in river water.  
As a consequence, the refractory pharmaceuticals pass through the WWTP and 
accumulate in the aquatic system. They continue to pose significant threats to sustainability 
of the eco-system and safety of drinking water. 
 
I.1.3 Tertiary treatment for the elimination of pharmaceuticals in 
wastewater 
    The incomplete removal of pharmaceuticals was observed from activated sludge 
process in the conventional wastewater treatment plants. Considering the threat they 
represent, a specific treatment of pharmaceuticals at source point has to be developed 
[16,17]. Escher et al. [17] suggested that separated treatment of hospital wastewater would 
reduce the pharmaceutical load of wastewater treatment plants, and the risk from the 
identified priority pharmaceuticals according to the EU Water Framework Directive. 
    In this context, membrane bioreactor (MBR) treatment shows an higher efficiency for 
removal of trace organics than the conventional activated sludge process in the wastewater 
treatment plants [22]. MBR is a process that integrates biological treatment and sludge 
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separation by microfiltration (MF) or ultrafiltration (UF) membranes which are placed 
either outside (outer loop) or inside the bioreactor (immerged membranes). MBR system 
can operate at a much higher mixed liquor suspended solids (MLSS) concentration which 
means higher biomass concentration than that of conventional activated sludge treatment 
[22].  
    Some studies propose to use MBR for hospital wastewater treatment [23–25], and they 
demonstrated that MBR system exhibited a higher efficiency and effluent quality than the 
conventional activated sludge system [23]. Kovalova et al. [24] operated the MBR 
treatment by directly feeding it from the hospital’s sanitary collection system at a Swiss 
hospital. The elimination of pharmaceuticals vary from 0 to 99% and depends on the 
species. Quesada et al [25] applied MBR system for the direct treatment of hospital 
wastewater at the outlet of a French hospital and observed the decrease of the eco-toxicity 
of wastewater but pass-through of some pharmaceuticals into the MBR effluent was still 
observed.   
Despite the high efficiency of MBR treatment, its remaining weakness comes from the 
fact that it is a process based on the biodegradation. Pharmaceuticals which exhibit poor 
biodegradability can persist in the MBR effluent. Tertiary treatment process is then 
necessary to ensure the purification. 
I.1.3.1 Membrane process for production of high quality water 
Pressure-driven membrane processes such as nanofiltration (NF) and reverse osmosis 
(RO) are recommended as powerful options which can be applied not only into wastewater 
treatment but also drinking water production for the removal of organic pollutants [26–29]. 
Several researches have shown that residues of pesticides, pharmaceuticals, endocrine 
disrupters and other trace organics can be effectively removed from contaminated waters 
by RO and also by NF. Bruggen et al. [30] concluded that NF can be a valuable alternative 
for the removal of micropollutants after having tested four NF membranes. Kiso et al. [31] 
demonstrated that NF membranes can reject effectively non phenolic pesticides and alkyl 
phthalates. Kimura et al. [27] showed that the polyamide membrane exhibited a better 
performance in terms of the rejection of selected pharmaceuticals and endocrine disrupters 
compared to cellulose acetate membrane. The rejections of them range from 57% to 91%. 
Verliefde et al. [28] reported NF can be a very powerful technique to remove not only large 
pollutants but also the smaller hydrophilic and/or charged organic micro-pollutants. 
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Radjenovic et al. [29] studied the removal of several pharmaceuticals such as ketoprofen, 
diclofenac, sulfamethoxazole and gemfibrozil by NF and RO processes. Even if the 
rejection of pharmaceuticals was related to their molecular charge, the authors 
recommended these processes for drinking water production due to their high efficiency of 
removal.  
NF and RO are increasingly applied as tertiary treatment to obtain high quality water 
for water reuse from a secondary treated effluent such as MBR effluent [32–37]. Benefiting 
from MBR process, especially excellent solids separation and turbidity was achieved by 
the UF membrane of MBR and acceptable and stable flux (productivity) of RO and NF can 
be achieved during wastewater treatment [32–34]. Dialynas and Diamadopoulos [32] have 
obtained high quality effluent, devoid of heavy metals and with very low organic matters 
concentration (DOC level below 4 mg L-1), after MBR-RO treatment of municipal 
wastewater. MBR-RO coupling also shows excellent capability for the removal of TOC, 
NH4+ and NO3- in domestic sewage and high productivity for RO with a good stability of 
the process over 5 months [33]. Finally, Alturki et al. [37] applied the combining MBR and 
NF/RO for the removal of 40 trace pharmaceuticals and organic micropollutants. These 
authors observed the MBR system shows effective removal of hydrophobic and 
biodegradable compounds, while remaining ones are mostly hydrophilic and can be almost 
completely removed by NF/RO. As a consequence, RO permeate complied with individual 
drinking water limits for organic contaminants and micro-organisms, and met water reuse 
regulations for several non-potable applications [34].  
    NF and RO applied as tertiary treatment of MBR effluent can then produce a treated 
water of excellent quality, free of pharmaceuticals. However, as a consequence, the 
retentate of NF/RO process which contains high concentrations of pharmaceuticals and 
other organic micropollutants could be more toxic than the influent. In this case, 
concentrate streams cannot be discharged into the environment and their further treatment 
is necessary. Also, the electrochemical oxidation can be a prospective process to eliminate 
the pharmaceuticals and organics of the NF/RO retentate. 
I.1.3.2 Electrochemical oxidation for elimination of pharmaceuticals  
The most important method well established and relatively cheap to decrease the 
chemical oxygen demand of wastewaters is based on biological treatment. But, 
unfortunately, certain substances responsible for chemical oxygen demand (COD) are not 
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easily biodegradable. In particular, toxic substances can inactivate microorganisms which 
slow down biological processes. Other methods for COD removal are hence required in the 
presence of refractory and/or toxic compounds. Physicochemical methods like wet 
chemical oxidation by O2 (high pressure, high temperature) [38] or hydrogen peroxide (in 
the presence of catalyst) [39] have given rise to efficient processes. However, these 
technologies are quite expensive.  
Electrochemistry is an alternative technique which has important advantage that 
degradation of organics into carbon dioxide, water and nontoxic substance can be achieved 
under particular conditions. Polcaro et al. [40] studied the EO of phenol and chlorophenols 
on porous carbon felt electrodes. Their results shows that this anode material allows to 
oxidize partially organic compounds and the total mineralization is not reached. This 
selective oxidation can serve as a pretreatment before biological treatment. Advanced 
oxidation process, electro-Fenton can be for degradation of persistent pollutant. In this 
process,·OH are produced through electrochemically assisted Fenton’s reaction in which 
the Fenton’s reagent (H2O2 + Fe2+) is electrochemical generated or regenerated [41]. Yahya 
et al. demonstrated that electro-Fenton process can be an efficient method for removal of 
pharmaceuticals through the study of degradation of ciprofloxacin [41].  
Electrochemical oxidation with specific anode materials which allows 
electrogenerated · OH from water discharge were studied in order to achieve 
mineralization without chemical doping. Electrochemical oxidation of 2-chlorophenol was 
carried out using the Ti/PbO2 and Ti/SnO2 anodes. The greater electrochemical treatment 
efficiency was obtained on Ti/SnO2 anode for its better ability to oxidize toxic compounds 
[42]. Currently, boron doped diamond (BDD) anode could be an efficient electrode for the 
mineralization of organic pollutants [43], because the use of BDD anode allows the 
production of electro-generated hydroxyl radicals which is a strong oxidant from water 
discharge. The BDD anode showed a better performance to degrade oxalic acid comparing 
to PbO2. BDD provided not only higher oxidation rate, higher current efficiency but also 
lower energy consumption than using the PbO2 electrode to reach mineralization [44]. The 
oxidation of cresol was studied using PbO2 and BDD [45]. BDD is proved more efficient 
for the removal of cresol and its intermediates than PbO2 at the same current density and 
electrolyte. Panizza et al. demonstrated that 2-naphthol and the intermediates can be 
oxidized using synthetic BDD thin film electrodes [46]. Weiss et al. [47] reported that a 
complete degradation of a phenol solution (20 mM) using a BDD anode obtained 99% 
removal of aromatics in 5 h under 47 mA cm-2. A completely degradation of the chlorpyrifos 
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pesticide solution can be observed after 6 h electro oxidation (20 mA cm-2) using BDD 
anode [48].  
BDD electrochemical oxidation is a process of choice for the mineralization of 
pharmaceuticals. However, because the action of hydroxyl radicals is located close to the 
anode, there are transfer limitations in dilute solution. Thus, the coupling of electrochemical 
oxidation with a pre-concentration step by filtration process renders it economically viable.  
 
I.1.3.3 Combining NF and electrochemical oxidation as tertiary treatment of MBR 
effluent  
From sections I.1.3.1 and I.1.3.2, it can be conclude that tertiary treatment of 
secondary effluent could be a solution for point source treatment. Considering the 
combination of membrane separation technique and electrochemical oxidation, 
concentrated pharmaceuticals in the NF or RO retentate can be mineralized by 
electrochemical oxidation using a BDD anode to prevent the spread of them and reduce the 
environmental risk of concentrate stream.  
Pérez et al. [49] investigated electrochemical oxidation of reverse osmosis 
concentrates using BDD anode. In this study the concentrates were generated from a 
UF (ultrafiltration) / RO pilot plant which treated the secondary effluent of a wastewater 
treatment plant. The authors presented the removals of COD, ammonium and ten emerging 
pollutants (including Caffeine, Naproxen and Gemfibrozil) from the RO concentrate using 
different applied current density, ranging from 2 to 20 mA cm-2. More than 90 % of the 
regular emerging pollutants were removed after 2 h of electrolysis. 
Urtiaga et al. [50] have studied a pilot system that integrated ultrafiltration (UF), reverse 
osmosis (RO), and electrochemical oxidation. The objective was to retain pharmaceuticals 
and other organic contaminants using UF-RO and mineralized the RO concentrate with 
BDD electrodes to avoid discharge of the compounds from municipal wastewater treatment 
plants. The coupling process shows great efficiency, not only the removal of the emerging 
contaminants but also their mineralization. UF pilot plant was applied to remove suspended 
solids and provide a disinfection barrier by retaining bacteria and viruses. Benefiting from 
the UF process, RO was subjected to a low pressure gradient (ΔP = 11 bar) and rejected 
more than 99% of all target compounds. The following EO treatment with boron-doped 
diamond electrodes removed more than 95% of most of the studied compounds from the 
 12 
Chapter I Background on the tertiary treatment of wastewater 
RO effluent. This study verifies the feasibility of the coupling of membrane separation and 
electrochemical oxidation for the complete removal of pharmaceuticals from wastewater 
after biological treatment.    
 
Considering the tertiary treatment of MBR effluent, which benefits of the separation 
and removal of the sludge and suspended solids due to integrated membrane process 
(microfiltration in most cases), an acceptable and stable flux (productivity) can be achieved 
using nanofiltration instead of RO. Moreover, it is evident that NF requires lower pressure 
and obtains higher permeate flux in comparison with RO for tertiary treatment of MBR 
effluent [36]. NF membrane can reject organics with molecular weight (MW) much lower 
than 200 Da and therefore it could remove pharmaceuticals and organic micro-pollutants 
by molecular exclusion, electrostatic repulsion or hydrophobic interaction between the 
membrane and the solute [51]. Also, the rejection of pharmaceuticals can be enhanced due 
to fouling mechanisms and presence of natural organic matters in wastewater [52–54]. NF 
which can satisfy simultaneously high removal of pharmaceuticals and high productivity 
(by comparison with RO) could be a great choice in the coupling process.      
I.2 Nanofiltration 
    In on-site applications, nanofiltration unit should operate in a cross-flow continuous 
mode. We propose in the following section to present this operating mode and to describe 
fouling mechanisms that are expected to impact productivity and selectivity over operation 
time.        
I.2.1 General Presentation of the process 
I.2.1.1 Cross-flow filtration  
Fig.I-1 illustrates the difference between the dead-end and cross-flow configurations 
during filtration. In the dead-end configuration, the feed flows normal to membrane while 
in cross-flow it flows parallel or “tangential” to the membrane [55]. NF and RO are 
normally operated in cross-flow mode as in this mode the cake formation and concentration 
polarization are limited and the steady state operation is possible. In contrast, cake 
continues to accumulate until the capacity of the filter is reached in dead-end filtration [55].  
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Fig.I-1 Dead-end and cross-flow modes of operation  
I.2.1.2 Continuous mode and batch filtration process 
A continuous membrane system is often operated as a feed-and-bleed mode. This 
operation mode is chosen for large-scale application. Fig.I-2 shows the single pass and 
feed-and-bleed continuous membrane filtration. In the feed-and-bleed mode, a portion of 
the retentate is recirculated, this requiring an additional pump. The presence of the 
recirculation loop increases the pressure of the fluid entering the module as well as the 
volumetric flow rate through the module.  
The batch system is schematized by a closed loop in which the retentate is returned to 
the feed tank and the permeate is removed continuously until the desired volume reduction 
factor is reached [56]. Batch mode used is generally well adapted for small-scale 
applications. Recirculation can also be used in batch system as shown in Fig.I-3.  
 
 
 
Fig.I-2 Process configurations for single pass and feed-and-bleed continuous membrane filtration [55] 
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Fig.I-3 Process configurations for batch membrane filtration process showing simple and recirculation 
options [55]. 
     
The limitation of the membrane process is the membrane fouling [51]. In constant flux 
mode, when the membrane gets fouled, the system pressure increases to maintain constant 
permeate and retentate flow. The system will continue operating until reaching a certain 
pressure and then, the system is stopped [57]. Membrane cleaning is necessary before the 
system restarts. In constant pressure mode, the flux could be maximized at high operating 
pressure, while rapid fouling of membrane resulting from the high flux would reduce 
severely the flux immediately. As a consequence, the fouling increases the cost due to the 
increase of energy demand, additional labor for maintenance and chemical costs for 
cleaning. It also induces the shorter lifetime of the membrane. The control of the flux is 
then important for the application of membrane process in an economically viable and 
sustainable way.  
I.2.2 Fouling mechanisms in nanofiltration 
Fouling is “the process resulting in loss of performance of a membrane due to the 
deposition of suspended or dissolved substances on its external surfaces, at its pore 
openings, or within its pores [58].” It can reduce the permeate flux in relation to both the 
productivity and selectivity of membrane process. The fouling declines the flux by 
increasing the osmotic pressure and reducing the membrane permeability by pore blocking, 
gel layer or cake formation. The selectivity of membrane could be also modified due to 
fouling [52,59,60]. Serious fouling types: concentration polarization, fouling by colloidal 
organics, and scaling, related to the nanofiltration process, are described as follow.   
I.2.2.1 Concentration polarization 
Concentration polarization (CP) is known as the process of accumulation of retained 
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solutes in the membrane boundary layer [61] due to the different membrane permeability 
for various compounds. It occurs when the solutes and particles in the feed are convected 
towards the membrane with the solvent in pressure-driven liquid-phase membrane 
processes, such as NF. The back diffusion of solutes from the membrane is assumed to be 
in equilibrium with the convective transport [51]. Concentration polarization is normally 
considered to form rapidly at the beginning of the filtration [62]. Although the 
concentration polarization is reversible, one attributes to this mechanism the more 
problematic fouling’s such as the adsorption and precipitation of solutes as well as the gel 
layer formation [63].  
I.2.2.1.1 Film Theory  
 
Based on the boundary layer mass balance, the permeate flux in presence of 
polarization concentration can be described by the Film Theory [64]. 
 
 
(Eq.I-1) 
 
where D (m2 s-1 ) andδ(m) are the solute diffusivity and the boundary layer thickness, 
respectively, k is the solute mass transfer coefficient in m s-1, Cm, Cb and Cp are the solute 
concentration at the membrane surface, bulk solute concentration and permeate solute 
concentration, respectively.  
I.2.2.1.2 Effect of concentration polarization on the membrane rejection 
 
The concentration polarization introduces complexity into the membrane retention. It 
should be noticed that the observed rejection (RObs) and the real rejection (R0) are 
conceptually distinct. The observed rejection can be measured in membrane application 
from permeate solute concentration (Cp) and bulk concentration (Cb) which is often 
approximated with either the feed concentration or the average of feed and retentate 
concentrations as Eq.I-2. 
 
(Eq.I-2) 
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membrane solute concentration (Cm) and permeate concentration as Eq.I-3. 
   
(Eq.I-3) 
 
R0 cannot be determined from Cp and Cm measurements, because the solute concentration 
on the membrane surface cannot be directly measured. 
    The observed rejection which is calculated by the bulk solute concentration 
underestimates the rejection of the membrane due to the difference between Cm and Cb. 
    The effect of polarization concentration can be traduced through the use of CP the 
concentration polarization degree which is defined by Eq.I-4 deduced from a combination 
of equations I-1, I-2 and I-3 [65,66] 
 
(Eq.I-4) 
 
Theoretically, the concentration polarization and, thus, CP increase with the flux. Higher is 
Cm, higher will be the solute diffusion from retentate to permeate compartments due to the 
difference between Cm and Cp. The observed rejection then decreases. 
In addition, some authors [67] describe the mechanism of “concentration polarization 
enhancement by cake layer”. They explain that cake (fouling layer) can hinder the back-
diffusion of solutes in the boundary layer and lead to enhancement of salt concentration 
polarization. This behavior also can lead to the decrease of the observed rejection of solute. 
I.2.2.2 Colloidal organics fouling 
Wastewater is usually rich in natural organic matters. The adsorption or deposition of 
them on the membrane surface decline flux irreversibly. The origin of organics fouling is 
complex. It can be related to the physicochemical characteristics of organic foulants, such 
as the charge and molecular conformation. The organics can also exhibit electrostatic 
interactions with membrane surface and ions in the matrix [68]. Organics fouling is 
normally related to a colloidal fouling due to the fact that organics in wastewater may be 
adsorbed onto colloids [69,70]. It was reported that foulants of greatest concern for 
nanofiltration are colloidal sized substances consisting of organics, silica, metal oxides, and 
microorganisms [51]. The organics fouling on the membrane not only induces the decline 
of the flux, but also modifies membrane characteristics by pore blocking [71], charge 
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interaction [71,72] and hydrophobic interaction [73].  
I.2.2.3 Inorganic fouling or scaling 
The membrane scaling is a serious problem in applications of NF process. It leads to 
physical damage of the membrane due to the difficulty of scaling removal and to 
irreversible membrane pore blocking [51,74]. The scaling (or inorganic fouling) results 
from the concentration of one or more species beyond their solubility limits and their 
precipitation onto the membrane surface [75]. The precipitation or crystallization of 
inorganics on a membrane surface involves the nucleation and crystal growth. Both of them 
relate to the supersaturation rate which is the thermodynamic driving force for precipitation. 
I.2.2.3.1 Driving force for inorganic precipitation- supersaturation ratio 
 
The definition of the supersaturation rate is explained as follow [51]. An ionic 
substance MnXm crystallizes according to the reaction: 
 
(Eq.I-5) 
 
The thermodynamic driving force for the precipitation either in the bulk or at the 
membrane surface is defined as the change of the Gibbs free energy of transfer from the 
supersaturated state to equilibrium:  
   
(Eq.I-6) 
                                           
 
where, Ksp is the thermodynamic solubility product of the phase forming compounds in 
mol2 L-2; IAP is the ion activity product. 
The supersaturation ratio in the bulk can be defined by:  
 
(Eq.I-7) 
  
Often in the literature S is written without the exponent. Activity coefficients can be 
estimated by the concentration of ions in dilute solution (or evaluated using various 
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equations applicable to low or high ionic strength). Thus, the supersaturation ratio can be 
simplified using following equation: 
 
 
(Eq.I-8) 
 
[Ma+] and [Xb-] are the ionic concentrations. For S > 1, ΔG < 0, the transition to solid 
is spontaneous. 
Indeed, precipitation of inorganics on membrane surface is actually related to the 
supersaturation ratio on membrane surface (Sm) which can be described by Eq.I-9: 
 
(Eq.I-9) 
     
             
 
where [Ma+]m and [Xb-]m are the ionic concentrations on the membrane surface. They are 
related to the bulk concentrations [Ma+]b and [Xb-]b, according to the concentration 
polarization degree CP as Eq.I-4. So, the supersaturation ratio of inorganic scalants on 
membrane surface Sm can be written as 
 
(Eq.I-10) 
 
CP is the concentration polarization degree which can be expressed by the flux and 
observed rejection as described in Eq.I-4. 
From a theoretical point of view, the supersaturation ratio higher than 1 (Sm >1) can 
be considered as the criterion for the crystal precipitation, but the precipitation of crystal is 
a complex process and relates to many factors such as the matrix, surface type and even the 
shape of droplet [76–78]. Thus, in real conditions, a critical supersaturation ratio (Scritical, 
most of case higher than 1) exist for the given salt [51]. When Sm exceeds Scritical (Sm > 
Scritical), the precipitation of salt occurs. Otherwise, the system stays in a steady state without 
precipitation of crystal.   
I. 2.2.3.2 Common scalants 
 
Most common constituents of scaling are CaSO4·H2O, CaCO3 and calcium phosphate 
in pressure-driving membrane processes [79–82]. The precipitation of inorganics relates to 
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their speciation and solubility in the matrix. 
 
Calcium sulfate  
The most common form of calcium sulfate that precipitates at room temperature is 
gypsum (CaSO4·H2O) [75]. The gypsum is relatively more soluble than calcium carbonate 
and calcium phosphate. The solubility of gypsum is 3.14 × 10−5 mol2 L−2 [83]. The effect 
of pH on gypsum solubility is marginal, while the effect of temperature is significant. The 
maximum solubility is observed around 25 °C [84]. 
 
Calcium carbonate 
Calcium carbonate is a most common alkaline scale formed [75]. Almost all naturally 
occurring waters contain bicarbonate and are rich in calcium. It is well known that the 
precipitation of calcium carbonate depends on water temperature and chemistry (e.g. pH, 
ionic strength) [51]. Nevertheless, for membrane processes operating at room temperature, 
water pH can be the most important factor. The breakdown of bicarbonate to carbonate 
occurs at alkaline pH. In these pH conditions, calcium carbonate precipitates owing to that 
its solubility (3.3 × 10−9 mol2 L−2 [85]) is much lower than the one of calcium bicarbonate. 
As shown in Fig. I-1, in the range of pH 6 to 8, the carbonate concentration is negligible in 
water, while for pH above 8, the concentration of carbonate species becomes significant.  
 
 
Fig. I-1Distribution of carbonate species in relation to solution pH [86]. 
 
Calcium phosphate 
Calcium phosphate scale has become more common in membrane processes due to 
the tendency to treat wastewaters which are rich in phosphates [87–90]. The solubility of 
the calcium phosphate highly depends on protonated species of phosphate. The solubility 
of common phases of calcium phosphate is shown in table I-1. It can be observed that the 
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phases of calcium hydrogen phosphate and calcium phosphate are the less soluble ones.  
 
Table I-1 Solubility of calcium phosphate at 25°C [91,92]   
 
The protonated species of phosphate relates to the pH of water. The fraction of phosphate 
at different pH is presented on Fig. I-2.  
 
 
Fig. I-2 Distribution diagram of phosphate species as a function of pH [93]. 
 
From the figure, it is clear that H2PO4- is the main specie for pH below 7 while HPO42- 
specie prevails for pH between 7 and 10. For pH higher than 12.5, the concentration of 
PO43- specie becomes significant. Consequently, the precipitation of calcium phosphate 
significantly relates to the water pH due to its solubility strongly dependent on the solution 
pH. 
 
In conclusion, various types of fouling can occur during NF process and the presence 
of them declines the permeate flux severely but also shortens the lifetime of membrane. 
Fouling is influenced by not only the feed water characteristics (such as types of foulants, 
Phase Formula Solubility 
-log (Ksp)
Monocalcium phosphate monohydrate Ca(H2PO4)2•H2O 1.14 
Monocalcium phosphate anhydrate Ca(H2PO4)2 1.14 
Dicalcium phosphate dihydrate CaHPO4•2H2O 6.59 
Dicalcium phosphate anhydrate CaHPO4 6.90 
Octacalcium phosphate Ca8(HPO4)2(PO4)4 • 5H2O 96.6 
Calcium-deficient Ca10-x(HPO4)x(PO4)6-x(OH)2-x ≈85.1 
Hydroxyapatite  Ca10(PO4)6(OH)2 116 
α-Tricalcium phosphate  α-Ca3(PO4)2 25.5 
β-Tricalcium phosphate β-Ca3(PO4)2 28.9 
Amorphous phosphate Cax(PO4)y• nH2O 28.9 
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pH and ionic composition), but also by the operating conditions (such as the flux, crossflow 
velocity, and temperature). For certain feed waters, the definition of the appropriate 
operating conditions to mitigate the effects of fouling is extremely important.   
I.2.3 Critical flux and Limiting flux  
 During NF operation, various types of fouling could occur depending on the feed 
water characteristics and operating conditions. In a certain feed, the permeate flux is a 
particularly interesting parameter to control fouling. Increasing flux enhances both the 
concentration polarization and the rate of foulants deposition due to the increase of 
hydrodynamic drag force on foulants towards the membrane surface [94]. Foulants 
interact in a complex way with the membrane surface due to various phenomenon: 
electrostatic repulsion, van der Waals attraction or hydrophobic/hydrophilic interactions 
with different interaction lengths [95]. Interactions between foulants and membrane surface 
can be summarized to be the force (flux) which drags foulants to the membrane surface and 
interactions between foulants and membrane which repulse them from the surface.   
Based on these, the critical flux (JC) concept was proposed in 1994 [96,97].  
Theoretically, the critical flux was defined as the flux above which an irreversible deposit 
appears at the membrane surface [95]. The critical flux is generally a balance between 
foulants–foulants or foulants–membrane repulsive forces and permeate flux drag forces. 
Above the critical flux, permeate drag forces overcome repulsive forces which induces the 
deposit of foulants on the membrane surface. At that time fouling occurs and the permeate 
flux declines. This can be described in filtration laws through an additional hydraulic 
resistance. 
As an extension of the critical flux concept, the flux exceeding the critical flux tends 
to a limiting value which is defined as limiting flux (JL) [98]. It is related to the concept 
that the higher the flux, the stronger the drag force towards the membrane (and hence 
deposition of foulants), thus, the concentration polarization will be stronger and the 
compaction of the deposit will be higher. At high flux, the drag force overcomes repulsive 
forces and the flux continues to decrease until the hydrodynamic drag force is lower or 
sufficiently close to the foulant-membrane and/or foulant deposited-foulant interaction 
forces [98].  
The critical and limiting flux has been studied for modeling and experimental analysis 
with latex particles by Bacchin et al. [99]. Then, Tang and Leckie [100] developed the 
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conception of critical and limiting flux by studying the flux behaviors for RO and NF 
membranes fouled by humic acid. They proposed that the critical flux is membrane 
dependent while the limiting flux is membrane independent. The limiting flux is considered 
to be achieved at steady state in a certain feed water composition.  
According to these authors [100], the critical flux JC can be considered as the 
triggering flux for the initial deposition of foulants, and its value shall be governed by the 
foulant-membrane interaction, Fbarrierf-m; when the limiting flux is reached, further foulants 
deposition is determined by the foulants-deposited foulants interaction, Fbarrierf-f. 
Based on relative magnitudes of Fbarrierf-m and Fbarrierf-f, three types of conceptual 
behaviors of liming and critical fluxes might be expected as described in Fig. I-3 [100].  
 
  
Fig. I-3 Conceptual flux behaviors when (a) the limiting flux is identical to the critical flux; (b) the limiting 
flux is greater than the theoretical flux; (c) the limiting flux is less than the critical flux [100]. 
 
(a) JC = JL, the pseudo stable flux versus initial flux plot completely corresponds to 
the magnitude of the limiting flux; when the initial flux J0 is lower than the limiting and /or 
critical flux, there is no flux reduction;  
(b) JC < JL when Fbarrierf-m is less repulsive than Fbarrierf-f , the foulants deposition and 
flux reduction start to occur once the critical flux is exceeded, as depicted by the transitional 
region between JC and JL;  
(c) JC > J L, this last behavior is a special case, no flux reduction will occur as long as 
the initial flux is below the critical flux, even if the limiting flux is exceeded. Such case is 
highly unstable. Soon after a small patch of foulants is deposited on the membrane surface, 
the interaction force is switched to foulants-deposited-foulants interaction locally, which 
enables the initial patch of foulants to serve as a “nuclei site” for further foulants deposition. 
     Series of NF and RO semi-aromatic and fully-aromatic polyamine membranes were 
tested [100] and belong to the type a and b. Type c has never been observed by these authors.   
The knowledge of the critical flux is particularly important in membrane processes to 
mitigate the effect of fouling and even to avoid it. An experimental procedure to determine 
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critical flux: “the square wave filtration method” has been developed by Espinasse et al. 
[95,101]. The principle of this technique will be introduced in chapter II. 
I.2.4 Factors affecting the rejection of pharmaceuticals during NF 
treatment  
 Several studies investigated the rejection capacities of nanofiltration membranes 
towards pharmaceuticals. The rejection of pharmaceuticals is greatly influenced by 
characteristics of compounds besides molecular structure, electrokinetic properties such as 
pKa, physicochemical properties (polarity and hydrophobicity) [51]. As a consequence, 
separation is considered to be accomplished via size exclusion, charge repulsion and 
hydrophobic interaction [51]. The mechanisms of pharmaceuticals rejection are then 
complex and not well understood. 
 
Size exclusion 
Sieving effect is mainly determined by the size of the solute relatively to the size of 
membranes pores: solutes larger than the pore size of the membrane are retained. However, 
in nanofiltration process, neither pores nor pharmaceuticals have a uniform size. Moreover, 
their size during filtration can be modified due to water matrix properties. Previous studies 
reported that pH, ionic strength of the matrix can impact the molecular weight cut-off 
(MWCO) of the membrane due to electrostatic interactions within membrane pores 
[72,102–105]. The relatively alkaline pH can promote the dissociation of functional groups; 
then increasing electrostatic repulsions in the pore enlarge their size [102–104]. Low ionic 
strength also leads to larger pore size [105]. On the other hand, pharmaceutical solutes are 
not easily represented by equivalent spheres. It seems that pharmaceuticals rejection 
correlates with different compound size parameters, such as the molecular weight, 
molecular volume, equivalent width or molecular length [52,53].  
 
Charge interactions  
Charge interactions can be related to pH directly. Some trace organics exhibit 
amphoteric properties, meaning that they can carry a negative or a positive charge 
depending on the pH. The pH value of the feed solution can also affect characteristics of 
the membrane [103]. Subsequently, electrostatic interactions between compounds and the 
membrane surface can vary according to characteristics of the solution and then affect 
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rejection. Some model studies about charge interactions are reported. Wang et al. have 
proposed a model to describe charge interactions named electrostatic and space-charge 
model by combining the space-charge and steric-hindrance pore physical phenomena [106].  
 
Hydrophobic interactions  
Organics can be adsorbed to the membrane surface due to high log P or hydrogen 
bonding capacity that contributes to the membrane rejection. Zhang et al. [107] showed 
high rejection (>90%) of BPA at the beginning of the filtration due to adsorption onto the 
membrane structure and a decrease of the observed rejection to around 50% when the 
adsorption sites on the membrane became saturated. The hydrophobic/hydrophilic 
attraction or repulsion also plays an important role in the pharmaceuticals rejection 
[73,108,109]. 
 
The effect of fouling 
In the application of NF process, the impact of matrix and fouling is significant on the 
pharmaceuticals rejection. Some studies focused on the influence of NF membrane fouling 
on the pharmaceuticals rejection [52,54,59,60]. The influence of fouling can be various. 
The difference in rejections of pharmaceuticals by clean and fouled membrane is based on 
the modification of membrane surface properties by fouling layer such as charge, 
hydrophobicity or adsorption capacity of pharmaceuticals. Yangali-Quintanilla et al. [52] 
investigated rejections of endocrine disruptors by clean and fouled nanofiltration 
membranes. Fouling with sodium alginate affected the selectivity of the NF-200 membrane 
by decreasing the rejection of hydrophilic neutral compounds as well as hydrophilic and 
hydrophobic ionic compounds. In contrast, rejections of hydrophobic neutral compounds 
by the fouled membrane increased by 5 to 38% depending on compounds. Verliefde et al. 
[59] evaluated the influence of different membrane fouling types on the rejection of 
pharmaceuticals. Various rejections of pharmaceuticals with different types of fouled 
membranes were attributed to the change of membrane surface hydrophobicity due to 
fouling but also to the modification of size exclusion and charge effect. Botton et al. [60] 
demonstrated the biomass attachment and growth on the membrane surface lead to a slight 
modification of surface charge and hydrophobicity comparing to the clean membrane. As 
a consequence, the presence of the negatively charged biofilm induced accumulation of 
positively charged pharmaceuticals within the biomass layer, which probably also hindered 
back diffusion. These effects caused a reduction in the rejection efficiency of positively 
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charged solutes while no variation was observed for neutral and negatively charged 
pharmaceuticals.  
In conclusion, the productivity/permeate flux and the selectivity/rejection of 
pharmaceuticals during NF operation in real matrix depend on numerous factors, the 
combined effect of which is not obvious to anticipate.  
Thus, in the present work, specific interest is focus on the improvement of productivity 
(to reduce or avoid the effect of fouling) and pharmaceuticals rejection in an MBR effluent 
matrix. 
I.3 Electrochemical oxidation 
Electrochemical oxidation is a physico-chemical technique convenient for the 
treatment of industrial effluents containing organics. Electrochemical techniques which 
allow reducing the quantity of organic pollutants in solution are: i) separation by 
electrofloculation, ii) oxidation by the electrogenerated Fenton's reagent, iii) direct 
oxidation on a suitable anode material. Electrochemical oxidation of organic compounds 
can be fully achieved under conditions for which transfer of oxygen atoms is efficient. It is 
generally assumed that hydroxyl radicals resulting from the water discharge are particularly 
active to carry out oxygen atoms transfer, as described in the reaction Eq.IV-11, below: 
 
(Eq.IV-11) 
   
    The strong activity of these radicals in aqueous solution results from the high value of 
their standard potential E0 = 2.74 V / SHE [110]. Organic molecules are degraded into 
smaller molecules by a succession of oxygen atom transfers until complete destruction of 
the carbon skeleton. A crucial point to operate mineralization is the choice of the anodic 
material; this one should have a high oxygen overvoltage to allow the production of ·OH 
radicals by water discharge while preventing oxygen evolution. Some metal oxides such as 
SnO2, PbO2, WO3 have electrocatalytic properties required for this application but since 
about twenty years the boron doped diamond (BDD) has been successfully used on the 
laboratory scale in reason of its electrochemical properties. 
2H O OH H e
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I.3.1 BDD anode  
    The first extensive study of the use of diamond electrodes in electrochemistry was 
performed by Pleskov et al. in 1987 [111]. Since then, synthetic BDD thin films have been 
applied in a number of applications due to their outstanding properties, which are 
remarkably different from those of other conventional electrodes, e.g., glassy carbon or 
platinum. In the 90’s, Fujishima and his group began to study the photo-electrochemical 
properties of boron doped diamond electrodes [112]. In 1993, Tenne et al  [110] studied 
the removal of nitrates with BDD electrode. After that the number of publications on BDD 
electrode increases exponentially from 1994 [43]. Indeed, BDD exhibits properties that 
distinguish it from conventional electrodes. Compared to graphite or glassy carbon 
electrodes, diamond electrodes have a good resistance towards corrosive conditions and 
resistance to fouling (deactivation). Furthermore, diamond thin films exhibit a very large 
potential window with respect to hydrogen / oxygen evolution, extending to almost 4 V, 
and a low background current. Compared to Pt electrodes, the potential window of BDD is 
about 2 V larger. High anodic stability of BDD in acid medium and high overpotential for 
oxygen evolution allow producing powerful oxidants of high redox potential.  
Boron-doped diamond films, Diachem ®, used in this study were synthesized by the 
hot filament chemical vapor deposition technique (HF CVD) on conducting p-Si substrate 
(0.1 cm, Siltronix). The filament temperature ranged from 2440 to 2560°C and the 
substrate was kept at 830°C. The reactive gas used was methane in an excess of dihydrogen 
(1% CH4 in H2). The doping gas was trimethylboron at a concentration of 3 ppm. The gas 
mixture was supplied to the reaction chamber, providing a 0.24 m h-1 growth rate for the 
diamond layer. Diamond films were about 1 m thick. This HF CVD process produces 
columnar, randomly textured, polycrystalline films. 
 
I.3.2 Hydroxyl radicals  
    It is commonly assumed that electrogenerated hydroxyl radicals, the most powerful 
oxidants in water, are very active in the degradation of organic molecules. In the particular 
case of BDD, because of the weak interaction between its surface and hydroxyl 
radicals, ·OH can be considered as quasi free [113]. Briefly, the main reaction pathways 
of ·OH in the reaction with organic compounds occurs in C-C, C-N and C-S double bonds 
and H-abstraction [114]. Since most organic compounds reveal structural moieties which 
allow addition and H-abstraction, ·OH react fast with a large variety of compounds (i.e., 
kinetic constant > 109 M-1 s-1) [115].  
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Although kinetics of most·OH addition reactions are close to diffusion controlled 
[116], different kinetics were observed in the mixture solution containing two compounds 
which have different reactivity with·OH [117]. Groenen Serrano et al. [117] observed and 
modelized the phenomenon in the case of a solution containing maleic acid and formic acid, 
and showed that the formic acid oxidation only began when the maleic acid had completely 
disappeared. 
   Kapałka et al [118] investigated an oxidation mechanism between organics and 
electrogenerated hydroxyl radicals for the mineralization of acetic acid. It was reported that 
the reaction allows the formation of organic radicals via dehydrogenation reactions, and 
then the addition of molecular oxygen to an organic free radical results in the formation of 
an organic peroxy radical [119]. Peroxy radicals are very reactive and can initiate 
subsequent chain reactions which can lead and involve the degradation of other organics in 
the solution, via several possible intermediates, to completely mineralization. The proposed 
procedure is shown on Fig.I-4 [118]. 
 
Fig.I-4 Simplified diagram for electrochemically induced oxidation of organic compounds via molecular 
oxygen dissolved in aerated solution on boron-doped diamond electrode; (1) water discharge to hydroxyl 
radical ·OH; (2) dehydrogenation of organic compound RH via ·OH and formation of free organic radical 
R·; (3) addition of molecular oxygen to R resulting in the formation of an organic peroxy radical RO2·; 
(4) dehydrogenation of RH via RO2·resulting in the formation of hydroperoxide ROOH and regeneration 
of R·; (5) decomposition of RO2· leading to the regeneration of ·OH and formation of RO; (6) 
decomposition of RO2·to R·; (7) oxygen evolution, a side reaction [118]. 
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Moreover, in the presence of salts, the·OH can react with these inorganic compounds 
(Cl-, SO42-, CO32-) to electrogenerate strong oxidants such as peroxo, oxo compounds, 
ozone, and chlorine species [120,121]. The electrogeneration of strong oxidants including 
the inorganic oxidants has been summarized by Groenen Serrano [122]. The presence of 
these strong oxidants can influence the organic removal.  
 
I.3.3 Theoretical model for oxidation of organic compounds on BDD  
Thanks to the properties of BDD, the radicals OH , which are free at the surface, react 
very fast with organics. The general pathway can be written as follow:  
the global rate of oxygen transfer depends on (i) the mass transfer rate to the electrode 
surface and (ii) intermediate compounds which are generated and their reactivity with 
hydroxyl radicals. 
For electrochemical processes two different kinetic regimes can be defined depending on 
the value of the current density for a given reactant concentration. 
 
(i) If the applied current density is lower than the corresponding limiting current 
density: the electrolysis is under charge transfer control, the current efficiency 
is then 100%.  
(ii) If the applied current density is higher than its limiting value, the electrolysis is 
under mass transport control; secondary reactions (such as oxygen evolution) 
occur. 
During electrolyses, concentrations of organics or intermediate species are unknown, 
so based on properties of BDD anode, a limiting current density can be defined by using a 
global parameter, the Chemical Oxygen Demand (COD) [123].  
 
(Eq.I-12) 
 
Where ilim is the limiting current density for organics mineralization (A m-2), F is the 
Faraday constant (C mol-1) and COD is in molO2 m-3. 
 
lim 4 di Fk COD
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The oxidation of organics can be considered to be carried out on the system presented 
in Figure I-5. 
 
Fig.I-5 The diagram of recirculation electrochemical reactor system, C(t) is the concentration into the reactor 
and C2(t) is the concentration out of the reactor, both of them in mol s-1 
 
    The model which gives the COD variation during galvanostatic electrolysis is based 
on the following assumptions:  
- volume of solution is constant during the electrolysis, 
- reservoir volume (1L) is much greater than that of the electrochemical reactor (63 mL), 
- flow is large enough to ensure that the concentration is the same in all the volume of the 
tank, 
- adsorption of organics at the electrode surface is negligible.  
 
 The mass balance in the reactor can be written as Eq.I-13 
 
(Eq.I-13) 
 
where, r is the specific electrochemical reaction rate in mol m-2 s-1, Φis the flow rate in m3 
s-1. This reaction rate is simply associated to the applied current density and the current 
efficiency is 100%, but not all of the current is necessarily used to oxidize the organic 
compound. This rate depends on the kinetic regime; its expression will be developed further. 
    On the tank side, the mass balance can be written as: 
  
 (Eq.I-14) 
 
where, V is the volume of the solution in m3. 
 
 
    2rA C t C t  Φ
      2dC tV C t C tdt  Φ
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Combining Eq.I-13 and Eq.I-14,  
 
(Eq.I-15) 
 
Then, Eq.I-15 can be expressed as a function of COD values to obtain Eq.I-16 
 
(Eq.I-16) 
 
where, rCOD is the reaction rate of COD. 
The applied current density can be higher or lower than the limiting current and the 
oxidation of organics is in different kinetic regimes: charge or mass transfer controlled.  
α is defined as the ratio of applied current density and the initial liming current density. 
Under galvanostatic conditions, α is constant  
 
(Eq.I-17) 
 
 i < ilim  
The oxidation is charge controlled and all the current is used to oxidize organics. The 
reaction rate of COD can be written as: 
 
(Eq.I-18) 
 
Combining Eq.I-16 and Eq.I-18, the equation I-19 can be obtained: 
 
(Eq.I-19) 
 
 
Integrating this equation subject to the initial condition COD = COD0 and t = 0 gives the 
evolution of COD with time in the operating regime i < ilim. 
 
(Eq.I-20) 
 
 dC tV rA
dt
 
      2 CODdC tV COD t COD t r Adt    Φ
4COD
ir
F

 
4
dCOD t iV A
dt F
 
  0 1 tCOD t COD  
    
0
lim
i
i
 
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This behavior persists until a critical time (tcr). At this time the applied current density 
is equal to the liming current density, which corresponds to: 
 
(Eq.I-21) 
Then the critical time can be obtained as Eq.I-22. 
 
(Eq.I-22) 
 i > ilim 
The oxidation is controlled by mass transfer to the electrode surface; the oxidation rate 
of COD is not related to the current. 
(Eq.I-23) 
 
Integrating this equation subject to the initial condition COD = COD0 and t = 0 gives the 
evolution of COD with time in the operating regime i > ilim. 
 
(Eq.I-24) 
 
I.3.4 Long-term sustainability of electrochemical oxidation treatment  
Considering the application of EO process for wastewater treatment, the long-term 
sustainability should be taken into account.  
The minimization of toxic intermediates from the degradation of pharmaceuticals 
should be considered to select appropriate operating conditions. A typical example showed 
that phenol oxidation under appropriate conditions of current intensity can control the 
formation of aromatic intermediates and reach mineralization efficiently [124]. 
In the wastewater, more attentions should be taken for the effects of the presence of 
organic matters and inorganic ions on the pharmaceuticals degradation and formation of 
by-products. The production of organohalogens were reported during the electrochemical 
oxidation of reverse osmosis concentrate from the study by Perez et al [49]. The 
concentration of organhalogens seems to increase with the electrooxidation time [125] and 
electric charge [126]. Moreover the formation of undesired perchlorate (ClO4-) during 
electrochemical oxidation also has been linked to health risks [127,128].  
0
crCOD COD
1
cr
d
Vt
Ak


    
 
d
dCOD t
V k A
dt
 
  0 exp dAk tCOD t COD
V
    
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The energy consumption has to be considered in parallel; the complete mineralization 
is not necessary for an economically viable tertiary treatment. 
I.4 Main problem need to be addressed during the research 
Considering that, in a membrane filtration process, the permeate flux is of particular 
interest to control fouling, thus, critical and limiting fluxes have been studied by numerous 
authors for conceptual and experimental analysis in synthetic solutions [95,100]. The key 
interest is to implement developed procedures, “the square wave filtration method” in the 
case of the filtration of a real wastewater and obtain information’s in this complex matrix 
considering the maximum process productivity and selectivity we can expect. This 
objective can be reached through prediction and possible control of fouling from the flux 
behaviors as a function of the water matrix properties such as pH, organic and salt 
concentrations. This question will be addressed in sections III-A and III-B. 
The rejection of pharmaceuticals directly influences the quality of treated water. 
Pharmaceuticals rejections by NF membrane can be influenced by molecular exclusion, 
electrostatic repulsion or hydrophobic interaction between the membrane and solutes [51]. 
The combination of these mechanisms is complex and not well understood mainly due to 
the specific properties of pharmaceutical molecules. On the other hand, several studies 
focus on the impact of membrane fouling on the pharmaceuticals rejection [52,54,59,60] 
with membranes fouled by certain matrix such as lake water, which can lead to the question 
whether the fouling composition and water matrix can affect the pharmaceutical rejection. 
This part will be discussed in section III-C. 
Electrochemical oxidation using BDD anode exhibits excellent performance for 
elimination of micro pollutants [43,46,47], even in wastewater matrix [49,50]. However, 
the risk of formation of toxic by-products is exposed and becomes a critical factor to apply 
electrochemical process. The challenge of electrochemical oxidation application is to 
consider both economic and environmental perspectives. To solve these questions, the 
strategy proposed is to study first the process using a synthetic solution to simplify the 
number of parameters and identify how operating conditions impact the mineralization 
efficiency. In a second step, it will be possible to study the influence of common organics, 
salts and other pharmaceuticals in a complex matrix on the degradation of specific 
pharmaceuticals; and go further in the identification of mechanisms and impacting factors 
on the formation of by-product, especially formation of organochlorine from chlorine ions. 
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These studies will be helpful to select appropriate operating conditions to improve the 
process efficiency and control the formation of toxic by-products, simultaneously. 
 Theoretical model allows an excellent prediction of COD decay in synthetic solution 
[123] and wastewater matrix [129]. Considering the target of the study to propose an 
economically viable process for wastewater treatment, more focus should be taken on the 
degradation of pharmaceuticals with electrooxidation time. Due to the properties of BDD 
which allows the electrogeneration of oxygen species, electroactive pharmaceuticals can 
be oxidized both by direct electron exchange and via·OH oxidation. The theoretical model 
for oxidation of organics by electron exchange could be limited to predict the variation of 
pharmaceuticals concentration in the electrooxidation process using BDD. Existing model 
will be then changed in this direction in chapter IV.  
Regarding to previous studies, the evaluation of the efficiency of a treatment process 
mainly focused on the concentration of pharmaceuticals in effluent and influent, while a 
study which determines the removal of pharmaceuticals and related toxicity could be more 
appropriate to address the process efficiency in term of removal with environmental 
perspective.  
Moreover, nanofiltration and electrochemical oxidation are usually studied as two 
processes, even if they are applied in coupling. How to select appropriate operating 
conditions in each process to obtain the mutual promotion in the coupling process could be 
an interesting question and is addressed in chapter V. 
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II.1 Solutions 
Two kinds of experimental solutions were used in the Nanofiltration (NF) and 
Electrochemical Oxidation (EO) processes. One was the hospital wastewater after 
membrane bioreactor treatment (MBR effluent). The other was synthetic solution which 
was prepared by doping pharmaceuticals in the ultrapure water.  
II.1.1 Water matrix  
MBR effluents of this study are supplied from PANACEE ANR project conducted in 
LGC. Characteristics of ultrapure water and MBR effluent from hospital are shown on 
table II-1. 
 
Table II-1 Characteristics of ultrapure water and MBR effluent from hospital 
Item MBR effluent Ultrapure water 
pH 6.0-8.0 5.6-6.1 
COD mg L-1 24.0-73.0 - 
TOC mg L-1 10.0-23.0 0.3 
HCO3-/CO32- 2.0-60.0 0.3 
UV254  0.46-0.84 - 
Na+ mg L-1 35.0-135.0 1.5-2.5 
K+ mg L-1 15.0-25.0 - 
Mg2+ mg L-1 3.0-5.0 0.3 
Ca2+ mg L-1 30.0-60.0 1.6 
Cl- mg L-1 37.0-65.0 0.9 
NO3- mg L-1 10.0-200.0 - 
SO42- mg L-1 20.0-50.0 - 
PO43- * mg L-1 5.0-20.0 0.2 
*Due to analysis method, all the H3PO4, H2PO4-1, HPO42- and PO43- in the solution were measured as PO43- 
form. 
 
The range of some of parameters is quite important (HCO3-/CO32-, Na+, NO3-) due to 
high variability of water usage in the hospital during day time and the difference in the time 
of sampling. Also, specific additions of NaHCO3 were done in the membrane bioreactor 
regularly to ensure good performances of the biomass, especially nitrification efficiency 
which explain the high variation of NO3-.  
Around 50 pharmaceuticals from 10 different therapeutic classes have been detected in 
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this MBR effluent from hospital [1]. Because of high concentrations in hospital wastewater 
and low to medium removal in the MBR, concentrations ranged from 10 ng L-1 to 90 µg L-1 
in MBR effluent. Ciprofloxacin (CIP), ifosfamide (IFO) and cyclophosphamide (CYP) 
were selected to be analyzed in the MBR effluent for this study. They are always present in 
the MBR effluent from hospital at concentrations due to their poor biodegradability [2–4]. 
In addition, these pharmaceuticals (Table II-2) represent different physicochemical 
properties (molecular weight, hydrophobicity, polarity, and charge) that have been reported 
to influence membrane rejection [5].  
 
Table II-2   Selected pharmaceuticals in MBR effluent and their physicochemical properties 
 Ciprofloxacin Ifosfamide Cyclophosphamide 
Formula C17H18FN3O3 C7H15Cl2N2O2P C7H15Cl2N2O2P 
Molecular weight 
(g mol-1) 
331.3 261.1 261.1 
log P (ALOGPS) 0.28 0.57  0.7  
pKaa 3.7, 6, 10.3 0.12, 13.24  -0.57, 12.78 
Charge at neutral pH Positively charge neutral neutral 
Chemical structure b 
  
pKa: Acid dissociation constant. 
log P: Octanol – water partition coefficient 
a http://www.drugbank.ca; b https://commons.wikimedia.org 
II.1.2 Chemicals 
The electrochemical oxidation was first carried out with synthetic solution. The 
model molecules were three pharmaceuticals (ciprofloxacin, salbutamol and 
sulfamethoxazole) and one common organics (urea). The ciprofloxacin (CIP) (≥ 98 % 
purity) was purchased from Fluka Company. USA). The salbutamol (SALBU) 
(Salbutamol·sulfate ≥ 99 % purity) and sulfamethoxazole (SMX) (≥ 98 % purity) were 
obtained from Alfa Aesar and Fluka , respectively. Urea was laboratory reagent grade from 
Fisher chemical. All synthetic solutions were prepared with ultrapure water. The structures 
of these molecules were reported in Table II-3. Potassium sulfate (≥ 99 % purity) as 
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supporting electrolyte for electrochemical oxidation in synthetic solution was analytical 
grade and supplied by Fisher Science. Other chemicals, organics or solvents were HPLC or 
analytical grade. 
Table II-3 Structure of pharmaceuticals for synthetic solution 
 
* http://pubchem.ncbi.nlm.nih.gov 
log P: Octanol – water partition coefficient 
 Ciprofloxacin 
(CIP) 
Salbutamol 
(SALBU) 
Sulfamethoxazole 
(SMX) 
Urea 
Formula C17H18FN3O3 C13H21NO3 C10H11N3O3S CH4N2O 
Molecular 
weight 
(g mol-1) 
331.3 239.3 253.3 60.06 
Log P 
(ALOGPS) 
0.28 0.44 0.79 -1.8 
Structureb 
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II.2 Nanofiltration equipment and membrane 
II.2.1 Nanofiltration set-up and filtration procedure 
Nanofiltration experiments were conducted in a cross-flow filtration unit (Fig.II-1). 
The volume of feed tank (1) was 10 L; the membrane was installed into a stainless 
cross-flow cell (Sepa CF II, Osmonics) (3) in which the effective membrane area was 
1.4×10-2  m2. Permeate can be collected in a vessel and weighted on a balance (5) 
connected to a computer for automatic acquisition. There are two modes of filtration 
applied in this study: (i) the concentration mode for which the recirculation of retentate 
stream back to the feed vessel is done while the permeate is collected in the permeate vessel, 
(ii) the constant feed concentration mode for which both retentate and permeate streams are 
recycled back to the feed tank in order to maintain a constant feed concentration. 
 
Fig. II-1 Nanofiltration set-up, (1)  feed tank, (2)  high pressure pump, (3) cross-flow filtrate cell, (4) 
pressure monitor, (5) permeate tank and balance 
II.2.1.1 Flux and rejection measurement under the concentration mode   
Filtrations of MBR effluent were firstly carried out in a concentration mode to reach 
volume reduction factor of 5 (VRF = 5). According to preliminary studies performed with 
the same equipment and same membrane NE 70 for the filtration of MBR effluent, VRF = 5 
was found to be the best compromise between keeping favorable NF productivity and 
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reaching high pollutants concentration for electro chemical oxidation step (mitigate the 
transfer limitation). The initial volume of feed were 7 L. Filtrations were performed at 
cross-flow velocities of 0.2 or 0.35 m s-1. The samples were collected from the feed tank 
(retentate) and permeate stream, when the volume reduction factor reached 1,2,3,4 and 5 
respectively. Concentrations of salts and pharmaceuticals were measured in both retentate 
and permeate. The rejection of salts and pharmaceuticals by the NF unit was determined at 
each volume reduction step using Eq. II-1:    
 
(Eq. II-1) 
 
Where Cp and Cf are the concentrations in the permeate and the feed tank, respectively. 
During the filtration, the permeate streams were weighed to determine the permeate 
flux. Moreover, temperature and pH of retentate and permeate were measured over time. 
 
II.2.1.2 Flux and rejection measurement at constant feed concentration 
Constant feed filtrations were conducted with MBR effluent once a volume 
reduction factor of 5 was reached to determine the sustainable flux and productivity of the 
nanofiltration process. Both feed and permeate streams were recycled into the feed tank. 
In order to determine the flux, the permeate was weighed every 30 min and all the 
permeate was poured back into the feed tank after measurement. When the permeate flux 
stabilized (variation of flux less than 1% of initial flux), the recirculation for a certain 
pressure was terminated. Permeate and retentate samples were collected and the rejection 
of salts and pharmaceuticals were calculated by Eq. II-1. The temperature and pH are also 
measured during filtration. The final retentate was stored in the fridge for electrochemical 
oxidation. 
II.2.1.3 Rejection of ciprofloxacin in ultrapure water 
 
The rejection of CIP as a function of the permeate flux in ultrapure water was 
evaluated in order to be compared to the rejection of CIP in the MBR effluent and then 
identify the impacts MBR effluent on the pharmaceuticals rejection. The ultrapure water 
was spiked with CIP as a feed solution. The concentration of CIP was in the same range 
as in the MBR effluent (0.07 to 0.09 mg L -1). In order to avoid the impact of adsorption 
f p
f
C C 100%CR
 
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of CIP on the system and overestimate the rejection, the feed solution was recycled without 
pressure in the NF system for 8 hours prior to the filtration experiment itself. Then the 
feed solution was stored into the system for 16 hours with cooling at 4°C to reach 
equilibrium [6]. The filtration was then conducted at a transmembrane pressure ranging 
from 3 to 35 bar in order to apply different permeate fluxes. At a certain pressure, the 
permeate and retentate were first recycled into the feed tank until flux stabilization. Then 
the samples of retentate and permeate were collected and the rejection was computed 
according to the Equation II-1. 
 
II.2.2 Membrane characterization 
II.2.2.1 Membrane characteristics 
All the nanofiltration experiments were performed using a NE 70 membrane 
(provided by Woongjin Chemical). Its characteristics are presented in Table II-4. 
Table II-4 Characteristics of membrane NE 70* 
Material MWCO 
(Da) 
Max. 
temperature (°C)
Max. 
pressure (bar)
pH 
range
Surface 
Charge 
Rejection (%) 
Thin film 
composite 
polyamide 
250 45 41.4 3-10 Negative 40-70 (NaCl) 
99.5 (MgSO4)
*Provided by manufacturer: Woongjin Chemical Co., Ltd., considering specific conditions: 2000 mg/l 
MgSO4, 25°C, recovery 15%, pressure 0.5 MPa, pH 6.5-7.0; 1500 mg/l NaCl, 25°C, recovery 15%, pressure 
1 MPa, pH 6.5-7.0  
 
The NE70 is a thin film composite polyamide membrane which is constituted of 
polysulfone as a sub-layer and polyamide as active layers. Manufacturer doesn’t provide 
any information about the coating layer. Tang et al. [7,8] indicated that polyvinyl alcohol 
was coated partially above the active polyamide layer of the NE70 membrane which was 
provided by Saehan Industries Inc© (South Korea). However, these authors did not 
mention the thickness and morphology of the coating layer. The possible structure of this 
kind of thin film composite membrane is shown on Fig II-2 (a) and the cross-section 
micrograph of NE 70 which was obtained from SEM in this study is presented 
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in Fig II-2 (b). 
 
Fig.II-2 Structure of a thin film composite polyamide membrane (a) Schematic diagram* (b) SME picture of 
NE70 
*http://www.ogj.com/articles/print/volume-94/issue-48/in-this-issue/production/membranes-solve-north-sea
-waterflood-sulfate-problems.html 
II.2.2.2 Membrane preservation and preparation  
Membranes were stored in a preservative solution at 4 °C (NaHSO3 0.1 g L-1). They 
were rinsed and cleaned with ultrapure water before filtrations and then installed in the 
cross-flow cell. The membrane compaction was performed by filtration of ultrapure water 
at a transmembrane pressure (TMP) equal to 40 bar until a constant flow rate was obtained 
(around 3 h).  
II.2.2.3 Pure water permeability 
The pure water permeability was measured after compaction by circulating ultrapure 
water in order to check if the membrane sample was in good condition.  
The water flux was measured at applied pressure such as 4, 10, 20, 30 and 40 bar at a 
cross-flow velocity of 0.35 m s-1. Collected permeate samples were weighed in order to 
(a)* 
(b)
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determine the permeation flux. The mean permeability (Lp) was then calculated from the 
slope of the plot of flux versus pressure as Eq.II-2.  
 
(Eq.II-2) 
 
where Lp is the permeability in L h-1 m-2 bar-1, J and ΔP are the permeate flux in L h-1 
m-2 and transmembrane pressure, respectively. 
Table II-5 shows the initial pure water permeability of each membrane used in this 
study. The pure water permeability varies from 12.9 to 17.4 L h-1 m-2 bar-1 and has average 
value as 15.6 L h-1 m-2 bar-1. In addition, the R² values obtained from the linear plots of the 
flux versus pressure were higher than 0.9889 and the average value was 0.9963. It can be 
stated that all membranes used for filtration experiments during this study were in good 
condition with a good reproducibility of their initial performances. 
 
Table II-5 Initial pure water permeability of NF 70 in this study (20°C and 3 to 40 bar) 
  Pure water permeability (L h-1 m-2 bar-1) R-square 
1 15.3 0.9964 
2 17.4 0.9909 
3 13.9 0.9929 
4 15.7 0.9971 
5 17.2 0.9906 
6 17.4 0.9889 
7 14.6 0.9911 
8 15.9 0.9962 
9 17.5 0.9951 
10 17.2 0.994 
11 15.6 0.9967 
12 14.3 0.9976 
13 13.0 0.9992 
14 12.9 0.9963 
Average 15.6±1.6 0.9945 
 
In addition, the membrane resistance can be computed by the initial pure water 
permeability (Lp0) with Eq. II-3. 
 
  (Eq. II-3) 
where, Rm (m-1) is the intrinsic hydraulic membrane resistance and μp is viscosity of 
permeate (Pa·s).  
0
1
p
p m
L
R
p
JL
P
 
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After filtrations, the NF system was rinsed 3 times by reverse osmosis water and once 
by ultrapure water. Then the pure water permeability after filtration (Lpf) was measured in 
order to determine the difference before and after. The irreversible fouling resistance after 
rinsing (Rir) can be calculated using Eq. II-3 and Eq. II-4. 
 
(Eq. II-4) 
  
where, Rm and Rir are the intrinsic hydraulic membrane resistance and the irreversible 
fouling resistance after rinsing, respectively. 
 
II.2.3 Square wave filtration method to determine the critical flux  
The square wave filtration technique developed by Espinasse et al. [9,10] can be 
applied to determine the critical flux and distinguish the reversible fouling due to osmotic 
pressure (Rrf) and irreversible fouling (Rif). The principle of it is to alternate stepwise the 
applied force (the pressure) with positive and negative variations, as presented in Fig. II-3, 
and to continuously measure the permeate flux.  
 
Fig.II-3 Principle of the square wave technique; pressure and flux vs time; upper and lower steps [9,10]  
 
U steps correspond to upper steps and L steps to lower steps. At each step, a pseudo 
steady state flux is reached. The stabilization of the system (i.e., steady state) takes from a 
few minutes to several hours depending on the system evolution.  By comparing the flux 
between steps Ln and Un−1 which have the same pressure, the decrease of flux is associated 
to the fouling phenomenon that took place at step Un. If the flux is the same at steps Un−1 
and Ln, the fouling is considered as totally reversible, the flux is below the critical value; if 
not, the fouling is partly irreversible, the flux is above the critical value. 
1
( )pf p m ir
L
R R 
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Fig.II-4 shows the fouling resistance against the pseudo stable flux, which can 
indicate the reversible fouling and irreversible fouling according to the filtration procedure 
developed by Espinasse et al. [9,10]. At the beginning of filtration the fouling resistance 
increases with increasing pressure, while a decrease of pressure allows it to go back to the 
preceding resistance value; in this case, the increase in resistance is reversible. Otherwise, 
an increase of resistance can be observed between steps n-1 and n, such that resistance 
remains constant when the pressure decreases at Ln (the increase of resistance is 
consequently irreversible).  
The significance of this pattern is the appearance of an irreversible deposit on the 
membrane surface. If the resistance at Ln is the same value as resistance at step Un, the 
resistance is totally irreversible. 
 
Fig.II-4 Evolution of the total fouling resistance vs flux obtained with the “square wave technique”: 
indication for reversible and irreversible components [9,10] 
 
The flux can be described by osmotic pressure model, as follow: 
 
(Eq. II-5) 
 
where J is the permeate flux, ΔP is the transmembrane pressure, Δπ is the osmotic pressure, 
µp is viscosity of permeate and Rm, Rif is the intrinsic hydraulic membrane resistance and 
resistance due to the irreversible fouling, respectively.  
The osmotic pressure can also be incorporated into the reversible fouling resistance. In 
this case, the reversible resistance associated with the polarization concentration layer can 
be treated like a term of osmotic pressure: 
 
(Eq. II-6)                   
(R )p m if
PJ
R


   
(R ) (R )p m if rf p m f
P PJ
R R R 
    
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where Rf is the total fouling resistance and Rrf is the resistance due to the reversible fouling 
which is related to the polarization concentration. 
According to the square wave filtration method, the fouling reversibility can be 
determined by comparing the fouling resistance at a same TMP before and after an upper 
pressure step. The irreversible resistance that appears for an upper pressure step Un can be 
reached by comparing the fouling resistance at step Ln and Un-1 as follow: 
 
(Eq. II-7) 
                                                                                      
where rif, n is the irreversible fouling resistance relative to the step. When Rf at step Ln 
equals Rf at step Un-1 the resistance observed at Un step is totally reversible. To calculate the 
value of the total Rif, at a given pressure step, all step resistances rif are summed. The 
fouling resistance at n is the sum of the resistance measured at the previous steps: 
                                                                                                         
(Eq. II-8) 
 
The relationship between the intrinsic hydraulic membrane resistance and fouling 
resistances is shown on Fig.II-5. 
 
Fig.II-5 The relationship of the intrinsic hydraulic membrane resistance and fouling resistances 
In the figure,  
Rm is the intrinsic hydraulic membrane resistance (m-1); 
Rf is the total fouling resistance (including Rrf , Rif) (m-1); 
Rrf is the resistance due to reversible fouling which is relative to the polarization 
concentration (m-1); 
Pressure
Decline Rinsing
Rir
Rif
Rrf
Rm
Rf
Time 
R (m-1)
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n
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Rif is resistance due to irreversible fouling (m-1) (unable to be removed by declining the 
pressure); 
Rir is the residual irreversible fouling resistance after rinsing (unable to be removed by 
declining pressure and rinsing) (m-1); 
II.2.4 Accumulation of salts and organic matters during nanofiltration 
process 
The accumulation of organics and salts on the membrane surface and in the structure 
was calculated by the mass balance between initial mass (total mass on the feed) and the 
mass after NF (the sum of mass on the permeate and the retentate). The concentration of 
salts was measured by ionic chromatography. The adsorption of organic matters was 
characterized by UV254 absorbance (see II.4.5). 
The accumulation of salts and organics on membrane are calculated for the two 
filtration modes: concentration mode and constant feed concentration mode. 
In the concentration mode, the permeate was collected while the retentate was 
recycled into the feed tank. The accumulated mass was computed by quantification of the 
concentration in the feed, concentration in the retentate and concentration in the mixed 
permeate (total permeate collected from the beginning to the end of the concentration step) 
as Eq. II-9. 
 
(Eq. II-9) 
 
where, Qads is the accumulated mass; Cf, CR and Cpmix are concentrations in the feed, 
retentate and mixed permeate in g L-1, respectively, and Vf, VR and Vp are corresponding 
volumes. 
At constant feed concentration, both permeate and retentate were recycled into the 
feed tank. The sample of collected permeate was less than 4% of the total volume in the 
tank. The accumulated mass was calculated by the concentration in the tank before and 
after circulation using Eq. II-10 
 
(Eq. II-10) 
where Cbe and Cend are concentrations before and after recirculation and V is the volume 
in the retentate loop and is assumed to be constant. 
ads be endQ C V C V  
mixads f f R R p p
Q C V C V C V    
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II.3 Electrochemical oxidation equipment 
II.3.1 Electrochemical oxidation set-up 
The experimental solution was stored in 1 liter thermoregulated glass reservoir (1) and 
circulated through the electrolytic cell using a centrifugal pump (2) (Fig. 2). The flow rate 
was 366 L h-1. Electrolyses were conducted at 30 °C in a one-compartment flow filterpress 
reactor under galvanostatic conditions (3). Electrodes were two discs of 69 cm2 of active 
surface separated 10 mm. The BDD anode from Adamant (Switzerland) was elaborated by 
chemical vapour deposition on a conductive substrate of silicium. The cathode was a 1 mm 
thick disc of zirconium. The current was supplied by an ELC AL 924 power supply.  
 
Fig.II-5 Discontinuous process with a single compartment electrochemical reactor, (1) tank, (2) pump, (3) 
electrochemical cell. 
 
The value of mass transfer coefficient (km) waries is correctly represented by a linear 
relation with flow rate (Φ) in the operating range of flow rate (120 - 300 L h-1) at 
30 °C [11], as shown in Eq. II-11. In the present study, the flow rate was 360 L h-1, the 
mass transfer coefficient can be calculated to be 2.30 × 10-5 m s-1. 
 
(Eq. II-11) 
 
where, k is the mass trnsfer coefficient (m s-1), Φ is the flow rate in L h-1 
II.3.2 Electrochemical oxidation of synthetic solutions and nanofiltration 
retentate 
The system was first washed by ultrapure water, then cleaned electrochemically with 
an electrolysis of a solution of K2SO4 at a current intensity of 1.5 A during 3 hours and 
5k 10 0.0051 0.4367  
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finally was rinsed by ultrapure water. TOC of the rinsing solution was measured in order to 
ensure the system was perfectly cleaned before next electrolysis. Electrolysis of synthetic 
solutions (electrolyte spiked with CIP) and NF retentate were carried out after polarization. 
The solution to be treated was filled (1L) into the tank and the electrolysis was carried out. 
K2SO4 (0.1M) as electrolyte was added in the synthetic solution for the sufficient 
conductivity but not in NF retentate. Samples were taken at regular intervals in the tank to 
measure the concentration of CIP, TOC and COD. The global volume of samples was less 
than 10 % of the total volume. After electrolysis, the treated solution was collected for 
further analysis of halogenates (AOX) and the evaluation of the remaining toxicity using 
bioassays was performed.  
 
II.3.3 Cyclic Voltammetry Study 
    Cyclic voltammograms were carried out in a conventional three-electrode cell of 100 
mL capacity using a computer controlled Autolab potentiostat Model 30. A BDD thin film 
of 0.196 cm2 from Adamant was used as working electrode, a Pt wire as counter electrode 
and a Hg/Hg2Cl2,Cl- (sat) electrode (SME) as the reference electrode. Before each 
experiment, the electrode was pre-treated using anodic polarization at 2.84 V/SHE during 
40 s into a 1 M H2SO4 solution. 
II.4 Analytical method  
II.4.1 High-performance liquid chromatograph (HPLC) 
    High performance liquid chromatography is a chromatographic technique used to 
separate a mixture of compounds with the purpose of individually identifying, quantifying 
or purifying components of a mixture. In this study HPLC connected with 
ultraviolet-visible spectrometry detector (HPLC-UV) or mass spectrometry (HPLC-MS) 
was applied to determine the concentration of pharmaceuticals in synthetic solutions, MBR 
effluents, nanofiltration and electro-oxidation treated samples.  
III.4.1.1 HPLC-UV 
HPLC-UV analyses were conducted on Agilent 1200 Series HPLC systems (Agilent 
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Technologies, USA). Two HPLC columns: Vydac reverse phase C18 column and Agilent 
ZORBAX Eclipse Plus C18 column are used for analysis the concentration of 
pharmaceuticals.  
Vydac reverse phase C18 column (5 µm, 4.6 mm × 250 mm) manufactured by Chrom 
Tech (USA) was applied for the quantification of CIP concentrations in pure synthetic 
solutions. The detection UV wavelength was set at 278 nm. The mobile phase of HPLC 
consisted of a mixture of water: acetonitrile: triethylamine (80: 20: 0.3 v/v/v) and the pH 
was adjusted to 3.3 with phosphoric acid. The flow rate was 1.0 mL min-1 and volume of 
injection was 20 µL as described in literature [12].With this analytical method, the 
detection limit of CIP is 0.1 mg L-1 and the analytical error is 1%. 
Agilent ZORBAX Eclipse Plus C18 column  (3.5 µm, 3 mm × 100 mm) from Agilent 
Technologies was used for the analysis of the concentration of SAL and SMX in pure 
synthetic solutions, the concentration of CIP, SAL and SMX in the mixture solution as 
well as the concentration of CIP in the MBR effluents (for EO). The detection UV 
wavelength was set at 278 nm. The mobile phase of HPLC consisted of a gradient of 
ultrapure water (with 0.1 % of formic acid) and acetonitrile (with 0.1 % of formic acid) and 
the column temperature was set at 30°C. The flow rate was 0.4 mL min-1 and volume of 
injection was 10 µL. 
The gradient for the mobile phase is reported in the table II-5 for the analysis of the 
concentration of SAL, SMX and CIP in synthetic solution. 
 
Table II-5 Gradient of the mobile phase for analysis of pharmaceuticals in synthetic solutions with ZORBAX 
Eclipse Plus C18 column 
Time (min) acetonitrile % (with 0.1 % formic acid) 
0 5 
3 5 
18 95 
21 5 
30 5 
Retention times, detection limits and analytical error for the measurement of 
pharmaceuticals are listed on Table II-6. 
Table II-6 The retention times detection limits and the analytical error for each pharmaceuticals with 
ZORBAX Eclipse Plus C18 column 
Compounds Retention time (min) Detection limits (µg L-1) Analytical error
Salbutamol 5.1 100 1 % 
Ciprofloxacin 9.9 10 0.18 % 
sulfamethoxazole 12.1 10 0.3% 
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The concentration of CIP in MBR effluents can also be measured using ZORBAX 
Eclipse Plus C18 column and the gradient to the mobile phase (mixture of ultrapure water 
with 0.1 % of formic acid and acetonitrile with 0.1 % of formic acid) is presented on table 
II-7. The detection limit of CIP is 10 µg L-1 and the analytical error is 0.8%.  
 
Table II-7 Gradient of the mobile phase for analysis of CIP in MBR effluent with ZORBAX Eclipse Plus C18 
column 
Time (min) acetonitrile % (with 0.1 % formic acid) 
0 5 
15 95 
18 5 
20 5 
 
    For quantification, calibration curves were established in pure water and MBR 
effluents spiked with known concentrations. They served as identification points during 
analysis of samples. 
III.4.1.2 HPLC-MS     
Concentrations of ciprofloxacin, ifosfamide and cyclophosphamide in MBR effluent 
samples, retentates and permeates from NF, as well as final effluents of electrochemical 
oxidation were measured by UPLC-MS/MS (Waters AcquityTM Ultraperformance LC - 
QuattroPremier XE Micromass MS Technologies) by LPTC in Bordeaux (Université de 
Bordeaux 1, EPOC, LPTC, UMR 5805, Laboratoire de Physico et Toxico Chimie de 
l'Environnement) after addition of specific internal standards and purification by solid 
phase extraction (SPE, Oasis HLBTM, 200mg, 6cc, Waters®). The quantification limits 
are shown in table II-8. Residual standard deviation is about 10%. 
Table II-8 Quantification limits of ciprofloxacin, ifosfamide and cyclophosphamide in MBR matrix with 
UPLC-MS/MS analysis from LPTC (Bordeaux) 
Compounds Quantification limits 
(ng L-1) 
Ciprofloxacin 22.3 
Ifosfamide 22.7 
Cyclophosphamide 50.5 
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II.4.2 Ionic chromatography (ICE) 
Ionic chromatography (ICE) is a process that allows the separation of ions and polar 
molecules based on their affinity to the ion exchanger. In this study, the concentrations of 
salts in both synthetic solution and MBR matrix were measured by ionic chromatography 
with an ICS 3000 system (Dionex, France). The injection volume is 25 µL and the column 
temperature was set at 30 °C. The concentrations of anions and cations were analyzed with 
two columns (Thermo Scientific, Dionex) as shown on table II-9. 
 
Table II-9 Analysis conditions for anions and cations using ionic chromatography 
 Colume Mobile phase Suppressor 
Anions IonPacTM AS11 NaOH: 5 mM (95%) and 
100 mM (5%) 
ASRS_4mm (137mA) 
Cation IonPacTM CS12 CH4O3SO3 20 mM CSRS_4mm (59 mA) 
 
The ionic chromatography can detect the concentration of anions and cations in a range 
of 1 mg L-1 to 100 mg L-1. Analytical errors of each ion are listed on table II-10. 
 
Table II-10 Analytical errors for anions and cations 
Anions Analytical error Cations Analytical error 
Cl- 2.1 % Na+ 1.8 % 
NO3- 1.5 % K+ 1.5 % 
SO42- 6.0 % Mg2+ 1.5 % 
PO43-* 3.1 % Ca2+ 1.4 % 
*Due to the analytical method, all forms of the phosphate (H3PO4, H2PO4- , HPO42- and PO43-) were measured 
as PO43- 
Calibration curves were obtained using a mixture of pure standard solutions and used for 
quantification. 
II.4.3 Total organic carbon (TOC)  
Total Organic Carbon (TOC) was measured during both NF and EO experiments as a 
global pollution parameter to evaluate the efficiency of both processes. TOC was measured 
with TOC-VCSN instrument (Shimadzu). From this measurement, the total carbon (TC) is 
obtained after complete combustion of the organic or inorganic carbon fractions at 680 ° C 
with a cobalt / platinum catalyst. The concentration of inorganic carbon is measured after 
acidification and degassing, performed automatically. Finally, total organic carbon can be 
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calculated from the difference between the total carbon and inorganic carbon (IC). The TC 
of all samples was measure three times and the coefficient of variation is less than 2 %. The 
detection limit is 50 ppb and the analytical error is 5%. Calibration curves were established 
using commercially available standard solutions (Shimadzu). 
II.4.4 Chemical oxygen demand (COD) 
Chemical oxygen demand actually indicates the mass of oxygen consumed per liter 
of solution, which is commonly used to indirectly measure the amount of organic 
compounds in water and widely used to analyze the efficiency of the organic pollutants 
removal in water. COD is also measured as a global parameter during NF and EO 
processes. COD was determined by photometry using disposable test tubes 
(HI93754H-25 LR from HANNA Instruments) and a HACH DR/2400 photometer. After 
sample addition, test tubes were heated at 150°C for 2 hours and cool down at room 
temperature before measurement.  
 
The organics can be oxidized by dichromate, as follow: 
 
(Eq.II-12) 
 
The amount of Cr3+ was determined after oxidization is completed with HACH 
DR/2400 photometer. The detection limit is 3 ppm and the analytical error is 5%. 
Specifications from the manufacturer are shown on Table II-11. 
 
Table II-11 Specifications of COD measurement from the manufacturer 
Standard value (mg L-1) Target value (mg L-1) Mean value (mg L-1) 
0 0 ± 5 0 
140 140 ± 7 142 
 
II.4.5 Ultraviolet-visible spectrometry (UV)  
Ultraviolet-visible spectrometry refers to absorption spectroscopy or reflectance 
spectroscopy in the ultraviolet-visible spectral region using light in the visible and 
adjacent (near-UV and near-infrared, NIR) ranges. The absorption or reflectance in the 
2 3
2 7 2 2 4
8 3(8 ) 22n a b c
a d cC H O N dCr O d c H nCO H O cNH dCr          
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visible range directly affects the perceived color of chemicals involved. It can be used for 
quantitative determination of different analytes according to Beer-Lambert law.  
In this study, UV spectrometry is applied for the determination of urea concentration 
(see II.4.6).  
Previous researches [13] proved good correlation between TOC and UV254, as well as 
between COD and UV254.Thus, UV254 can be successfully applied to determine natural 
organic matter concentrations using the relationship below: 
 
(Eq.II-13) 
 
Where, α is the correlation slop between the UV254 and concentration of organic 
matters. 
Using this equation, an estimation of the adsorption of organic matters on the 
membrane during NF has been calculated as described in the table II-12. As shown in the 
example, the concentration of organic matters in feed, permeate and retentate were 
estimated by UV254. Comparing the mass in the feed and in retentate as well as in 
permeate, the adsorption of organic matters can be computed as 0.85α mg which 
represents 26 % of the initial mass for the present example. 
 
Table II-12 Example of calculation to estimate organic matters adsorption on the membrane 
 Feed Retentate Permeate (Average)
UV254 absorbance 0.46 1.37 0.08 
[organic matters] (mg L-1) 0.46α 1.37α 0.08α 
Volume (L) 7 1.4 5.6 
Mass (mg) 3.22α 1.92α 0.45α 
Qads   (mg) 0.85 α 
Percentage of Qads to the initial mass 26% 
 
II.4.6 The concentration of urea  
Concentrations of urea were determined by a L-Arginine/Urea/Ammonia kit from 
Nzytech (Portugal). The principle of the measure is shown as follow, according to the 
Eq.II-14 and Eq.II-15. The amount of nicotinamide adenine dinucleotide phosphate 
(NADP+, measured at UV 340 nm) formed through the combined action of urease (URE) 
and glutamate dehydrogenase (GlDH), is stoichiometric with the amount of urea. 
(Eq.II-14) 
 
2 3 22UREUrea H O NH CO  
 254UV Organic matters
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(Eq.II-15) 
 
The sensitivity of the assay is based on 0.005 absorbance units and a sample volume of 
2.00 ml. The detection limit of urea is 0.13 mg L-1. The relative standard deviation of urea 
test is 3%. 
II.4.7 Adsorbable Organic Halogens (AOX)  
The Adsorbable organic halogens in the synthetic solution, MBR effluent, NF 
retentate and solution after EO treatment were analyzed by the Laboratoire Départemental 
31: Eau - Vétérinaire - Air in Toulouse, according to the ISO 9562 Method [14]. ISO 9562 
usually specifies the methodology for the direct determination of a concentration of 10 µg 
L-1 in water for organic chlorine, bromine and iodine (expressed as chloride) adsorbable on 
activated carbon. This method is applicable to test samples with concentrations of 
inorganic chloride ions of less than 1 g L-1. Samples with higher concentrations are diluted 
prior to analysis. 
II.4.8 Quantification of “endocrine disruptor effects” by in-vitro 
bioassays 
    A set of in-vitro bioassays allowing the quantification of receptor-mediated activities, 
namely estrogen (ER), androgen (AR), and pregnane X (PXR) receptors was performed 
by INERIS according to previous studies [15,16].  
    Briefly, 250 to 500 mL of samples were filtered on GF/C glass fiber filters (1.2 µm, 
Whatman) and extracted by SPE on Oasis HLBTM (200mg, 6cc, Waters®) prior bioassays 
testing. 
In both assays, results are expressed as percent of maximal luciferase activity 
induced by the positive controls, Estradiol E2 10 nM in MELN cell line for estrogenic 
activity, Dihydrotestosterone (DHT) or Dexamethasone (Dex) 1 nM in MDA-kb2 cell line 
for androgenic and glucocorticoid activities, and the cholesterol lowering drug, SR12813 
(SR) 3 µM in HG5LN-hPXR cell line for PXR-like activity. The last one corresponds to 
the detoxication activity induced by xenobiotic compounds. Limits of detection for the 
different bioassays are reported in the table II-13. 
 
4 22 GIDHOxoglutarate NADPH NH L Glutamate NADP H O       
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Table II-13 Limits of detection for the different bioassays for quantification of “endocrine disruptor 
effects” 
bioassays and receptor-mediated activities Limits of detection in the culture medium*
MELN, Estrogenic (ER) 0,8 ng L-1 
MDA-kb2 
Androgenic (AR) and glucocorticoid (GR)
DHT : 23 ng L-1 
Dex : 0,15 µg L-1 
 
HG5LN-hPXR 
PXR-like (PXR) 4,5 µg L
-1 
*estimated from EC5 value (concentration inducing 5% of the total effect) 
 
Dose–response curves were modelled by using Hill equation with the ExcelTM 
macro RegTox (http://www.normalesup.org/~vindimian/fr_index.html) which allows 
obtaining EC20 (concentrations of test chemical or sample extract that induce 20% of the 
maximal response). Biological activities of samples were quantified as biological toxic 
equivalents (BioT-EQ), E2-equivalents (E2-EQ), DHT-EQ and SR-EQ and were 
determined by dividing the EC20 of reference chemicals (expressed in ng L-1) by the EC20 
value of the sample. 
 
II.5 Membrane surface characterization methods  
   Virgin and fouled membrane surfaces were characterized after drying at 60 °C with a 
vacuum degree fixed at -0.8 bar (C3000 – XF020 France Etuves). 
II.5.1 ATR-FTIR 
ATR-FTIR spectra (Attenuated total reflection-Fourier transform infrared 
spectroscopy) were obtained with Thermo-Nicolet Nexus 670 (USA). It was applied for 
identification of some functional groups which are present on the surface of materials. 
The sample was supported on diamond crystal substrates and the analytical depth is 
around 2 µm. Virgin and fouled membranes were examined using ATR-FTIR to identify 
the property of membrane and the fouling composition.  
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II.5.2 SEM-EDX  
Surface morphology of membranes was examined with a Scanning Electron 
microscope (SEM, Hitachi Tabletop Microscope TM-1000) interfaced with Energy 
Dispersive X-ray (EDX) spectroscopy system (Thermo-Fisher). SEM-EDX analysis is a 
non-destructive approach for surface analysis, by which some qualitative elemental 
information on the membrane surface can be obtained. 
Membrane samples were sputtered with a thin layer of gold before SEM analysis for 
better contrast. The EDX analyses were carried out at the same time. Elemental analysis 
begins from sodium. EDX measurements were taken place at different locations of 
membrane surface in order to obtain the comprehensive elemental composition. 
Cross-sections of samples are prepared by cryo-fracture: membranes were first 
immersed in ethanol and fractured in liquid nitrogen.  
II.5.3 Contact angles 
The hydrophilicity of the membrane samples was characterized by membrane 
contact angle measurements which were performed using GBX Digidrop goniometer 
(model DGD/Fast 60, France). The water droplet (0.5 µL) was deposed on the membrane 
surface and the contact angle can be measured as shown on Fig.II-6. Measurements were 
carried out several times at different locations on the dried membrane surface using ∼2 μL 
liquid droplet in ambient conditions. The measurement of contact angles was reproducible 
in the range ±5° and an average valued was determined. 
 
 
 
Fig.II-6 The measurement of contact angles by GBX Digidrop contact angle meter: (a) picture during 
measurement, (b) Schematic diagram, θ is the contact angles.  
 
 
 
 
 
Membrane
θ
Water droplet
(b) (a) 
 65 
Chapter II Materials and methods
References 
[1] I. Quesada, Y. Gonzalez, S. Schetrite, H. Budzinski, K. Le Menach, O. Lorain, et al., 
PANACÉE : évaluation du fonctionnement d’un bioréacteur à membranes immergées 
traitant des effluents hospitaliers d’oncologie, Rev. Sci. Eau. 28 (2015) 1.  
[2] A. Al-Ahmad, F.D. Daschner, K. Kümmerer, Biodegradability of Cefotiam, 
Ciprofloxacin, Meropenem, Penicillin G, and Sulfamethoxazole and Inhibition of 
Waste Water Bacteria, Arch. Environ. Contam. Toxicol. 37 (1999) 158–163.  
[3] K. Kümmerer, T. Steger-Hartmann, M. Meyer, Biodegradability of the anti-tumour 
agent ifosfamide and its occurrence in hospital effluents and communal sewage, 
Water Res. 31 (1997) 2705–2710.  
[4] T. Steger-Hartmann, K. Kümmerer, A. Hartmann, Biological Degradation of 
Cyclophosphamide and Its Occurrence in Sewage Water, Ecotoxicol. Environ. Saf. 36 
(1997) 174–179. 
[5] V. Yangali-Quintanilla, A. Sadmani, M. McConville, M. Kennedy, G. Amy, Rejection 
of pharmaceutically active compounds and endocrine disrupting compounds by clean 
and fouled nanofiltration membranes, Water Res. 43 (2009) 2349–2362.  
[6] A.M. Comerton, R.C. Andrews, D.M. Bagley, P. Yang, Membrane adsorption of 
endocrine disrupting compounds and   pharmaceutically active compounds, J. 
Membr. Sci. 303 (2007) 267–277.  
[7] C.Y. Tang, Y.-N. Kwon, J.O. Leckie, Effect of membrane chemistry and coating layer 
on physiochemical properties of thin film composite polyamide RO and NF 
membranes: I. FTIR and XPS characterization of polyamide and coating layer 
chemistry, Desalination. 242 (2009) 149–167.  
[8] C.Y. Tang, Y.-N. Kwon, J.O. Leckie, Effect of membrane chemistry and coating layer 
on physiochemical properties of thin film composite polyamide RO and NF 
membranes: II. Membrane physiochemical properties and their dependence on 
polyamide and coating layers, Desalination. 242 (2009) 168–182.  
[9] B. Espinasse, P. Bacchin, P. Aimar, Filtration method characterizing the reversibility 
of colloidal fouling layers at a membrane surface: Analysis through critical flux and 
osmotic pressure, J. Colloid Interface Sci. 320 (2008) 483–490.  
[10] B. Espinasse, P. Bacchin, P. Aimar, On an experimental method to measure critical 
flux in ultrafiltration, Desalination. 146 (2002) 91–96.  
[11] C. Racaud, A. Savall, P. Rondet, N. Bertrand, K. Groenen Serrano, New electrodes for 
silver(II) electrogeneration: Comparison between Ti/Pt, Nb/Pt, and Nb/BDD, Chem. 
Eng. J. 211–212 (2012) 53–59.  
[12] N.M. Kassab, A.K. Singh, E.R.M. Kedor-Hackmam, M.I.R.M. Santoro, Quantitative 
determination of ciprofloxacin and norfloxacin in pharmaceutical preparations by 
high performance liquid chromatography, Rev. Bras. Ciênc. Farm. 41 (2005) 507–
513.  
[13] R. Albrektienė, M. Rimeika, E. Zalieckienė, V. Šaulys, A. Zagorskis, Determination 
of Organic Matter by UV Absorption in the Ground Water, J. Environ. Eng. Landsc. 
Manag. 20 (2012) 163–167.  
 66 
Chapter II Materials and methods 
[14] ISO 9562:2004(en) Water quality — Determination of adsorbable organically bound 
halogens (AOX), (n.d.).  
[15] S. Kinani, S. Bouchonnet, N. Creusot, S. Bourcier, P. Balaguer, J.-M. Porcher, et al., 
Bioanalytical characterisation of multiple endocrine- and dioxin-like activities in 
sediments from reference and impacted small rivers, Environ. Pollut. 158 (2010) 74–
83.  
[16] N. Creusot, S. Kinani, P. Balaguer, N. Tapie, K. LeMenach, E. Maillot-Maréchal, et 
al., Evaluation of an hPXR reporter gene assay for the detection of aquatic emerging 
pollutants: screening of chemicals and application to water samples, Anal. Bioanal. 
Chem. 396 (2009) 569–583.  
 
 
  
 
 
 
 
 
Chapter III 
 
Nanofiltration for removal of 
pharmaceuticals from MBR effluent：  
 
Productivity and selectivity 
 
 
  
   
 Contents 
 
III.A Limiting flux and foulant identification during nanofiltration of MBR effluent 
following a square wave filtration method .................................................................. 67 
III.A.1 Experimental procedure ................................................................................ 67 
III.A.2 Flux behavior ................................................................................................ 69 
III.A.2.1 Variation of permeate flux with time during concentration and recirculation 
steps....................................................................................................................... 69 
III.A.2.2 Pseudo stable flux against applied pressure ........................................... 70 
III.A.2.3 Limiting and critical flux ....................................................................... 71 
III.A.3 Reversible and irreversible fouling resistances – determination of critical     
flux ............................................................................................................................ 73 
III.A.4 Fouling layer characterization ...................................................................... 75 
III.A.4.1 Composition of NF feed and of the retentate after recirculation step .... 75 
III.A.4.2 Roles of ions during concentration step ................................................. 75 
III.A.4.3 Roles of ions during recirculation step .................................................. 77 
III.A.4.3 ATR-FTIR analysis ................................................................................ 80 
III.A.4.4 SEM-EDX analysis ................................................................................ 81 
III.A.5 Effects of fouling phenomena on flux behavior ........................................... 83 
III.A.5.1 Role of colloidal silica and organics fouling layer in the initiation of scaling
............................................................................................................................... 83 
III.A.5.2 Development of scaling and limiting flux .............................................. 84 
III.A.6 A method predicting scaling - threshold permeability before scaling .......... 87 
III.A.7 Conclusions .................................................................................................. 92 
III.B Flux behavior during independent nanofiltration experiments - limiting flux and 
influence of the water matrix ....................................................................................... 94 
III.B.1 Experimental procedure ................................................................................ 94 
III.B.2 Flux behavior ................................................................................................ 95 
 III.B.2.1 Variation of permeate flux with time ...................................................... 95 
III.B.2.2 Influence of cross-flow velocity on pseudo-stable fluxes and existence of 
limiting flux .......................................................................................................... 96 
III.B.3 Fouling resistances ........................................................................................ 98 
III.B.4 Fouling layer characterization .................................................................... 100 
III.B.4.1 SEM-EDX analysis .............................................................................. 100 
II.B.4.2 ATR-FTIR analysis ................................................................................ 111 
III.B.5 Influence of the feed matrix composition on fouling mechanisms and flux 
behavior .................................................................................................................. 114 
III.B.5.1 Influence of the concentration of organic matters ................................ 114 
III.B.5.2 Influence of salts concentration and solution pH ................................. 116 
III.B.5.3 Conclusions .......................................................................................... 118 
III.B.6 Filtration with adjusted pH ......................................................................... 118 
III.B.6.1 Experimental procedure ....................................................................... 118 
III.B.6.2 Variation of permeate flux with time in different matrix pH ............... 119 
III.B.6.3 Characteristics of fouling layer in different matrix pH ........................ 120 
III.B.7 Productivity control .................................................................................... 123 
III.B.8 Conclusion .................................................................................................. 126 
III.C Process selectivity - Influence of fouling types (water matrix) and operating 
conditions on the rejection ......................................................................................... 128 
III.C.1 Salts rejection .............................................................................................. 128 
III.C.2 Pharmaceuticals rejection ........................................................................... 131 
III.C.2.1 Effect of fouling types and pharmaceuticals properties - hydrophobic 
interaction and size exclusion ............................................................................. 131 
III.C.2.2 Effects of water matrix ......................................................................... 134 
III.C.2 Conclusion .................................................................................................. 135 
III. Conclusion ........................................................................................................... 136 
Reference ................................................................................................................... 137
 67 
Chapter III Nanofiltration for removal of pharmaceuticals from MBR effluent 
The objective of this chapter is to investigate the main parameters which influence the 
productivity and the selectivity of nanofiltration for the removal of pharmaceuticals in the 
primary step of tertiary treatment. Thanks to the knowledge acquired, we aim at optimizing 
operating conditions in order to improve permeate flux and pharmaceuticals rejection.  
Considering that the limitation of nanofiltration is membrane fouling, part of the study 
is dedicated to the identification of fouling mechanisms during filtration of the complex 
MBR effluent matrix. The critical flux (before the occurrence of irreversible fouling) and 
the limiting flux are determined and linked to the different fouling mechanisms. Based on 
the results obtained, a diagram showing the permeate flux behavior versus the applied 
pressure will give us information’s about the necessary conditions to reach a high process 
productivity as a function of the treated water matrix.  
 Simultaneously, the pharmaceuticals rejection is evaluated. The influences of the 
water matrix and of the fouling types during the filtration on pharmaceuticals removal are 
studied. 
III.A Limiting flux and foulant identification during 
nanofiltration of MBR effluent following a square wave 
filtration method  
This section investigates the critical and limiting fluxes during the filtration of MBR 
effluent following the square wave filtration method (see section II.2.3). This method 
consists in one unique filtration using the same water matrix during which we increase and 
decrease alternatively transmembrane pressure. After the calculation of the reversible and 
irreversible fouling resistances at each applied pressure, we will focus on the identification 
of fouling phenomena involved in the irreversible part of the fouling. These results will 
allow us to define a threshold permeability below which scaling occurs, decreasing 
drastically the flux. 
III.A.1 Experimental procedure 
The pilot batch experiments simulate a feed-and-bleed continuous mode (see chapter I). 
The cross flow velocity is fixed to 0.2 m s-1. As presented in chapter 2 (see section II.2.1.1 
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and II.2.1.2 experimental procedure is divided in two steps as shown in Fig III-1. The feed 
solution (MBR effluent) is firstly filtrated in a concentration mode. The retentate stream is 
recycled into feed tank while the permeate is collected until a VRF of 5 is reached; this step 
corresponds to a transient state as retentate concentration increases over filtration time. The 
second step is a recirculation step at constant retentate composition: both retentate and 
permeate streams are recycled into the feed tank. The permeate flux is monitored during 
both filtration steps. The square wave filtration method developed by Espinasse et al. [1,2] 
(see chapter II.2.3) is applied during the recirculation step. The pseudo stable flux is 
considered to be obtained when the change of flux over a 30 min period is less than 2% of 
the initial flux for typical runs. Beginning from 3 bar, when the flux becomes pseudo stable 
at a certain applied pressure, the pressure is altered positively and negatively to a new value 
(see Fig.III-1). For example, 5 bar is a positive variation (from 3 to 5) of pressure and 5 
bar* is the negative variation (from 10 to 5).   
As the square wave filtration method allows the identification of fouling type 
(reversible or irreversible), the critical flux can be identified. For instance, the fouling type 
at 10 bar can be identified by comparison of fluxes at 5 bar and 5 bar *. If the fluxes are 
equal, the fouling produced at 10 bar is totally reversible; if the flux at 5 bar * is lower than 
the one at 5 bar, it means that irreversible fouling occurs and the initial flux exceeds the 
critical flux. 
 
 
 
Fig.III-1 Experimental procedure 
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III.A.2 Flux behavior 
III.A.2.1 Variation of permeate flux with time during concentration and recirculation 
steps 
Fig III-2 presents the flux evolution over the experimental procedure (Fig.III-1). 
During the concentration step (at 3 bar), the flux slightly increases at the beginning and 
then reaches an almost stabilized value at around 62 L h-1 m-2 when VRF = 5 is reached. 
Following recirculation step, the applied pressures range from 3 to 35 bar. Clearly, when 
the applied pressure is maintained at 3 bar, the flux stabilizes at around 62 L h-1 m-2. As 
expected, when the pressure is switched to 5 bar, the flux immediately increases. After that 
a decline of the flux during recirculation time is observed until it reaches a stable value 
again at 67 L h-1 m-2. The similar increase of flux with pressure increase is observed with an 
applied pressure of 10 bar. However, the pseudo stable flux reaches a new value of 33 L h-1 
m-2. The procedure continues with an increase of applied pressure step by step until 35 bar. 
With the applied pressures of 15, 25, 35 bar, the fluxes also stabilize at about 33 L h-1 m-2 
(first reach), after an increase of flux at the beginning of positive variation of pressure. 
 
 
Fig. III-2 Flux evolution following the experimental procedure over time:  the continuous line represents 
the applied pressure;  the dotted line denotes the permeate flux.  
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III.A.2.2 Pseudo stable flux against applied pressure 
Fig.III-3 plots the membrane pseudo stable flux against applied pressure following the 
procedure shown in Fig.III-1.  
 
 
Fig.III-3 Pseudo stable flux vs applied pressure following the procedure shown on Fig.III-1;  the 
continuous line is the pure water permeability of membrane;  the dotted line is the initial MBR effluent 
permeability; hollow and bold points are the first pseudo stable flux reached at a certain pressure; the crosses 
are the stable flux reached after negative variation of pressure (5 bar*, 10 bar*, 15bar*, 25 bar* in Fig.III-1). 
Arrows represent the positive or negative variations of pressure.  
 
At low pressure 3 bar, the pseudo stable flux is slightly higher above the line of pure 
water permeability. First, it can be assumed that this increase of flux is due to the presence 
of some components such as surfactants in the MBR effluent. These components can 
adsorb on the membrane surface and structure, enhancing membrane’s wettability. 
However this explanation is contradictory with results presented later in the manuscript 
(contact angle measurements which reveal an increase of hydrophobicity and decrease of 
pharmaceuticals rejection which could deal with higher hydrophobic surface). Secondly, 
this increase in flux could be attributed to effects of the matrix pH. Previous studies [3–5] 
observed that the permeability of polyamide membranes increased with pH and that this 
phenomenon was more significant when the pH tended to alkaline. The authors [3,4] 
explained this behavior from the chemical nature of the polymer chains in the membrane 
skin layer: dissociating groups in the polymer made the surface looser when charges of the 
polymer chains started to repel each other at elevated pH. Braghetta et al. [3] observed 15 % 
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of permeate flux increase when the solution pH increased from 4 to 10 in an organic-free 
solution. In the present study, the new membrane was prepared in ultrapure water, the pH of 
which was around 6 and then the filtration carried out in MBR effluent matrix at a pH of 8. 
The flux increases then from 55 L h-1m-2 to 65 L h-1m-2 which represents 18 %. As a 
consequence, the increase of flux at the beginning of filtration could be attributed to a slight 
enlargement of pore size. However, considering the complex water matrix, the 
accumulation of ions and organics could also play a role by modifying membrane charge 
and pore size [6,7]. If we consider now the evolution of flux with time, we observe that 
under 3 bar the flux does not decrease, which means that no fouling occurs at this pressure. 
Then the permeability at the end of 3 bar (described as dotted line in Fig.III-3) is considered 
as initial permeability for filtration of MBR effluent in further calculations of fouling 
resistances. 
When the applied pressure switches to 5 bar, the pseudo stable flux is obtained at a 
lower value than the one expected from initial permeability. It can be suggested that fouling 
occurred at 5 bar, since a flux decline with time is observed at this pressure (FigIII-2). With 
the increase of pressure from 5 to 10 bar (positive variation), the pseudo stable flux 
considerably drops. 
     Crosses in the Fig.III-3 represent the flux values from decreasing pressure (negative 
variations: 5 bar*, 10 bar*, 15bar*, 25 bar* in Fig III-1). It can be observed that two 
different fluxes are obtained at 5 bar and 5 bar*, the latter being well lower, which indicates 
that an irreversible fouling occurs during the recirculation step at 10 bar. As a consequence, 
the initial flux under 10 bar is above the critical flux.  
III.A.2.3 Limiting and critical flux 
Fig.III-4 presents the pseudo stable flux of each applied pressures. For an applied 
pressure of 3 bar, the pseudo stable flux is on the line of initial permeability, which means 
no fouling occurs. The pseudo stable flux starts to deviate from the initial permeability with 
an applied pressure of 5 bar due to fouling. It can be expected that the flux then obtained is 
not far away from the possible critical flux. When the applied pressure varies positively to 
10 bar, the pseudo stable flux reduces sharply and reaches a value around 33 L h-1 m-2 that 
is much lower than the flux obtained when the pressure increases to 5 bar and even lower 
than the flux at 3 bar. It can be inferred that the possible critical flux exists in between the 
stable fluxes at 3 and 5 bar (between 62 L h-1 m-2 and 67 L h-1 m-2). Moreover the fact that 
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the positive variation of pressure from 10 to 35 bar cannot lead to an increase in pseudo 
stable flux indicates that the limiting flux is reached. 
 
 
Fig.III-4 Pseudo stable flux versus pressure during filtration of MBR effluent (positive variation only);   
the pure water permeability of membrane;  the initial MBR effluent permeability. 
 
According to the study of Tang and Leckie [8], the critical flux depends on the 
membrane types, while the limiting flux is membrane independent. Based on that, three 
types of conceptual behaviors of critical flux and limiting flux were developed 
(section I.2.3). Regarding type (a) and type (b), the limiting flux is higher or equal to the 
critical flux. For type (c), the limiting flux is lower than the critical flux. Several types of 
semi-aromatic and fully aromatic membranes were tested in the study of Tang and Leckie 
[8] to measure the limiting flux, including the same type of membrane as the one used in the 
present study: NE70. The membranes were fouled by humic acid in different ionic 
strengths with or without calcium. All of the tested membranes including NE 70 were 
described as type (a) and type (b). Type (c) was not observable during humic acid filtration 
in the conditions tested by the authors. In the present study, the critical flux is probably 
exceeded with an applied pressure of 5 bar and the behavior of flux seems to correspond to 
type (a) or type (b) in accordance with the results of Tang and Leckie [8]. However, a 
further increase of the pressure (10 to 35 bar) leads to a drastic decrease of flux until a 
limiting value which is rather low by comparison to probable critical flux. This limiting 
flux behavior is similar to type (c), observation which has never been reported before.  
     The origin of this flux behavior will be discussed in next sections based on: i) the 
calculation of reversible and irreversible fouling resistances, ii) the characterization of 
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fouling layer at each step of the filtration procedure. 
III.A.3 Reversible and irreversible fouling resistances – determination of 
critical flux  
    Thanks to the application of the square wave filtration method (alternating positive and 
negative variations of applied pressure), reversible and irreversible part of the fouling can 
be deduced [1,2] (see II.2.3). 
The total fouling resistance corresponding to each pseudo stable flux can be calculated 
from Eq. II-5 (section II.2.3). Fig.III-5 illustrates the evolution of total fouling resistance 
against pseudo stable flux obtained at each pressure according to the square wave method 
(section II.2.3).  
 
Fig III-5 Evolution of the total fouling resistance (Rf) v.s. pseudo stable flux obtained at each pressure 
according to the square wave method procedure (see Fig.II.4,section II.2.3) 
     
From Fig.III-5, it can be indicated that the total fouling resistance formed at 10 bar 
includes both reversible and irreversible parts. First, the total fouling resistance at 5 bar* 
(as Ln step in Fig.II.4, section II.2.3) is larger than the total fouling resistance at 5 bar (as 
Un-1 step in Fig.II.4). It means that after an up pressure (10 bar as Un step in Fig.II.4) the 
resistance cannot recover the preceding value, and this remaining resistance is the 
irreversible part (the difference of fouling resistance at 5 bar and 5 bar*). On the other hand, 
the total resistance declines from 10 bar (as Un step in Fig.II.4) to 5 bar* (as Ln step in 
Fig.II.4), which refers to the reversible fouling. Similarly, the total fouling resistance 
formed at 15 bar, 25 bar, 35 bar includes reversible and irreversible components. Following 
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Eq.II-6 and Eq.II-7 (section II.2.3), the resistances due to reversible and irreversible fouling 
can be calculated respectively from Fig.III-5.  
Fig.III-6 plots the evolution of pseudo stable flux, reversible and irreversible fouling 
resistances against transmembrane pressure. As we can see in Fig.II-6, both resistances due 
to irreversible and reversible fouling increase with the transmembrane pressure, the 
irreversible fouling being the dominate part of total fouling resistance. In particular, from 
the figure we can define a critical pressure (between 3 and 5 bar) below which irreversible 
fouling is not observed. In contrast, when the pressure exceeds this critical value, the 
irreversible fouling occurs. From the linear relationship between irreversible fouling 
resistance and transmembrane pressure, this critical value can be estimated to be 3.4 bar. 
The corresponding critical flux is evaluated to be around 69 L h-1m-2. These results verify 
the inference drawn in section III.A.2.3 according which critical flux is reached for an 
applied pressure between the 3 and 5 bar.  
 
 
Fig.III-6 Evolution of pseudo stable flux , irreversible fouling resistance  and reversible fouling 
resistance  as function of pressure.  
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III.A.4 Fouling layer characterization  
    In order to explain the flux behaviors presented previously, the chemical composition 
of foulant layer will be identified in this section. First, the accumulation of salts can be 
quantified from a mass balance calculation. Then, two analytical methods are applied to 
identify the fouling layer components: ATR-FTIR (Fourier transform infrared spectroscopy) 
and SEM-EDX (scanning electron microscope with energy dispersive X-ray spectroscopy). 
III.A.4.1 Composition of NF feed and of the retentate after recirculation step 
As mentioned previously, the feed solution of the nanofiltration system is the MBR 
effluent from hospital. It is firstly concentrated 5 times in a concentration mode and then 
the concentrated MBR effluent (recirculation solution) is filtrated at constant retentate 
concentration (recirculation mode). The characteristics of the feed and the recirculation 
solution are presented in Table III-1. 
 
Table III-1 Characteristics of MBR effluent and of the recirculation solution after concentration step 
 
Item MBR effluent 
(NF feed) 
Recirculation solution  
(after concentration step VRF = 5)
pH 7.9 ± 0.2 7.6 ± 0.2 
COD (mg L-1) 48 ± 3 112 ± 3 
TOC (mg L-1) 19.6 ± 0.1 55.1 ± 0.1 
UV254 0.46 1.37 
Na+ (mg L-1) 62.4 ± 1.1 77.9 ± 1.4 
K+ (mg L-1) 19.6 ± 0.3 25.4 ± 0.4 
Mg2+ (mg L-1) 3.3 ± 0.1 4.9 ± 0.1 
Ca2+ (mg L-1) 29.3 ± 0.9 43.2 ± 0.6 
Cl- (mg L-1) 44.9 ±0.9 41.6 ± 0.9 
NO3- (mg L-1) 7.1 ± 0.1 5.6 ± 0.1 
SO42- (mg L-1) 26.8 ±1.6 76.5 ± 4.6 
PO43- * (mg L-1) 8.0 ± 0.2 18.6 ± 0.6 
*Due to the analytical method, all the H3PO4, H2PO4-1, HPO42- and PO43- in the solution were measured as 
PO43-. 
III.A.4.2 Roles of ions during concentration step 
      During the concentration step, even if the permeate flux does not decrease and the 
fouling does not occur according to the flux behavior as discussed above, the accumulation 
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of salts on the membrane and system is observed. The accumulation of Na+, Ca2+ is the 
most important when the one of Cl- is weaker as shown in table II-2 (calculation, see 
section II.2.4)  
Table III-2 Accumulation of ions during concentration step 
 
The accumulation of Na+ and Ca2+ is probably due to the electrostatic attraction 
between the negative charge of the virgin membrane and the positive charge of Na+ and 
Ca2+. Li and Elimelech [6] observed the reduction of the negative charges on the membrane 
surface in Na+ and Ca2+ solution, Ca2+ being more effective than Na+ in reducing the 
negative charges on the membrane surface. The authors explained these phenomena from 
the complexation of Ca2+ with the COO- groups on the NF270 membrane (polyamine) 
surface. Moreover, Yoon et al. [9] found that calcium can act as a bridge between 
negatively charged functional groups of humic acid and membrane as shown on Fig.III-7. 
Li and Elimelech [10] reported that in consequence the presence of Ca2+ was able to induce 
specific membrane-NOM (natural organic matters) and NOM-NOM interactions. 
 
 
Fig.III-7 ‘Bridge’ affection of Ca2+ to humic acid adsorption (a) Van der Waals force and electrostatic 
repulsion to the negative groups of humic acid and (b) bridging of calcium ion between negatively charged 
functional groups[9]. 
 
Considering the specific interactions between Ca2+ and negatively charged functional 
groups of organics, the accumulation of organic matters is deduced from the measurement 
of UV254 during the concentration step (table II-12, section II.4.5). During this step, 26% of 
Mass (mg) Na+ K+ Mg2+ Ca2+ Cl- NO3- SO42- PO43-
Feed  436.2 137.3 23.0 205.0 314.1 5.0 18.8 56.3
Retentate +Permeate 
VRF = 5 405.5 136.3 21.4 187.0 299.7 5.7 18.0 55.3
Qads 30.7 1.0 1.6 18.0 14.4 -0.7 0.8 1.0 
Error ± mg 10.7 2.9 0.4 3.6 9.1 0.1 1.6 2.6 
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organic matters from the feed are accumulated on the membrane and system, which implies 
that the combined accumulation of Ca2+ and organic matters occurs. However, according to 
the flux behavior during the concentration step, it appears this accumulation of organics 
and ions does not lead to a decrease of flux. The combined accumulation could be loose and 
relax on the membrane surface/structure and system in the pressure conditions used during 
this step: 3 bar, which is quite soft.  
III.A.4.3 Roles of ions during recirculation step  
    The concentrations of ions in the tank are monitored during recirculation step by 
samples collection when a stable flux is reached at each applied pressure (the volume of 
samples collected is less than 4% of the total volume of recirculation solution).  
As we can see, in the Fig.III-8, the concentrations of Na+, K+, Mg2+, Cl-, SO42- and 
HCO3- keep almost stable and equal to the initial concentration. The variation of Na+ is 
specific, it increases and then decreases, when the concentrations of Ca2+, PO43- exhibit a 
slight decrease during filtration.  
 
 
Fig.III-8 Concentrations of ions in the tank during recirculation step when stable flux is reached at each 
applied pressure  
     
During the recirculation step, both retentate and permeate were recycled into the feed 
tank. The lost mass of ions is supposed to be accumulated on the membrane surface and 
structure. The accumulated mass is calculated from the concentration difference between 
the beginning of recirculation and the time at which the pseudo stable flux is reached at 
each pressure (see II.2.4).  
Considering the fact that the accumulation of ions could contribute to the increase of 
irreversible fouling resistance, Fig.III-9 plots the evolution of both irreversible fouling 
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resistance and ions accumulation on the membrane surface versus the applied pressure. 
Three different tendencies of ions accumulation are observed. First, the accumulation of 
Na+ exhibits a negative value, which implies the release of Na+ accumulated during the 
concentration step (see III.A.4.2) from the membrane surface and structure to the retentate 
when at the same time irreversible fouling increases. Second, the accumulation of Cl- is 
fluctuant around a mean value whatever the applied pressure and the irreversible fouling 
resistance. Third, Ca2+ which is slightly accumulated during concentration step is released 
from the membrane surface and structure to the retentate during the recirculation at 3 bar, 
while its accumulation increases at higher pressure (when fouling occurs). Similarly, the 
accumulation of PO43- also enhances with the aggravation of fouling.  
 
 
 
Fig. III-9 Evolution of irreversible fouling resistance  and ions accumulated mass: (a) Na+ , Cl- , (b) 
Ca2+ , PO43-  on the membrane with increasing applied pressure during recirculation step. 
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Considering these tendencies, the accumulation of Na+ and Cl- seems to be not related 
to the increase of the membrane fouling resistance. On the contrary, the accumulation of 
Ca2+ and PO43- on the membrane surface and structure is probably correlated to the 
occurrence of irreversible fouling. Fig.III-9 (b) shows that the accumulation of PO43- and 
Ca2+ exhibits good linear relationships with applied pressure during recirculation from 5 to 
35 bar, while other tendency is observed during recirculation at 3 and 5 bar. This change of 
slope in Fig.III-9 (b) occurs for the same pressure range (between 5 and 10 bar) as the 
change in flux behavior in Fig III.4 (drastic drop), but we don’t have at this stage all data to 
properly correlate both. 
    The accumulations of Ca2+ and PO43- can induce different modifications on 
membrane surface characteristics. As discussed on section III.A.4.2, the accumulation of 
Ca2+ on the membrane surface acts like a bridge between membrane surface and negatively 
charged functional groups of organic matters. However, here the increasing accumulation 
of Ca2+ does not lead to more adsorption of organic matters. Only 2 % of organic matters 
from the feed (calculation, see II.2.4) is accumulated on the membrane surface and 
structure during the recirculation step, which is quite lower than adsorbed amount during 
concentration step (26% of organic matters from the feed). We can then assume in our 
conditions that during the recirculation step the increase of irreversible fouling resistance 
versus pressure is not related to organics adsorption but to salt deposit on membrane 
surface and structure. On the other hand, the accumulation of calcium is also referred to 
inverse-solubility of salts (CaCO3, CaSO4.xH2O, calcium phosphate etc.) which can 
precipitate and form a hard fouling layer on the membrane named scaling [11]. 
Consequently, the accumulation of Ca2+ during recirculation step is probably relative to the 
membrane scaling. For PO43-, it has been found in previous studies [12] that the presence of 
phosphates can cause the formation of a viscous gel with silica and other metals at a higher 
hydration number resulting in a hard cement-like layer irreversibly bonded to the 
membrane surface. In addition, phosphates can precipitate with calcium and induce the 
common calcium phosphate scaling as some autopsies on membrane elements shown 
[11,13]. 
Consequently during recirculation step, the accumulation of PO43- and Ca2+ contribute 
strongly to irreversible fouling resistance, while Cl- and Na+ accumulation certainly plays a 
negligible role on it.  
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III.A.4.3 ATR-FTIR analysis     
ATR-FTIR spectra of virgin and fouled membrane over a wave lengths range of 
4000-750 cm-1 are presented on Fig.III-10. The relative penetration depth during analysis is 
2 µm.  
 
 
Fig.III-10 ATR-FTIR spectra of fouled and clean membrane 
 
For virgin NE70 membrane, the characteristic absorbance of active polyamide layer, 
polysulfone as sub-layer, in addition to coating layer (top of the active polyamide layer) are 
detected. Concerning the polyamide top-layer, the peak at 1631cm-1 corresponding to the 
amide band [14] is observed. According to the study of Tang et al. [14], polysulfone groups 
are detected at 1587, 1504, 1488, 1365, 1350-1280, 1245, 1180-1145, and 830 cm-1. These 
peaks are clearly observed on the spectra of virgin membrane. The peaks observed in high 
wave number region (3700 - 2700 cm-1) are associated to the coating layer [14]. The strong 
peak around 3000 cm-1 suggests that the coating layer probably has rich aliphatic carbon 
and the peak around 3440 cm-1 is probably due to the additional O-H groups from the 
coating. 
For the fouled membrane after filtration, almost all the characteristic peaks of 
sub-layer of polysulfone and polyamide layer cannot be observed and are replaced by the 
ones of foulants; even the peaks related to the coating layer (top of the active polyamide 
layer) are weak and difficult to be recognized. It seems that in the thickness analyzed by the 
equipment (2 µm) signal can be mainly attributed to fouling layer. It can be then assumed 
that the fouling layer thickness is close to 2 µm. The absorbance at 1545, 1647 and 1040 
cm-1 indicates the presence of colloidal organics on the fouling layer [15]: the peaks at 1545 
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and 1647 cm-1 are related to the colloidal reflected functional groups of primary and 
secondary amides; the absorbance at 1040 cm-1 is indicative of proteins and N-acetyl amino 
sugars, possibly present in bacterial cell [16]. OH stretching and Si-OH group vibration 
are observed in the regions 830-1110 cm-1 and 3700-3200 cm-1 [17] , the vibration of Si-O 
bond appears at 791 and 754 cm-1 [18]. In particular, the absorbance around 820 cm-1 
associates with the symmetric bond stretching vibration of network Si-O-Si [19]. These 
signals imply the presence of colloidal silica fouling. The wide and intensive peak at 1049 
cm-1 is proposed to be characteristic of phosphate (including PO43-, HPO42-, HPO4-1) and 
crystallized calcium phosphate [20–22]. The presence of the absorbance of calcium 
phosphate is in accordance with the accumulation of Ca2+ and PO43- on membrane 
surface/structure which was highlighted previously (Fig III-9). 
III.A.4.4 SEM-EDX analysis 
SEM analysis was performed on membrane surface and cross-section before and after 
filtration to observe fouling layer and characterize its structure and morphology (Fig.III-11). 
Comparing the micrographs of virgin and fouled membrane, a variety of foulants is 
observed evenly distributed over the entire membrane surface. As shown on images (b) and 
(d), the homogenous “bright” points superpose on the dark foulant layer. According to the 
FTIR analysis and the morphology of the foulant, the “bright” points could be the surface 
crystallization of calcium phosphate and dark layer is possibly the colloidal silica and 
organics foulant. The image (c) presents the cross-section of fouled membrane. By 
comparing with the cross-section of virgin membrane (shown in Fig.II.2, chapter II), the 
bottom and porous part is the polysulfone sub-layer. Above it, the thin and bright layer 
(around 0.2 μm) is the active polyamine layer. The fouling layer which is around 2 µm is on 
the top and its thickness is quite uniform. 
Combined with SEM, EDX was used to analyze the element compositions on the 
surface of virgin membrane and fouling layer. EDX sampled different locations on the 
virgin and fouled membrane surface. The virgin membrane surface is composed by 100 % 
of sulphate, while the elements on the fouled membrane surface are various. The weight 
percentages of main elements are shown in table III-3. The major elements on the fouling 
layer (analyzed by the instrument) are phosphorus and calcium, which is in good 
agreement with the calculation of accumulated ions on the membrane and FTIR analysis. 
Moreover these analysis also confirm the occurrence of scaling during NF and that the 
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main salts responsible for scaling are calcium and phosphate. The distribution of calcium 
and phosphate is quite uniform, which confirms that the scaling is homogeneous on the 
membrane surface and structure. 
 
Fig. III-11 SEM images of virgin and fouled membrane: (a) Clean membrane surface 1000 ×; (b) fouled 
membrane 1000 ×; (c) Section of fouled membrane 5000 ×; (d) Fouled membrane surface10000 ×.  
 
Table III-3 EDX elements analysis at different locations on fouled membrane surface* 
 
Samples 1 2 3 4 Average 
Main element Weight % from different locations  
Silicon 0 2.4 0 0 0.6 
Phosphorus 24.6 26.6 23.2 28.8 25.8 
Calcium 50.3 53.7 57.4 54.6 54 
Chromium 4.8 5.0 0 7.6 4.3 
Iron 4.7 4.9 0 0 2.4 
Sulfur 0 0 19.3 9.8 14.6 
*This instrument cannot detect C, N, O.   
Membrane 
Fouling layer 
(c) 
(a) (b)
(d) 
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Based on FTIR and SEM analysis, the composition of fouling layer indicates the 
combined presence of colloidal silica and organics fouling and calcium phosphate 
inorganic fouling during filtration of MBR effluent. 
III.A.5 Effects of fouling phenomena on flux behavior  
The flux behaviors during filtration of MBR effluent with square wave filtration 
method are shown in section III.A.2. During recirculation at 3 bar, the flux keeps stable 
and the pseudo stable flux follows the initial permeability. The critical flux is detected 
around 69 L h-1m-2 (corresponding to a transmembrane pressure of 3.4 bar) from the study 
of fouling resistances on section III.A.3. At 5 bar, the pseudo stable flux (67 L h-1m-2) 
begins to slightly deviate from the initial permeability. Its value of 67 L h-1m-2 is quite 
close to the value of critical flux (69 L h-1m-2). With the applied pressure increasing to 10 
bar, the pseudo stable flux decreases sharply to 33 L h-1 m-2. During the filtration with a 
continuing increase of applied pressure to 15, 25, 35 bar, pseudo stable fluxes keep this 
value identified to be the limiting flux which is well below the critical flux.  
According to the characterization of fouling layer on section III.4, the fouling 
mechanism during filtration of MBR effluent is proposed to be the combination of 
colloidal silica and organics and calcium phosphate inorganic fouling. Based on this 
ensemble of results, it can be considered that the first deviation of stable flux from the 
initial permeability at 5 bar is probably due to the colloidal silica and organics fouling, the 
flux behavior is then in accordance with the results of Tang and Leckie [8] who fouled the 
membrane with humic acid. Then the sharp decline of pseudo stable flux from 5 bar to 10 
bar can be attributed to the occurrence of scaling which could reduce the flux more 
severely than colloidal silica and organics. The following section is devoted to the 
identification of the phenomenon responsible for the initiation of scaling in the water 
matrix used in the present study. 
III.A.5.1 Role of colloidal silica and organics fouling layer in the initiation of scaling  
As discussed above, the sharp decrease of flux from 67 to 33 L h-1 m-2 is due to the 
occurrence of scaling. According to previous studies, there are two pathways of scaling in 
membrane systems: bulk (homogeneous) and surface (heterogeneous) crystallizations 
[23,24]. In the present study, the bulk crystallization is not observed (scaling does not occur 
at pressures 3 and 5 bar). Scaling in our system is then considered to be mainly linked to 
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surface crystallization [25]. Moreover, the experimental velocity 0.2 m s-1 is in the range of 
low velocity, which is in favor of surface crystallization according to the study of Lee and 
Lee [26]. 
There are two prerequisites for the occurrence of scaling at a surface: the presence of 
crystallization nuclei or the large enough supersaturation ratio on the membrane surface 
to exceed the critical supersaturation ratio for nucleation [27]. In our experiments both of 
them can be associated with colloidal silica and organics fouling layer built at 5 bar.  
    The colloidal silica and organics fouling layer possibly serves as “nuclei site” for 
scaling. It can be assumed that the probably electrostatic attractive interactions between 
the negatively charged functional groups of organic foulants adsorbed (or deposited) on 
membrane surface and calcium [9,10] help the formation of crystallization nuclei. 
Specially, it was reported that polysilicon which acts as a substrate can promote the 
nucleation of calcium phosphate crystal (hydroxyapatite) from the solution [28]. 
On the other hand, colloidal silica and organics fouling layer can increase the 
supersaturation ratio on the membrane surface (Sm) by means of concentration 
polarization. According to the study of Heok and Elimelech [29], the colloidal silica and 
organics cake layer hinders the back-diffusion of salt ions, which results in an 
enhancement of salt concentration polarization on the membrane surface.  
    Moreover, based on the theory of nucleation, the nucleation barrier is extremely 
sensitive to details (such as roughness) of the surface [25]. The colloidal silica and 
organics fouling layer can modify the surface state of the membrane and then the contact 
of liquid and membrane surface can be changed.  
For all these reasons, we can believe that the colloidal silica and organics fouling 
layer plays a major role in the initiation of scaling formation. 
 
III.A.5.2 Development of scaling and limiting flux 
We remember that the supersaturation ratio on the membrane surface (Sm) is the 
driving force for the development of scaling and that Sm is associated with salts 
concentration on the membrane surface, in other words is linked to concentration 
polarization. We then propose in the following to describe the link between the permeate 
flux (responsible for the polarization concentration) and scaling development. 
In the present study, at each positive pressure increment the flux increases at least 
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temporarily (just after the pressure increase) leading to a more serious polarization 
concentration. Consequently, the increase of salts concentration on the membrane surface 
leads to a Sm value higher than the critical supersaturation ratio (Scritical) on the membrane 
surface (chapter I), which results in the precipitation of scalants, as shown in Fig.III-12 
(b).  The development of scaling causes the decline of flux due to a more important 
surface area occupied by the scalants. At the same time, both the precipitation and 
decrease of flux can reduce the salts concentration on the membrane surface and then 
decrease Sm. The further development of scaling continues until the value of Sm reduces 
to Scritical. Then flux reaches a pseudo stable value again as shown in Fig.III-12 (c). Thus, 
it can be assumed that in the steady state conditions, the supersaturation ratio on the 
membrane surface reaches the critical value and the permeate flux reaches the limiting 
flux. 
 
 
 
Fig.III-12 Relationship between the permeate flux (responsible for the polarization concentration) and 
scaling development. [Ca2+]m and [HxPO4z-]m are the concentration of calcium and phosphate on membrane 
surface, respectively. 
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As discussed on chapter I, the supersaturation ratio on membrane surface can be 
expressed as Eq.III-1. 
 
 
(Eq.III-1) 
 
where, [Ca2+]b and [HxPO4z-]b are the concentration of calcium and phosphate in the bulk, 
CP is the concentration polarization degree; Ksp is the thermodynamic solubility product 
of the scalant compound;  
    The concentration polarization degree for each ion is written as Eq.III-2 [30,31]. 
 
 
(Eq.III-2) 
 
 
 
(Eq.III-3) 
  
where [Ca2+] m, [Ca2+] b and [HPO42-] m, [HPO42-] b are the ion concentrations on the 
membrane surface and in the bulk of calcium and phosphate, respectively; J is the permeate 
flux; 2( )Obs CaR   and 4( )zxObs H POR   are the observed ion rejections; 4zxH POk   and 2Cak   are the 
mass transfer coefficients of phosphate and calcium, respectively.  Considering the 
observed salt rejections of Ca2+ and PO43- approximate 1 in presence of scaling (results 
shown in section III.C.1), Eq.III-2 and III-3 can be simplified to Eq.III-4 and III-5 as follow. 
Both of them relate to the flux. 
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Combining the Eq.III.1, Eq.III-4 and Eq.III-5, the supersaturation ratio on the membrane 
surface can be expressed as Eq.III-6 
(Eq.III-6) 
 
 
 
In steady state conditions described at the beginning of the paragraph, this equation 
can be rewritten as: 
 
 
(Eq.III-7) 
 
 
where, Scritical is the critical supersaturation ratio and Jlim is the limiting flux. 
We then assume through the mechanisms proposed in this section that, at each 
increment of pressure, the obtention of a pseudo stable flux corresponding to the limiting 
flux comes from the stabilization of supersaturation ratio on the membrane surface at its 
critical value Scritical, all other parameters in Eq.III-7 being constant at a certain applied 
pressure and tangential velocity. 
 
III.A.6 A method predicting scaling - threshold permeability before 
scaling 
    Based on the discussion in section III.A.5, the colloidal silica and organics fouling is 
found at 5 bar. This fouling layer built at 5 bar plays a critical role to induce scaling. One 
assumption here is that there is a threshold colloidal silica and organics fouling layer which 
can be characterized by a threshold irreversible fouling resistance above which scaling 
occurs. Corresponding to this threshold resistance, we propose in this section to estimate 
the threshold permeability Lt, below which scaling starts to form. 
As developed before, we consider in our system that the main scaling mechanism is 
surface crystallization. Scaling due to the surface crystallization follows the surface 
blockage mechanism. The membrane surface would be blocked by the lateral growth of 
crystals and the permeate flux only can pass through the membrane surface which is not 
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occupied by the crystals [26,32], as shown in Fig.III-13[26]. 
 
 
Fig.III-13 surface blockage fouling mechanism by surface crystallization in NF [26]  
If fouling does not occur, the initial permeate flux can be expressed as Eq.III-8.  
 
(Eq.III-8) 
 
In which µp and Rm are the viscosity of permeate (Pa·s) and the membrane resistance (m-1), 
respectively. 
    When the scaling layer is formed following a surface blockage mechanism, assuming 
the area occupied by crystals is completely impermeable, the flux could be expressed as 
follow:    
   
 
 
(Eq.III-9) 
 
 
where Ja is the permeate flux estimated from the surface blockage model, Am is the 
membrane active area , Afree and Aoc are the membrane area unoccupied and occupied by 
surface crystals respectively. With the assumption that the thickness of the crystal formed 
on the membrane surface is constant [33], the Aoc could be defined as Eq.III-10: 
 
   (Eq.III-10) 
 
where β (m2 mg-1) is the area occupied per unit mass and ms (mg) is the weight of the 
scaling layer formed directly on the membrane surface.  
Jt is defined as flux decline due to colloidal silica and organics fouling, and it can be 
described as: 
 
(Eq.III-11)
                  
free m oc
a
p m m p m m
A A AP PJ
R A R A 
   
(R )
t
t
p p m t rf
L PJ P
R R 
    
OC SA m
p m
PJ
R

 89 
Chapter III Nanofiltration for removal of pharmaceuticals from MBR effluent 
 
where Rt is the threshold irreversible fouling resistance which include colloidal silica and 
organics fouling ; Rrf is reversible fouling resistance corresponding to the concentration 
polarization.  
When scaling occurs (from 10 to 35 bar), the flux declines due to colloidal fouling layer, 
relative concentration polarization and surface crystals hindering. This flux can be 
represented by combining eq. (Eq.III-9) and (Eq.III-11): 
 
(Eq.III-12) 
 
where Jb is the decline of flux combining two fouling mechanisms (colloidal silica and 
organics as well as scaling). 
The reduction of permeability by surface crystallization superposed on the colloidal 
silica and organics layer can be expressed as follow: 
 
(Eq.III-13)     
                                                                                                     
where Lb is the permeability combining two mechanisms (colloidal silica and organics 
fouling and scaling); Lt is the permeability before scaling (corresponding to Rt). When the 
permeability is lower than Lt, scaling occurs.  
    Combining Eq.III-10 and Eq.III-13, Lb can be written as: 
 
(Eq.III-14)               
 
    This function provides the relationship between the threshold permeability before 
scaling, the permeability combining two fouling mechanisms, and the weight of the 
scaling layer formed directly on the membrane surface. ms can be estimated from the 
mass balance during the filtration. Lb can be obtained from the filtration with square wave 
filtration method. Thus, from this relationship, the threshold permeability Lt can be 
evaluated. 
     Considering that the organic and scaling combined fouling occurs from 10 to 35 bar, 
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at a certain pressure and stable flux after negative variation of applied pressure according to 
the experimental procedure (Fig.III-14). For example, Lb at 10 bar can be evaluated from 
the pseudo stable fluxes at 10 bar and 5 bar*. Moreover, due to this procedure, the value of 
Lb then determined is not impacted by the concentration polarization and the reversible 
fouling. Consequently, Lt which is evaluated from Lb doesn’t include the reversible fouling. 
The relationship between the threshold permeability (Lt) and the threshold fouling 
resistance (Rt) can be then written as Eq.III-15.      
                                                                                                  
 
(Eq.III-15)   
 
 
 
Fig.III-14 Experimental permeability measurement  the continuous line is the pure water flux of membrane; 
bold points are the first pseudo stable fluxes reached at a certain pressure; the crosses are the stable fluxes 
reached after negative variation of pressure (5 bar*, 10 bar*, 15bar*, 25 bar* in Fig.III-1). 
                                                                                                             
    As shown on Fig.III-14, the first permeability of 3.42 L h-1 m-2 bar-1 (begin from left) 
is Lb after reaching pseudo stable flux at 10 bar. The following values are the permeability 
reached at 15, 25 and 35 bar. 
 
In sections III.A.4.2 and III.A.4.3, we have shown that the increase in irreversible 
fouling resistance (from 10-35 bar) is directly linked to the accumulation of calcium and 
phosphate on the membrane surface. As a consequence to estimate the weight of the 
scaling layer on the membrane surface (ms), the accumulated masses of Ca2+ and PO43- are 
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calculated in the pressure range 10 to 35 bars and reported on table III-4.  
 
Table III-4 Experimental permeability and accumulated mass of ions on the membrane 
Pressure ( bar) Lb (L h-1 m-2 bar -1) ms = ms (Ca2+) + ms (PO43-) (mg) 
10 3.42 1.79 
15 2.33 6.01 
25 1.37 7.43 
35 0.89 11.16 
 
Fig.III-15 illustrates a great linear relationship between accumulated mass of Ca2+ 
and PO43- and Lb permeability combining two fouling mechanisms. From this linear 
relationship, the threshold permeability Lt is calculated as 3.85 L h-1 m-2 bar-1 and the 
corresponding Rt as 6.83×1013 m-1. Using this relationship the area occupied per unit mass 
(β) can also be deduced as 1.02 × 10-3 m2 mg˗1, considering the membrane surface is 1.4× 
10-2 m2. 
The threshold fouling resistance (Rt) value is between resistance when pseudo stable 
flux was reached at 5 bar (2.02 ×1012 m-1) and 10 bar (8.07 ×1013 m-1). Lt predicts scaling 
occurs between the pressure 5 and 10 bar, which is accordance with the experimental flux 
behavior. The actual value of threshold pressure before scaling is not experimentally 
measured in this study and more filtrations are necessary to identify this pressure. It 
should be noticed that this threshold permeability is obtained for a given feed water 
composition, effects of water matrix will be discussed in next section III-B. 
 
Fig.III-15 Relationship between Ca2+ and PO43- accumulated mass on membrane and Lb permeability 
combining two fouling mechanisms. 
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Based on these results, if during the filtration of a certain water matrix in a certain 
pressure range, a great linear relationship is obtained between Lb and accumulated mass 
of ions, we can conclude that scaling controls fouling. If not, the process productivity is 
probably not affected by the problem of scaling.  
The value of Lt estimated here will be verified in section III-B during independent 
filtrations. 
 
III.A.7 Conclusions 
The critical flux is determined with the square wave filtration method during 
nanofiltration of MBR effluent. For permeate fluxes exceeding the critical flux, two pseudo 
stable flux behaviors are observed due to different fouling mechanisms in the complex 
matrix used in this study. 
In the first case, flux approximates to the value of critical flux, which is probably due to 
colloidal silica and organics fouling. This flux behavior is in accordance with the results of 
Tang and Leckie [8] who fouled the membrane with humic acid. 
In the second case, flux is well below the critical flux and reaches the limiting flux. The 
analysis by ATR-FTIR and SEM-EDX of the fouling layer confirms that this limiting flux 
is dominantly induced by membrane scaling. Calcium and phosphate are proved to be the 
scaling salts. The FTIR analysis also verifies that colloidal silica and organics fouling and 
scaling are simultaneously present on fouled membrane surface. 
The colloidal silica and organics layer plays a critical role in the inducement of the 
calcium and phosphate scaling. The applied pressure has also a certain effect on the 
development of scaling by means of flux. When the permeate flux increases, salts 
supersaturation ratio on membrane surface increases suddenly (concentration polarization) 
and gives the driving-force to continue the development of scaling until reaching the 
equilibrium between increase of the supersaturation ratio with flux and the decrease of flux 
due to the development of scaling. This equilibrium flux is the limiting flux of scaling. 
    Based on the critical role of colloidal silica and organics fouling in initiation of scaling, 
threshold permeability before scaling is defined and estimated from the observed 
permeability (combining colloidal fouling and scaling) and the accumulation weight of 
scalants. Lt predicts that scaling occurs between the pressure 5 and 10 bar in this system, 
which is in accordance with the experimental flux behavior. 
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The verification of the relevance and accuracy of Lt value is carried out in section III-B 
with independent filtrations.  
 
Conclusion Figure 
 
Fig.III-16 Relation between flux behaviors versus applied pressure and fouling mechanisms. The continuous 
line  is the initial MBR effluent permeability; bold points are the pseudo stable flux at the applied 
pressure. 
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III.B Flux behavior during independent nanofiltration 
experiments - limiting flux and influence of the water matrix 
This section investigates flux behaviors, fouling mechanisms and productivity 
control during independent filtrations of MBR effluents with variabilities of water matrix. 
Similarly to calculations in the previous section, a critical flux can be determined by the 
study of fouling resistances. The association between limiting flux and the fouling 
mechanisms is probed from the characterization of fouling layer on the membrane surface 
after filtrations. The effects of effluent matrix and pH on fouling and as a consequence on 
flux are then discussed. Finally, these results are used to propose some actions to control 
nanofiltration productivity.  
III.B.1 Experimental procedure  
Separate filtrations were conducted at various constant applied pressures (5 to 35 bar) 
and two cross-flow velocities (0.2 m s-1 and 0.35 m s-1). The operating pressures and 
velocities used during the filtrations are presented on Table III-5 
Table III-5 Operating pressures and velocities used during independent filtrations 
Pressure (bar) Velocity = 0.2 (m s-1) Velocity = 0.35 (m s-1) 
3 M  
5 I H 
10 K  
15 E,G F, L* 
25 B A,P,Q 
35 D C 
A, B, C, D, E, F, G, H, I, K, L, M, P and Q are the serial name for the filtrations. 
         *Filtration L follows slightly different procedure, see section III.B.6 
For each experiment, a new membrane sample and a new MBR effluent were used. 
After compaction of the membrane with ultrapure water for 3 hours, the feed (7 L of MBR 
effluent) was poured into the feed tank. The filtration was firstly conducted in a 
concentration mode (concentration step) at the selected pressure with the collection of 
permeate until a volume reduction factor (VRF) of 5 was reached. Then both permeate and 
retentate were recycled in the tank in order to keep a constant feed concentration during the 
recirculation step. The recirculation was stopped when the flux reached a pseudo stable 
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value (change of the flux over 1 hour was less than 1% of the initial flux). After the 
collection of the retentate, the system was rinsed with ultrapure water and then the pure 
water permeability was measured again.  
III.B.2 Flux behavior 
III.B.2.1 Variation of permeate flux with time  
Fig.III-17 presents the evolution of permeate flux during nanofiltration of MBR 
effluent with cross-flow velocity of 0.2 and 0.35 m s-1. The applied pressure ranges from 
3 to 35 bar.  
 
  
  
Fig.III-17 Evolution of permeate flux during NF at various pressures and two cross-flow velocities: (a) 0.35 
m s-1 and (b) 0.2 m s-1 
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At low pressure (5 bar at 0.35 m s-1, 3 and 5 bar at 0.2 m s-1), the flux increases at the 
beginning of filtrations. The same rise of flux has been observed in section III.A and 
explained by an increase of permeability with the change of water matrix (from pure 
water to MBR effluent with different pH, salt composition…). When the cross-flow 
velocity is 0.35 m s-1 and the pressure 5 bar, the flux keeps stable at 100 L h-1m-2 after the 
increase, which indicates that fouling does not occur. The same tendency is observed at 3 
bar and 0.2 m s-1 with a stable flux at 61 L h-1m-2. During the filtration at 5 bar and 0.2 m 
s-1, the initial flux and steady state flux are greater than the ones at 3 bar, but the flux 
seems to decrease slightly from 400 min and stabilizes at 84 L h-1m-2, these conditions 
certainly approximate critical flux.  
We can then assume that for both velocities the possible critical flux is not so far 
from the initial flux at 5 bar, around 100 L h-1m-2 at 0.35 m s-1 and 86 L h-1m-2 at 0.2 m s-1. 
Thus, the filtration at higher velocity (0.35 m s-1) can tolerate higher applied pressure and 
reach greater flux before fouling. The relationship between critical flux and velocity is in 
accordance with previous study which showed that cross-flow velocity increased the 
critical flux [11]. The critical pressure and flux before irreversible fouling occurs will be 
evaluated on section III.B.2.2 at each cross-flow velocity by means of fouling resistances 
calculation. 
In presence of fouling, in most of the cases, filtrations at low applied pressure 
(corresponding to low theoretical initial flux) exhibit less flux decline to reach pseudo 
stable flux. In contrast, the higher the applied pressure, the greater is the flux decline 
whatever the velocity. These results are generally similar with the results reported by 
Tang and Leckie [8], Hong and Elimelech [34]. The authors suggest that the greater flux 
reduction at higher initial flux is probably due to the increased hydrodynamic drag force 
on foulant in addition to the concentration polarization. 
At high applied pressure (e.g. at 35 bar), the low flux value observed at the very 
beginning of filtration owing to the immediate occurrence of severe fouling. Then the flux 
continuously decreases until it reaches pseudo stable value around 10 L h-1m-2 which is 
well below stable flux at 5 bar.  
III.B.2.2 Influence of cross-flow velocity on pseudo-stable fluxes and existence of 
limiting flux  
Fig.III-18 plots pseudo-stable fluxes against applied pressure for both studied 
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velocities. In this figure, the stable fluxes of most filtrations at 10 bar to 35 bar reach a 
quite similar value around 16 to 10 L h-1m-2. However, it can be noticed that filtrations P, 
Q, E and G reach greater pseudo stable flux than the others conducted at the same 
velocity and applied pressure. Due to the different flux behavior of these 4 filtrations, 
they are separated from the other ones and named “superior filtration”, in the following 
study.   
At low applied pressures, the results are in good agreement with previous studies: 
higher is the cross-flow velocity during filtration, higher is the pseudo-stable flux [35–37]. 
This beneficial effect of high cross-flow velocity on the flux is attributed to the reduction of 
concentration polarization and to the greater shear force along the membrane surface which 
might help to sweep foulant away from the membrane [37,38]. Nevertheless, it seems that 
the benefits of high cross-flow velocity are not so significant at high applied pressures. For 
pressures 25 and 35 bar, the stable fluxes at 0.35 m s-1 and 0.2 m s-1 are close to each other. 
Especially at 35 bar, the stable fluxes reach the same value of around 10 L h-1m-2 for both 
velocities. 
As mentioned on section III.B.2.1, figure III-18 shows that no fouling occurs for 
pressures lower or equal to 5 bar.  
 
  
Fig.III-18 Pseudo stable flux against applied pressure with different velocities: 0.35 m s-1, 0.2 m s-1 
during independent filtrations. The continuous line corresponds to the average pure water permeability of 
membranes. A, B…Q is the serial name of filtrations (see table III-5)  
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increase of pseudo stable flux which indicates the limiting flux is reached. The limiting 
value is rather low (around 10 L h-1m-2) by comparison to the probable critical flux: 
100 L h-1m-2 at 0.35 m s-1 and 86 L h-1m-2 at 0.2 m s-1. This location of limiting flux by 
comparison to critical flux is described as type (c) by Tang and Leckie [8] and is similar 
to the behavior observed in section III.A during a unique filtration using the square wave 
filtration method.  
The four “superior filtrations” lead to higher stable flux than the others at the same 
applied pressure, even if the flux of them also deviates from the pure water permeability. In 
particular, the pseudo stable flux reaches at the end of P and Q experiments approximates 
the possible critical flux obtained at 5 bar (100 L h-1m-2). Tang and Leckie [8] tested the 
same membrane (NE70) fouled by humic acid and obtained identical results. They 
described this relationship between limiting flux and critical flux as type (a) or type (b) as 
developed in chapter I. 
Interestingly, it seems to exit two types of limiting fluxes during nanofiltration of MBR 
effluent with different water matrixes: one approximates the possible critical flux; the other 
is surprisingly well below the critical flux. As mentioned by Tang and Leckie [8], the 
limiting flux is membrane independent and relates to the feed matrix and the 
physicochemical properties of the foulants. To explain the flux behaviors observed in the 
present study and identify the effective parameters which influence them, further studies 
are carried out to characterize the foulants and to seek the relation between these 
characteristics and the observed limiting flux.  
III.B.3 Fouling resistances 
    The total fouling resistance (Rf) includes the effect of concentration polarization, 
reversible fouling which can be removed by rinsing and the irreversible fouling remaining 
after rinsing (Rir) (as described in Fig.II-5, chapter II). For each filtration, Rf can be 
calculated using the pseudo stable flux from Eq.II-7 (chapter II) and Rir can be deduced 
from pure water permeability after filtration and rinsing using Eq.II-8 (chapter II). 
Considering the different flux behaviors of the four “superior filtrations” (E, G: 15 bar 
and 0.2 m s-1 and P, Q: 25 bar and 0.35 m s-1), they will be discussed separately. 
Fig.III-19 (a) illustrates the evolution of total and irreversible fouling resistance against 
the applied pressure.  
The variation of Rir with pressure is presented on Fig.III-19 (b). Irreversible resistance 
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after rinsing follows the same tendency for both velocities in the range 5-25 bar. The higher 
cross-flow velocity seems to slightly reduce the irreversible fouling remaining after rinsing 
but the lack of experimental points in the range 5-25 bar doesn’t allow us to precisely locate 
the critical pressure for each velocity. We can only mention that we expect a critical 
pressure between a minimum value of 4.7 at 0.2 m.s-1 and a maximum value of 13 bar at 
0.35 m.s-1. 
    The variation of Rf with pressure (Fig.III-19 (a)) follows a linear relationship for both 
cross-flow velocities with almost the same slope excepted for one point at 35 bar and 0.35 
m s-1, for which Rf increases drastically. For all the other experiments, as expected, total 
fouling resistance at velocity 0.2 m s-1 is higher than the one at 0.35 m s-1. 
 
  
  
Fig.III-19 Fouling resistances: (a) total fouling resistance, (b) irreversible fouling resistance (remaining after 
rinsing) during each nanofiltration at various pressure and two velocities.   
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For the “superior filtrations”, they exhibit as expected low total fouling resistance (Rf). 
Rir of filtrations P and Q at 25 bar and 0.35 m s-1 are also well below the ones of other 
filtrations. It can be assumed that the fouling mechanism during these 2 experiments is 
distinct from the other filtrations. In contrast, Rir values for filtrations E and G at 15 bar 
and 0.2 m s-1 seem to follow the same relationship with the pressure as the one of the 
other filtrations, which indicates the mechanism leading to irreversible fouling in these 2 
specific experiments is similar to the one in others filtration at the same pressure. 
In next section we propose to investigate the fouling mechanisms during the various 
filtrations performed thanks to characterization of fouling layer.  
 
III.B.4 Fouling layer characterization 
    To understand the flux behaviors, the physico-chemical properties of the foulants were 
analyzed by SEM-EDX and FTIR. 
III.B.4.1 SEM-EDX analysis 
Fig.III.20 shows the SEM images and the EDX surface element analysis of the 
membrane after nanofiltration in various conditions. As already mentioned, the instrument 
cannot detect the elements: carbon, nitrogen and oxygen. 
Picture (a) is the image by SEM of the clean membrane surface. It shows a clean and 
homogenous surface. Sulfur is the only element detected by EDX analysis. 
Picture (b) shows the membrane surface after filtration at 5 bar, 0.2 m s-1. It can be 
observed that few spots on the surface are covered by some foulants which seem to be 
loose on the membrane surface. The element analysis shows the corresponding results. 
Only sulfur which corresponds to the membrane structure is detected on most of locations 
and few sample points exhibit silicon and calcium which belong to the fouling layer. 
Considering the flux behaviors, it can be inferred that this loose and partial fouling layer 
on the membrane surface does not impact on the membrane permeability.  
Picture (c) presents the micrograph of membrane surface after filtration at 25 bar; 0.35 
m s-1 (P). This filtration is one of “superior filtrations” which leads to high stable flux. The 
surface seems to be fouled homogeneously, which is confirmed by the EDX analysis: all 
the sample points show around 12 % of silicon coming from foulants and 87 % of sulfur 
related to membrane structure.  
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Picture (d) is the micrographs of fouled membrane after “superior filtration” at 15 
bar, 0.2 m s-1 and the Picture (e) is the microscopy images of fouled membrane exhibiting 
a low pseudo stable flux at 15 bar, 0.35 m s-1. The pictures show a dark layer with some 
“gel-like” particle and bright white “points” above it (especially on picture e). The 
distribution of these “points” is inhomogeneous on the surface. The elements correlated 
with fouling are disparate: silicon, calcium, phosphorus, iron, aluminum et al. The 
percentages of them are also various.  
Pictures (f) and (g) show the fouled membrane surface after filtrations at 25 and 35 
bar. During these filtrations, the stable fluxes were significantly inferior to the possible 
critical flux. The surfaces of these fouled membranes seem to present an homogeneous 
distribution of ‘bright’ particles. The shape of these “bright” particles is sharper and the 
size of them (varying from 0.5 µm to 2 µm) is larger in the case of 35 bar on picture (g) 
than the ones at 25 bar on picture (f). From the cross-section image, it can be observed 
that the thickness of the foulant layer containing the dark and bright parts is homogenous 
around 2µm. The species and the percentage of elements are uniform on both fouled 
membranes, mainly Ca and P. The percentage of Ca increases from 56% to 73% for the 
membrane after filtration at 25 and 35 bar, respectively. In both cases the detection of 
sulfur related to membrane structure is scarce. Especially at 35 bar, most of measurements 
do not contain sulfur.  
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(a) 
 
Fig.III-20 (a) SEM pictures of the virgin membrane surface  
 
Table III-6 (a) EDX surface element analysis of the virgin membrane 
 
(b) 
Fig.III-20 (b) SEM pictures of the membrane surface after nanofiltration at 5 bar, V = 0.2 m s-1 (filtration I) 
 
Table III-6 (b) EDX surface element analysis of different locations on the membrane after filtration H 
Element Weight % 
Sulfur 100.0 
Samples Point 1 Point 2 Point 3 Point 4 Average 
Element weight % from the different locations 
Silicon 0 9.8 14.4 0 12.1 
Sulfur 100 90.2 60.3 100 87.6 
Calcium 0 0 25.3 0 25.3 
×1000 ×2500
×2500×1000 
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(c) 
 
Fig.III-20 (c) SEM pictures of the membrane surface after nanofiltration at 25 bar, V = 0.35 m s-1 
(filtration P) 
 
Table III-6 (c) EDX surface element analysis of different locations on the membrane after filtration P 
 
Samples Point 1 Point 2 Point 3 Point 4 Point 5 Average
Element weight % from the different locations 
Silicon 9.1 14.2 16.7 12.6 9.2 12.4 
Sulfur 90.9 85.8 83.3 87.4 90.8 87.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
×300 ×2500
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(d) 
 
Fig.III-20 (d) SEM pictures of the membrane surface after nanofiltration at 15 bar, V = 0.2 m s-1 (filtration 
G) 
 
 
Table III-6 (d) EDX surface element analysis of different locations on the membrane after filtration G 
Samples Point 1 Point 2 Point 3 Point 4 average 
Element weight % from the different locations 
Silicon 16.9 10.5 0 7.5 8.7 
Sulfur 70.9 89.5 24.5 25.9 52.7 
Calcium 12.2 0 45.4 33.5 22.8 
phosphorus 0 0 14.7 33.1 12.0 
Iron 0 0 15.4 0 3.7 
 
 
 
 
×500 
×2500×2500 
×1000
 105 
Chapter III Nanofiltration for removal of pharmaceuticals from MBR effluent 
 (e) 
 
Fig.III-20 (e) SEM pictures of the membrane surface after nanofiltration at 15 bar, V = 0.35 m s-1 (filtration 
F) 
 
Table III-6 (e) EDX surface element analysis of different locations on the membrane after filtration F 
 
Samples  Point 1 Point 2 Point 3 Point 4 Point 5 Average 
Element  weight % from the different locations 
Silicon 28.6 0 0 0 0 4.8 
Sulfur 71.4 41.2 41.3 26.5 34.8 43.0 
Calcium 0 47.9 45 55.3 46.2 38.9 
phosphorus 0 0 13.7 18.2 19 10.2 
Aluminum 0 10.8 0 0 0 1.8 
 
 
 
 
×500 ×7000
×2500×2500 
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(f) 
Fig.III-20(f) SEM pictures of the membrane surface after nanofiltration at 25 bar, V=0.35 m s-1(filtration A) 
(g) 
Fig.III-29 (g) SEM pictures of the membrane surface after nanofiltration at 35 bar, V=0.2 m s-1 (filtration D) 
 
(h) 
Fig.III-20 (h) SEM pictures of the cross-section of membrane surface after nanofiltration at 35 bar, V = 0.2 
m s-1 (filtration D) 
×10000×2500 
×10000×2500 
×1000 ×5000
Membrane 
Polysulfone layer
Fouling layer 
Membrane 
Polysulfone layer 
Fouling layer 
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Table III-6 (f) EDX surface element analysis of different locations on the membrane after filtration at 
25 bar ,V = 0.35 m s-1 (filtration A) 
 
Samples  Point 1 Point 2 Point 3 Average 
Element  weight % from the different locations 
Silicon 2.7 3.6 2 2.8 
Sulfur 11.8 7.7 7.2 8.9 
Calcium 57.4 62.7 47.2 55.8 
phosphorus 28.1 24.1 21.2 24.5 
Magnesium 0 1.9 0 0.63 
Antimony 0 0 16.3 0 
Iodine 0 0 6.1 0 
 
 
 
Table III-6 (g) EDX surface element analysis of different locations on the membrane after filtration at 
35 bar , V = 0.2 m s-1 (filtration D) 
 
Samples  Point 1 Point 2 Point 3 Point 4 Point 5 Point 6 Average
Element  weight % from the different locations 
Sulfur 0 0 19.3 0 0 0 3.2 
Calcium 80.5 80.1 57.9 72.8 71.6 78.7 73.6 
phosphorus 19.5 19.9 22.7 27.2 28.4 21.3 23.2 
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    According to the EDX element analysis, sulfur is related to the membrane structure 
when calcium and phosphorus are the main elements detected in foulant layer. In order to 
understand the impact of these elements on fouling mechanisms, Fig.III-21 plots the 
relation between the percentage of calcium and sulfur, phosphorus and sulfur of sample 
spots on the virgin and fouled membrane surfaces.  
 
 
 
Group 1 
Virgin membrane (a) 
I :P = 5 bar, V = 0.2 m s-1 (b) 
P:P =25bar Q, V=0.35 ms-1 (c) 
      Group 2 
F: P = 15 bar, V =0.35m s-1 (e) 
G: P =15 bar, V= 0.2 m s-1 (d) 
Group 3 
A: P =25 bar, V =0.35m s-1 (f) 
D: P = 35 bar, V = 0.2 m s-1 (g) 
Fig.III-21 Relation between the percentages of calcium and sulfur, phosphorus and sulfur on different spots 
on clean and various fouled membrane samples from EDX analysis (Table III-6 (a-g)). A, D, F, I, G and P 
are the serial names of filtrations.  
 
The Y-axis is the percentage of sulfur which related to the membrane structure on the 
virgin and fouled membrane surfaces from the EDX analysis (Table III-6(a-g)). The 
X-axis is the percentage of calcium or phosphorus which related to foulants on the 
membrane surface (Table III-6(a-g)). The virgin membrane corresponds to a coordinate 
point (0,100) which means 100% of sulfur for both comparisons Sulfur/Calcium and 
Sulfur/Phosphorus. The other coordinate points on the Y-axis indicate that the foulants on 
the membrane surface are not related to the X-axis element (calcium or phosphorus). The 
coordinate points on the X-axis correspond to samples on which the sulfur from the 
membrane structure cannot be detected due to severe fouling. The distribution of 
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coordinate points gives us information on homogenous or inhomogeneous distribution of 
analyzed elements on the membrane surface. For example, in group 3, all the coordinate 
points distribute in the same region approaching to X-axis, which means that the elements 
on the membrane surface is quite homogenous with less percentage of sulfur and higher 
percentage of calcium and phosphorus. In contrast, in group 2, the coordinate points 
correspond to large range of percentages of sulfur and calcium/ phosphorus, which means 
these percentages are different from points to points. This observation characterizes an 
inhomogeneous distribution of the elements on the membrane surface. 
Based on the distribution of coordinate points which relates to the percentages of 
calcium, phosphorus and sulfur on the membrane surface, the fouling layers characterize 
after filtrations have been separated into three groups on Fig.III-21. 
Moreover, Fig.III-22 illustrates the relationship between element ratio (Ca/S, P/S) on 
the fouled membrane surface and pseudo stable flux for all conditions tested. The higher 
the ratio Ca/S and P/S are, the more the membrane surface area is occupied by calcium 
and phosphate. It can be observed that the stable fluxes decrease with the increase of ratio 
of Ca/S and P/S. The presence of calcium and phosphorus reduces the flux seriously, in 
particular phosphorus which can lead to rather inferior flux even if presents at low 
percentage.  
 
Fig.III-22 Relationship between element ratio (Ca/S, P/S) on the membrane surface and pseudo stable flux. 
A, D, F, H, G, and I are the serial names of filtrations.  
   
Finally, according to Fig.III-20 to Fig.III-22, the various pseudo stable fluxes can be 
associated with different fouling characteristics. 
Group 1, most of sample points in Fig III-21 are in the high percentage of sulfur with 
0
50
100
150
0 5 10 15
Ps
eu
do
 st
ab
le 
Flu
x  
(L
h-1
m-
2 )  
Element ratio
Ca/S
P/S
L
F
G
I
A
A
D
D
 110 
Chapter III Nanofiltration for removal of pharmaceuticals from MBR effluent 
seldom calcium and phosphorus. This group includes two cases in the present study: 
membrane after filtration at 5 bar and fouled membrane after filtration at 25 bar (one of 
the “superior filtrations”), the coordinate points of which is on the Y-axis. For the 
filtration at 5 bar, no fouling occurs (stable flux 86 L h-1m-2). For the “superior filtration” 
at 25 bar (stable flux 85 L h-1m-2), fouling is not related to calcium and phosphorus 
deposit but associated with silicon presence (EDX analysis) and probably organics.     
Group 2, the coordinate points in Fig.III-21 are distributed in large region. The 
percentages of sulfur, calcium and phosphorus are different from sample points. The 
distribution of elements on the membrane surface is then inhomogeneous. This group 
includes two filtrations at 15 bar which lead to different stable fluxes: 19.5 L h-1m-2 for 
the “normal” filtration (picture (e) and table III-6(e)) and 53 L h-1m-2 for the “superior 
filtration” (picture (d) and table III-6(d)). As shown thanks to SEM-EDX analysis, 
membrane sample with more calcium and phosphorus on the surface (both observation 
and percentage) reaches lower pseudo stable flux. Then, the higher stable flux obtains at 
the “superior filtrations” (E, G) is due to less membrane surface area occupied by calcium 
and phosphorus.  
Group 3, the coordinate points in Fig.III-21 are in the same region close to the 
X-axis (or even on it). In this group, membrane surface is almost completely covered by 
the foulant layer and the distributions of calcium and phosphate are homogeneous on the 
membrane surface. Filtrations at 25 and 35 bar, for which lower stable fluxes in the range 
of 10 L h-1m-2 are observed, belong to this group. When distribution of calcium and 
phosphorus is homogeneous (Fig.III-21) and the ratios of Ca/S and P/S are above 1.3 and 
0.4 (Fig.III-22), the increasing percentage of Ca and P seems to not affect the pseudo 
stable flux severely: the percentages of Ca and P are higher on the membrane after 
filtration at 35 bar (D) than the ones at 25 bar (A), while the stable fluxes are quite similar 
(12 L h-1m-2 at 25 bar and 9 L h-1m-2 at 35 bar).  
   It is then evidenced that calcium and phosphorus are the most important components 
in the fouling layer. Calcium probably comes from Ca2+, while the identification of the 
form of phosphorus needs further studies to be confirmed. Silicon has been confirmed to 
be related to colloidal fouling during NF and RO processes [39,40]. It is detected on the 
fouled membrane surface exhibiting the higher stable flux and its percentage decreases 
when the pseudo stable flux is low. The absence of sulfur and silicon in the case of severe 
fouling is probably due to the fact that they are beneath calcium and phosphorus layer and 
out of the range of detection depth of EDX analysis.   
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II.B.4.2 ATR-FTIR analysis 
    The chemical composition of the foulants was qualitatively analyzed by FTIR. Fig 
III-23 presents the ATR-FTIR spectra of virgin and fouled membranes. On the spectrum 
of the virgin membrane, peaks at 1587, 1504, and 1488 cm-1 are attributed to the 
polysulfone support; peaks at 1630 cm-1 to the polyamide active layer, and peaks over 
(3000-2900 cm-1) corresponds to the absorbance of the coating layer. The spectra of 
fouled membranes are separated in three groups according to the different fouling 
characteristics discussed above. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 112 
Chapter III Nanofiltration for removal of pharmaceuticals from MBR effluent 
 
Group 1: 
 
Group 2: 
 
Group 3: 
 
Fig III-23 FTIR spectra of virgin and fouled membranes after filtration at various pressures 
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Group 1: The absorbance at the wave numbers of 1545, 1647 and 1040 cm-1 relates 
to the colloidal organics fouling on NF membrane [15]. The OH stretching vibrations of 
the Si-OH group are observed in the regions of 900-1110 cm-1 and 3700-3200 cm-1 [17]. 
These absorbances specially associate with the Si-O vibrations of silanol [19]. The 
perpendicular vibration of Si-O appear at 754 cm-1 [18], which confirms the presence of 
silica. The absence of the absorbance of Si-O-Si indicates that the form of silica in the 
fouling layer is mainly monosilicic acid. The foulant layer is then proposed to be 
composed of colloidal organics and monosilicic acid.  
Group 2: The absorbance of the membrane structure (polysulfone and polyamide) is 
weaker. The absorbance of the colloidal organics fouling is observed as in group 1. The 
absorbance in the regions of 830-1110 cm-1, 3700-3200 cm-1 and 754 cm-1 correlates with 
the monosilicic acid presence. The absorbance at the wave numbers of 820 cm-1 
associated to the symmetric bond stretching vibrations of network Si-O-Si [19] indicates 
the presence of polysilicic acid or colloidal silica on the fouling layer. In addition, an 
absorbance peak at 1080 cm-1 is observed corresponding to phosphate and calcium 
phosphate presence [21,22,41]. It can be confirmed that the form of calcium and 
phosphorus on the fouling layer is calcium phosphate. These results infer that the 
combined fouling of colloidal silica, organics and scaling (calcium phosphate) occurs, 
while the scaling part (calcium phosphate) distributes on the membrane surface and 
structure heterogeneously according to SEM-EDX analysis.     
 Group 3: The absorbance of the membrane structure is scarcely observed, we can 
then assume that the fouling layer thickness is around 2 µm above the membrane surface, 
considering the analyzed depth. The absorbance relating to colloidal silica and organics 
fouling becomes weaker, while the peak corresponding to calcium phosphate is intense 
and wide in the range of 1000-1100 cm-1 [21,22,41]. The scaling layer becomes thicker 
and homogenous (according to the discussion on SEM-EDX results).  
From the SEM-EDX and ATR-FTIR analysis, it is confirmed that the two ranges of 
limiting fluxes during nanofiltration with NE70 is due to distinct fouling mechanisms.  
The limiting flux with the value approaching to the possible critical flux (86 L h-1m-2) 
is induced by an homogeneous colloidal silica and organics fouling (group 1).  
The limiting flux is well below the possible critical flux when the membrane is fouled 
simultaneously by colloidal silica and organics and homogenous calcium and phosphate 
scaling. The fluxes reduce severely in this case. The limiting flux is in the range of 10 
L h-1m-2 (1% - 2% of theoretical initial flux). In this case the increasing percentage of Ca 
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and P on the membrane surface seems not to affect the pseudo stable flux, because the 
membrane surface is almost completely occupied by an homogenous calcium phosphate 
layer. The filtrations at 25 (A) and 35 bar (D) associated with this type of fouling 
mechanisms belong to the group 3 according SEM-EDX and ATR-FTIR analysis.  
There is an “intermediate” case for which the fouling layer exhibits the characteristics 
of both colloidal silica and organics fouling and calcium phosphate scaling, but in this case 
calcium and phosphate distribute inhomogeneously on partial membrane surface. The 
pseudo stable flux can be in a wide range between the limiting flux due to silica organic 
fouling and the one due to combined effects of silica organic fouling and homogenous 
scaling. The pseudo stable flux then greatly depends on the surface area occupied by 
calcium phosphate scaling. The two filtrations at 15 bar correspond to this situation. The 
pseudo stable fluxes obtained can be 53 or 19 L h-1m-2 depending on the distribution and the 
percentage of calcium and phosphate on membrane surface. These results are in 
accordance with the discussion of Rir development with pressure: “superior filtrations” at 
15 bar follows almost the same tendency with the other filtrations in section III.B.3 
(Fig.III-19). 
Thus, three types of fouling mechanisms related to the different ranges of pseudo 
stable and limiting fluxes have been proposed in the present section. The next paragraphs 
are dedicated to the study of the effects of feed matrix composition and pH on the extent 
of these mechanisms. 
 
III.B.5 Influence of the feed matrix composition on fouling mechanisms 
and flux behavior 
 
This section is devoted to investigate the influence of matrix composition on the 
pseudo-stable fluxes obtained during filtration, based on the fouling mechanisms discussed 
on section III.B.4. Especially we will focus on the influence of concentrations of organics, 
calcium and phosphate but also of the pH of the feed.  
III.B.5.1 Influence of the concentration of organic matters  
According to the film theory, when the concentration of the solute in the permeate is 
negligible and the tangential velocity kept constant, Eq.III-9 links pseudo-stable flux (Jstab), 
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solute concentration in the retentate (CR) and at the membrane surface (Cm) (see Chapter I) 
 
(Eq.III-9) 
From Eq.III-9, Jstab exhibits a linear relationship with lnCR which allows the calculation of 
mass transfer coefficient of the solute in the boundary layer (k). In our experiments, 
filtrations for which fouling and related fluxes are controlled by organics are the ones 
belonging to group 1 (H, P and Q). In these experiments organics concentration in the 
recirculation solution (CR) was determined by the UV absorbance of the solution at the 
wavelength of 254 nm when the pseudo stable flux was reached. 
Fig.III-24 exhibits the relationship between pseudo-stable flux and lnUV254 for 
filtrations of group 1 and velocity 0.35 m s-1 (filtrations H, P, Q)). For these experiments, 
it has been verified that organics rejection is higher than 90%.  
 
 
Fig. III-24 Relationship between pseudo-stable flux and lnUV254 (absorbance of the retentate) obtained 
during independent filtrations at a velocity of 0.35 m s-1 and belonging to group 1 (homogeneous colloidal 
silica and organics fouling).  
 
The linear relationship obtained between lnUV254 and Jstat confirms the role of the 
organics concentration in the value of the steady-stable flux obtained during filtrations 
belonging to group 1. The mass transfer coefficient for organics deduced from this figure 
is 5.2×10-6 m s-1 (for the velocity 0.35 m.s-1). 
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III.B.5.2 Influence of salts concentration and solution pH 
It was illustrated on section III.B.4 that the serious fouling and low limiting flux are 
induced by the scaling from precipitation of calcium phosphate. The precipitation of these 
components depends on the supersaturation ratio on membrane surface (Sm) as Eq III-I (in 
section III.A.5.2) as consequence on [Ca2+] and [HxPO4z-] the concentration of calcium 
and phosphate in the solution.  
Fig III-25 plots the pseudo stable flux against [Ca2+]•[HxPO4z-] for all the filtrations 
performed. Salt concentrations and pH are measured in the recirculation solution once the 
flux is stabilized.  
  
Fig III-25 Pseudo stable flux of independent filtrations against [Ca2+]•[HxPO4z-] at various applied pressures 
(10 to 35 bar) and velocities (0.2 and 0.35 m s-1), the letter around the points indicates the serial name of the 
filtration (see Table III-5 for operating conditions). *all H3PO4, H2PO4-, HPO4-, and PO43- are analyzed as 
PO43- by the ionic chromatography.  
 
Two different behaviors can be observed on the figure. First, when the pH is in the 
range 7.2 to 8.3, the pseudo stable flux decreases with the increase of [Ca2+ ] • [HxPO4z-] 
until the stable flux reduces to around 10 L h-1m-2. Second, pH in the range 6.0 to 6.8, the 
pseudo stable flux keeps a high value which is not influenced by the concentration of Ca2+ 
and HxPO4z-.  
Scaling by Ca2+ and HxPO4z- is not observed on the fouled membrane after filtration 
of a solution the pH of which is lower than 7 (see section III.B.4). 
It is worth noting that the pH of MBR effluents is in the range 6.08 to 8, the phosphate 
is then in the form of dihydrogen phosphate ion (H2PO4-) or hydrogen phosphate ion 
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(HPO4-) depending on the pH. The acidic dissociation constant of them is equals to 7.21 
as Eq. III-17.   
pKa = 7.21 (Eq. III-17) 
 
According to previous studies [42,43], the solubility of calcium phosphate depends on 
the form of phosphate. Table III-7 presents the relative forms of calcium phosphate and 
their solubility. It can be observed that all calcium and hydrogen phosphate (HPO4-) 
compounds have rather lower solubility than calcium and dihydrogen phosphate (H2PO4-) 
compounds. For example, the solubility of CaHPO4 is 105 times lower than the one of 
Ca(H2PO4)2. According to Eq. III-16, the supersaturation ratio of CaHPO4 is then 105 times 
the one of Ca(H2PO4) 2 at the same concentrations of calcium and phosphate. Thus, the 
hydrogen phosphate (HPO4-) present in the solution with higher pH has much more risk to 
precipitate with calcium due to the low solubility.  
 
Table III-7 Solubility product of calcium phosphate (in form of H2PO4 and HPO4) [42,43]   
 
Thus, the two kinds of impact of [Ca2+]•[HxPO4z-] on the pseudo stable flux shown on 
Fig III-25 can be explain as follow.  
When the pH of the filtration feed is higher than 7.2, the main form of phosphate in the 
filtrated solution is HPO42-. Considering its lower solubility, the supersaturation ratio of it 
and calcium is extremely higher than the one of a feed the pH of which ranges between 6 
and 6.8 (phosphate in the form of H2PO4-). The precipitation of calcium phosphate (scaling) 
has much more risk to occur on the membrane. The pseudo stable flux then depends on the 
concentrations of calcium and phosphate in solution. These concentrations being link to the 
extent of scaling at the membrane surface, higher are the concentrations in solution, more 
important is the membrane surface area occupied by the calcium phosphate, lower is the 
Compound Formula Ksp at 25°C 
(mol2L-2) 
Monocalcium phosphate monohydrate Ca(H2PO4)2•H2O 7.24×10-2 
Monocalcium phosphate anhydrate Ca(H2PO4)2 7.24×10-2 
Dicalcium phosphate dihydrate CaHPO4•2H2O 2.57×10-7 
Dicalcium phosphate anhydrate CaHPO4 1.26×10-7 
Octacalcium phosphate Ca8(HPO4)2(PO4)4 • 5H2O 5.51×10-97 
Calcium-deficient Ca10-x(HPO4)x(PO4)6-x(OH)2-x ≈7.94×10-86 
Hydroxyapatite  Ca10(PO4)6(OH)2 1×10-116 
2
2 4 4H PO HPO H
  
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pseudo stable flux until the entire surface is covered by the scaling. This meets the 
discussion in section III.B.4 on the relationship between element analysis of fouling layer 
and pseudo-stable flux (Fig.III-22).  
When the pH of the filtration feed is in the range 6 - 6.8, the main form of phosphate is 
H2PO4-. The system can tolerate higher concentration of calcium and phosphate before 
scaling occurs on the membrane surface.  
In this study, the fouling types (see section II.B.4) highly relate to the feed pH and the 
concentration of calcium and phosphate. For pH lower than 7, scaling doesn’t not occur at 
the given concentration of calcium and phosphate and the foulant layer composition is 
colloidal silica and organic (fouling type 1). In contrast, for pH≥ 7.2, scaling can occur. 
The fouling types can then belong to groups 2 or 3: inhomogeneous or homogeneous 
scaling, depending on supersaturation ratio of CaHPO4.  
III.B.5.3 Conclusions 
The fouling types highly relate to the pH of the filtrated solution and in a second step 
to the concentration of calcium and phosphate in water matrix. Higher stable flux 
(productivity) can be obtained when the pH of the feed solution is lower than 7, scaling of 
calcium and phosphate being avoided at this pH. The pseudo stable and limiting fluxes 
depend in this case on the concentration of organic matters. For a feed pH equals or higher 
than 7.2, the risk of scaling is much higher. The value of the pseudo-stable flux then 
decreases with the increase of membrane surface area occupied by the calcium phosphate 
until an almost homogeneous scaling occurs corresponding to a low limiting flux. 
III.B.6 Filtration with adjusted pH  
    Considering the study of flux behaviors and fouling mechanisms, the higher 
productivity is proposed to be obtained at pH around 6. This section is devoted to verify the 
influence of pH on the fouling mechanism and the associated variation of flux. 
III.B.6.1 Experimental procedure 
All the steps of the filtration are conducted with a transmembrane pressure of 15 bar 
and a cross-flow velocity of 0.35 m s-1. The pH is adjusted with H2SO4 1M.  
After installing and preparing the membrane, a MBR effluent (solution (a)) is 
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introduced in the tank after adjusting its pH to 6. The filtration is first conducted in a 
concentration mode until the volume reduction factor reaches 5. Then the filtration 
follows the procedure corresponding to the recirculation mode during which the retentate 
(solution (b)) and permeate are both recycled into the feed tank. After 1 hour of 
recirculation, the pH is adjusted to 6 again and the recirculation continues for 2 hours 
with a continuous regulation of pH at 6. Then the recirculation solution (solution (c)) is 
collected for a new recirculation step with a virgin membrane. In this step, both retentate 
and permeate are normally recycled into feed tank and again the pH is adjusted to keep it 
constant at 6. The serial name of this filtration is “L”. The characteristics of solutions (a), 
(b) and (c) are reported in Table III-8.  
 
Table III-8 Characteristics of filtrated solutions during experiment with adjusted pH  
Item MBR effluent 
solution (a) 
Retentate (VRF = 5) 
solution (b) 
Retentate (VRF = 5) 
solution (c) 
pH 6.06± 0.2 7.06 ± 0.2 5.9± 0.2 
COD (mg L-1) 38 ± 3 67 ± 3 67 ± 3 
UV254 0.527 1.21 0.979 
Na+ (mg L-1) 222.4 ± 4.0 390.2 ± 7.0 339.6 ± 6.1 
K+ (mg L-1) 20.6 ± 0.3 42.3 ± 0.6 36.6 ± 0.5 
Mg2+ (mg L-1) 4.2 ± 0.1 11.1 ± 0.2 10.4 ± 0.1 
Ca2+ (mg L-1) 63.5 ± 0.8 152.9 ± 2.0 147.0 ± 1.9 
Cl- (mg L-1) 60.6 ± 1.3 54.1 ± 1.1 41.9 ± 0.9 
NO3- (mg L-1) 199.4 ± 3.0 167.9 ± 2.5 130.1 ± 2.0 
SO42- (mg L-1) 209.6 ± 12.6 888.0 ± 53.3 893.6 ± 53.6 
PO43- * (mg L-1) 29.4 ± 0.9 49.7 ± 1.5 39.2 ± 1.2 
*Due to the analytical method, all the H3PO4, H2PO4-1, HPO42- and PO43- were measured as PO43-. 
III.B.6.2 Variation of permeate flux with time in different matrix pH 
Fig.III-26 exhibits the variation of flux with time during the different filtration steps. 
During the concentration step of solution (a), pH increases from the initial value of 6 to 
6.9. Simultaneously, the flux significantly decreases from 185 to 35 L h-1m-2. During the 
recirculation of concentrate (b), the pH slightly rises to 7.06. The reduction of flux 
continues in this pH condition until 32 L h-1m-2. As soon as pH in controlled to 6, the 
permeate flux stabilizes at 32 L h-1 m-2 over the 2 hours of recirculation. Then the 
recirculation solution (c) is collected and the filtration is restarted with a new membrane. 
The pH is maintained at 6 during this step. The initial flux (166 L h-1m-2) is almost the 
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same than the one obtained with solution (a). However, it can be observed that the 
reduction of flux is less than during the filtration of solution (a) even if the concentrations 
of organics and ions in solution (c) are higher. The pseudo stable flux is obtained at 127 L 
h-1m-2. 
 
Fig. III-26 Variation of flux during filtrations in different pH conditions. The hollow points represent the 
flux and the solid points represent the pH of the filtrated solution at the same time. 
 
A high correlation between the permeate flux and the feed pH is observed during these 
filtrations. In the concentration and the first recirculation steps, the flux continuously 
decreases, when the value of pH rises from 6 to 7. The reduction of flux is stopped when the 
pH of the matrix is adjusted again to 6. We have previously demonstrated that this last pH 
value is inappropriate to form scaling. However, the permeate flux cannot recover its initial 
value from the shift of pH, which verifies the irreversibility of the fouling layer formed. 
The slight decrease of flux during recirculation using a new membrane maintaining the pH 
at 6 confirms that the fouling can be controlled by adjusting pH. 
Based on the discussion in sections III.B.4 and III.B.5, it can be confirmed that the 
severe reduction of flux during the filtration at elevated feed pH is due to the occurrence of 
scaling. The characterization of fouling layer on membrane samples is carried out in next 
section to verify the effect of pH on the fouling mechanisms.   
III.B.6.3 Characteristics of fouling layer in different matrix pH 
The SEM-EDX analysis was conducted to determine the characteristics of fouling layer. 
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Fig. III-27 shows the micrographs of the membranes after filtrations.  
The first membrane is the one that reached rather low flux after concentration and 
recirculation steps with elevated pH of the filtrated solution. The second membrane is the 
one that obtained greater pseudo stable flux with pH of the filtrated solution maintained at 
6. From the images, it can be observed that the morphology of the two membranes 
surface is different after dehydration in the same conditions (see section II.5). For the first 
membrane, serious surface cracking is observed. The surface cracking after dehydration is 
probably due to the different compositions and characteristics of the fouling layer. The 
top flat-board-like fouling seems to be compact. The surface cracking is not significant in 
the micrograph of second fouled membrane. The fouling layer is looser than the one on 
the other membrane. 
 
Fig. III-27 SEM images of membranes after filtrations: (a) first fouled membrane 300×, (b) first membrane 
fouled 3000×, (c) second fouled membrane 300×, (b) second fouled membrane 3000× 
 
The EDX analysis was conducted to measure the elements composition at different 
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locations on the membrane surface. Tables III-9 and III-10 present the elements 
composition for the first and the second membrane, respectively. 
 
Table III-9 Elements composition on different locations on the first fouled membrane surface 
Top fouling layer 
Samples  1 2 3 4 5 6 7 Average 
Elements  Weight % from the different locations 
Silicon 7.3 8.8 8.3 9 5.2 8.2 12.2 8.4 
Sulfur 0 3.9 0 0 4.1 0 0 1.1 
Calcium 45.6 47.9 40.4 38.1 51.6 39.6 38 43.0 
phosphorus 29.6 24.5 27.8 29.3 23.6 31.4 30.1 28.0 
Magnesium 0 0 0 3.5 0 0 2.9 0.9 
Aluminum 8.4 7.3 6.8 8.9 5.8 9.8 9.1 8.0 
Iron 9.1 0 11.1 0 9.6 10.9 7.7 6.9 
Bottom dark layer: fouling layer below and top of membrane surface 
Samples  1 2 3 Average 
Elements  Weight % from the different locations 
Silicon 0 12.5 13.3 8.6 
Sulfur 100 87.5 86.7 91.4 
 
Table III-10 Elements composition on different locations on the second fouled membrane surface 
Samples 1 2 3 4 5 Average 
Element  Weight % from the different locations 
Silicon 9.3 13.2 7.9 0 12.6 8.6 
Sulfur 35.6 30.4 26.7 0 71.1 32.8 
Calcium 19.5 23 18 39.4 16.3 23.2 
phosphorus 11.9 0 17.8 0 0 5.9 
Magnesium 0 0 5.2 0 0 1.0 
Aluminum 6.6 10.2 9.7 0 0 5.3 
Iron 17.2 14.7 0 0 8.0 
Chlorine 0 0 0 28.8 0 5.8 
Potassium 0 0 0 39.1 0 7.8 
 
From the analysis, the major elements on the flat-board-like top fouling layer of the 
first membrane are calcium and phosphate, which confirms that the scaling occurs during 
the concentration and the first recirculation steps. The distributions of calcium and 
phosphate are quite uniform, which indicates that the scaling is homogenous on the 
membrane surface. The sulfur that correlates with the membrane structure is present in low 
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percentage and even cannot be detected on most of locations. It means that the 
flat-board-like top fouling layer is thicker than the analyzed depth by EDX. The Ca/S and 
P/S ratio are equal to 39 and 25, respectively. The main elements detected on the bottom 
dark layer (cracks ) are silicon and sulfur which correlates with colloidal silica fouling and 
the membrane structure, respectively. The cracks between flat-board-like pieces could be 
the bottom fouling layer and top of membrane.  
For the second membrane, the main elements detected in the fouling layer are silicon 
and calcium. The phosphate can be detected rarely on some locations of the membrane 
surface. Sulfur is detected on almost all locations with a high percentage. The average P/S 
ratio which is related to scaling is calculated to be 0.18 much less than in the first 
membrane. The P/S is of great accordance with the relationship between elements ratio and 
pseudo stable flux presented in Fig.III-22 (point L, section III.B.4.1). Moreover, it was 
studied on section III.B.5 that in absence of scaling, pseudo-stable flux is correlated to 
organics concentration according the film theory. The pseudo stable flux obtained during 
this last filtration (L) at pH 6 is not so far from the linear relationship with concentration of 
organics (UV254) (point L, Fig.III-24, section III.B.5.1). These results confirm that the main 
fouling type during the recirculation at pH = 6 is colloidal silica and organics fouling even 
if some other elements can be detected on the membrane surface. 
Thus, the first membrane after filtration at elevated pH (6-7) is fouled by a 
combination of colloidal silica fouling and homogenous calcium phosphate scaling. The 
fouling type for the second membrane after filtration at a pH maintained at 6 is colloidal 
silica and organics fouling in absence of scaling. These results are in accordance with the 
study on section III.B.5.2 showing that the fouling types (with or or without scaling) are 
greatly influenced by the pH of filtrated solution. It is confirmed that the severe calcium 
and phosphate scaling can be avoided by controlling the pH of feed at 6 (or lower) 
increasing considerably the productivity of the process.  
III.B.7 Productivity control  
This section is devoted to investigate the productivity control during nanofiltration 
process, according to the studies of critical flux and limiting flux, fouling mechanisms 
and parameters influencing them. 
According to previous sections, three types of flux behaviors associated with fouling 
mechanism are described as follow.  
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Type 1: the limiting flux approximates to the critical flux, membrane is fouled by an 
homogenous colloidal silica and organics layer. 
Type 2: the limiting flux is lower than the estimated critical flux. Membrane is fouled 
by colloidal silica and organics and an inhomogeneous scaling. The value of limiting flux 
depends on the membrane surface area occupied by scaling.  
Type 3: the limiting flux is well below the possible critical flux. The coupling of 
colloidal silica and organics fouling and homogenous scaling is observed.    
Scaling that is the most important fouling mechanisms can lead to severe reduction of 
stable flux. Base on the study above, it can be controlled by the pH, the concentration of 
calcium and phosphate.   
It was assumed on section III-A-5 that there is a colloidal silica and organics fouling 
layer which can be characterized by a threshold fouling resistance above which scaling 
occurred. This threshold resistance (Rt) and the corresponding threshold permeability (Lt) 
before scaling were defined. Lt was estimated on the section III-A-5, as 3.86 L h m-2 bar-1. 
In Fig.III-28, we can separate the variations of pseudo stable flux as a function of 
applied pressure into three regions through the pure water permeability and the threshold 
permeability before scaling (Lt): non-fouling region, fouling by colloidal organics and 
fouling by scaling. The non-fouling region is enclosed on the left by the average pure water 
permeability (full line). The region in between pure water permeability and threshold 
permeability before scaling (Lt) (dashed line) corresponds to conditions for which colloidal 
silica and organics fouling is observed (fouling type 2). Finally flux in the region on the 
right side of Lt (region of scaling) indicates scaling occurs (fouling type 2 and 3). 
 
Fig III-28 Experimental pseudo stable flux as a function of applied pressure with various cross flow velocities: 
 0.35 m s-1, 0.2 m s-1. The full line is the average pure water permeability of all pieces of membrane 
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used. The dashed line is the threshold permeability (Lt).  
The experimental fluxes obtained during the whole study are also shown on Fig.III-28. 
A great accordance between the experimental results and the predictive regions is obtained. 
     -The filtration at the pressure (3 and 5 bar) lower than the critical pressure, the 
corresponding flux is on the line of pure water permeability.  
     -The fluxes of filtrations L, P, Q (15, 25, 35 bar) are in the region of colloidal organic 
fouling and close to Lt. The fouling type of them is confirmed to be colloidal silica and 
organics fouling by ATR-FTIR and SEM-EDX analysis on section III.B.4 and III.B.6. 
     -The fluxes of filtrations E, G, F (15 bar) are included in fouling type 2: combination 
of inhomogeneous scaling and colloidal silica and organics fouling. From the SEM-EDX 
analysis, for the filtrations E and G, less surface area of membrane is occupied by calcium 
phosphate scalant, the stable flux of them is then close to Lt; in contrast, the stable flux of 
filtration F deviates more from Lt due to higher membrane surface coverage by calcium 
phosphate scalant. 
-The flux of filtrations A, B, C, D (25 and 35 bar) with a pseudo stable flux around 
10 L h-1m-2 are in the region of scaling (type 3). The fouling analysis evidences an 
homogenous scaling on the fouled membrane surface after filtration.   
It can be observed a slight shift of fluxes for filtrations P and Q beyond Lt line, 
noting that no scaling occurs during these experiments. This is due to the fact that Lt is 
evaluated experimentally with a certain feed from the filtration experiment following the 
square wave method. The exact value of this threshold permeability can “shift” depending 
on the water matrix due to different organics concentrations.  
In this study, UV254 absorbance (related to the concentration of organic matters) of the 
various feeds used (MBR effluents) is in the range of 0.78 to 2.18. Table III-10 compares 
UV254 absorbance of feeds used in filtrations L, P, Q to the one used for the evaluation of Lt 
(UV254 1.38). 
Table III-10 Absorbance of UV254 for various filtrations 
 
-In the case of a feed with lower concentration of organics, the pseudo stable flux is 
above Lt in the region of colloidal silica and organics fouling (like point L in Fig III.28) 
-In the case of a feed with higher concentration of organics, the pseudo stable flux can 
 Exp. for evaluation of Lt L P Q 
UV254 1.38 0.97 2.09 2.18 
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exhibit a shift as points P and Q in Fig.III.28. However, this shift is slight, even if the UV254 
absorbance of these feeds is almost twice the one of the water matrix used to evaluate Lt. 
    Thus, in the context of the water matrix variability identified in the MBR effluent used 
in this project, Lt quantification for a certain matrix composition from the method presented 
in section III.A can give a satisfactory evaluation of the threshold permeability below 
which scaling is expected.  
To conclude, the productivity is ideal in the un-fouling region, acceptable in the region 
of colloidal organics fouling, while low in the region of scaling. During the continuous 
nanofiltration process, if the flux approaches the scaling region, some actions such as 
adjusting feed pH and even cleaning membrane could be considered to avoid the scaling.  
III.B.8 Conclusion  
    For independent nanofiltration of MBR effluent, the pseudo stable flux increases 
with the transmembrane pressure and does not decrease with filtration time until the 
initial flux above the critical flux. Greater critical flux is obtained with higher cross-flow 
velocity.  
    Two limiting fluxes are observed: one approximates possible critical flux, the other 
is well below the critical flux. Considering that the limiting flux may relate to the fouling 
types, the fouling compositions are determined by FTIR and SEM-EDX. It is evidenced 
that the two limiting fluxes relate to different fouling mechanisms. The one 
approximating possible critical flux is induced by an homogeneous colloidal silica and 
organics fouling; the other one with rather low flux is due to the presence of homogenous 
calcium phosphate scaling and colloidal silica and organics fouling simultaneously on the 
membrane surface. In this last situation, membrane surface is almost completely occupied 
by an homogenous calcium phosphate layer. Even if the percentage of Ca and P on the 
membrane surface increases, no further decrease of flux is observed. There is an 
“intermediate” case for which calcium and phosphate distribute inhomogeneously on 
partial membrane surface. The pseudo stable flux can be in a wide range between the two 
extreme limiting fluxes mentioned before. Its value then greatly depends on the surface 
area occupied by calcium and phosphate scaling.  
    The fouling types highly relate to the pH of the filtrated solution and in a second step 
to the concentration of calcium and phosphate in solution. When the pH of the feed 
solution is lower than 7, scaling of calcium and phosphate is avoided. The pseudo-stable 
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flux depends in this case on the concentration of organic matters in solution. For a feed 
pH equal or higher than 7.2, the risk of scaling is much higher.  
    The effect of pH on fouling types and related flux is verified by an additional 
filtration with adjusted pH. The combined fouling by colloidal silica and homogenous 
calcium phosphate scaling occurs at elevated pH (6-7) and the pseudo stable flux is rather 
low in this case. In contrast, at a pH maintained at 6 only colloidal silica and organics 
fouling is observed leading to greater flux. It is then confirmed that the severe calcium 
and phosphate scaling can be avoided by controlling the feed pH at 6 (or lower), 
increasing considerably the productivity of the process.  
Finally, the relevance of threshold permeability before scaling (Lt) which is 
estimated in section III-A is verified from fluxes obtained in a series of independent 
filtrations. Thus, it can be recommended to estimate Lt for certain filtration system and 
matrix (from the method presented in section III.A) before application of nanofiltration 
process. If the flux approximates to the scaling region, some actions such as adjusting 
feed pH and even cleaning membrane could be considered to avoid the scaling.    
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III.C Process selectivity - Influence of fouling types (water 
matrix) and operating conditions on the rejection 
This section investigates the selectivity of the nanofiltration process with regard to 
components (pharmaceuticals and salts) of the MBR effluent. Rejection of salts and 
pharmaceuticals is studied to determine the influence of the water matrix and the fouling 
types on the selectivity, beside other significant factors such as membrane material and 
structure and pharmaceuticals properties.  
III.C.1 Salts rejection 
Rejections of salts were calculated according to the equation Eq.II-1 as stable flux 
was reached at the end of different filtration experiments. Results are reported in 
Fig.III-29. Variations of the rejection of salts are presented considering the different 
fouling types described in previous section.  
 
 
Fig.III-29 Salts rejections according to different fouling types: unfouled membrane (type 0), membrane 
fouled by homogenous colloidal silica and organics (Fouling type1), membrane fouled by colloidal silica 
and organics fouling and homogenous scaling (Fouling type 3) 
 
For the unfouled membrane, the salts rejection is mainly influenced by size 
exclusion and electrostatic repulsions [11]. The pore size (rp) of NE 70 which is estimated 
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from filtration of organic tracers and model fitting [44] and the hydrated radius of ions of 
interest for us [45,46] are presented in the table III-11. 
 
Table III-11 Estimated membrane pore radius and hydrated radius of ions 
NE 70 Membrane pore (rp): 0.34 - 0.36 [44] 
Hydrated ionic radius (rh) (nm) 
 Na+ K+ Mg2+ Ca2+ Cl- NO3- SO42- HPO42- H2PO4-
Kiriukhin and 
Collins [45]   
0.178 0.201 0.300 0.253 0.195 - 0.300 0.327 0.302 
Marcus [46]     0.181 0.179    
 
By taking into account hydrated ionic radius; big ions should exhibit higher rejection. 
Fig III-29 shows that the rejection of SO42- is higher than the rejection of Mg2+, even if 
hydrated ionic radiuses (table III-11) of them are approximately the same. These rejection 
behaviors can be explained by electrostatic interactions between ions and the membrane 
surface [47]. Considering the negative charge of the membrane surface, the higher 
rejection of SO42- can be explained by the electrostatic repulsions between SO42- and 
membrane surface. The positive charge of Mg2+ could lead to electrostatic attractions with 
the membrane surface, which can enhance the concentration of Mg2+ on membrane 
surface and the diffusion of Mg2+ to the permeate side. HPO42-/ H2PO4- and SO42- have 
similar hydrated ionic radiuses; however rejections of them are difficult to be compared. 
The filtrated solution pH being 7.4 the ratio of HPO42- and H2PO4- is 2.3:1. HPO42- is a 
divalent ion as SO42-, while H2PO4- is a monovalent ion.  
Considering electrostatic repulsions, negative rejections of Cl- and NO3- are 
observed. Previous studies demonstrated that co-ions (ions with the same sign of charge as 
the membrane) rejection decreases dramatically with the ion charge and may even become 
negative [48–50]. The authors explained the co-ions behavior by the Donnan exclusion. In 
the present study, the negative rejection of Cl- and NO3- can be understood by the Donnan 
effect and steric exclusion. A more significant negative rejection of NO3- than Cl- probably 
attributed to the smaller hydrated ionic radius of NO3-, which is commonly reported in NF 
process [51–53]. On the other hand, rejections of cations are low because of electrostatic 
attractive interactions with the membrane surface. This also contributes to the transfer of 
smaller anions Cl-, NO3-, respect of electroneutrality in the permeate side being in this 
case the driving-force. 
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For the membrane fouled by homogenous colloidal organics and silica layer (Fouling 
type 1), rejection of SO42- and Mg2+ follows the same tendency as unfouled membrane 
(R(SO42-) > R (Mg2+)) which indicates the dominant effect of electrostatic repulsions on 
ions rejection.  
When the membrane is fouled by colloidal silica and organics layer and homogenous 
scaling (type 3), the rejection of ions seems not being significantly related to the 
electrostatic effects. Rejections of SO42- and Mg2+ reach the same high value. The ions 
rejection follows the order: 
 
    
 R (SO42-) ≈ R (Mg2+) ≈ R (HPO42-/ H2PO4-) > R(Ca2+) 
 
This order is in excellent accordance with the size of hydrated ionic radius. 
 
         
rh (SO42-) ≈ rh (Mg2+) ≈ rh (HPO42-/ H2PO4-) > rh (Ca2+) 
 
These results indicate that ions rejections by fouled type 3 membrane are governed 
by the size exclusion. Indeed, it can be assumed that the scaling layer on the membrane 
surface attenuates (or even cancels) the effect of the negative charge of the membrane 
surface on the rejection of solutes. Previous studies [47,54,55] reported the positive shift 
of zeta potential on membrane surface after fouling. The electrostatic repulsions between 
solutes and membrane surface being attenuated we can assume that size exclusion 
mechanism becomes predominant. The membrane active pore size can be changed by 
pore blocking which can increase the sieving effect. The rejection of SO42- , Mg2+, 
HPO42-/ H2PO4- and Ca2+ is greater than 85 % by means of size exclusion even if their 
hydrated ionic radius is less than the estimated virgin membrane pore radius. 
It can be noticed that the membrane manufacturer specifications for rejections of 
NaCl (40~70 %) and MgSO4 (99.5 %) which are obtains in specific conditions seem to 
not relate well to the salts rejection in MBR effluent, excepted for SO42-. 
In conclusion, the rejection of ions by the unfouled membrane and the membrane 
fouled by an homogenous colloidal organics and silica layer (fouling type1), is 
dominantly governed by electrostatic repulsions; while the ions rejection by a membrane 
fouled by colloidal silica and organics and homogenous scaling (fouling type 3) is 
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governed by size exclusion. Concerning the ions rejection by the membrane fouled with 
inhomogeneous scaling (fouling type 2) it is expected to be an intermediate situation 
between fouling type 1 and type 3 depending on the membrane surface area occupied by 
scalants.  
 
III.C.2 Pharmaceuticals rejection 
III.C.2.1 Effect of fouling types and pharmaceuticals properties - hydrophobic 
interaction and size exclusion  
 
This section is devoted to quantify pharmaceuticals rejection in MBR effluent and 
identify key factors affecting it. The rejection of three selected pharmaceuticals in MBR 
effluent is studied in consideration with the different fouling types previously defined. 
These three pharmaceuticals: ciprofloxacin (CIP), ifosfamide (IFO) and 
cyclophosphamide (CYP) present different physico-chemical properties reported in table 
II-2 (section II.1.1). Based on these properties and on the literature [47,56,57], factors 
affecting these pharmaceuticals rejection by a nanofiltration membrane are expected to be 
not only size exclusion and electrostatic interactions but also hydrophobic-hydrophilic 
interactions. In order to be able to discuss this point, the contact angle of the membrane 
surface was measured at the end of each filtration (corresponding to the different fouling 
types) and was reported as a function of the weight percentage of calcium and phosphate on 
the membrane surface after filtrations (Ca+ P%), considering that calcium and phosphate 
are the most important components contributing to scaling (section III.B). 
Fig.III-30 shows the variation of membrane contact angle after filtration of MBR 
effluent as a function of the percentage of Ca and P detected on the membrane surface 
(from EDX analysis, table III-6 in section III.B.4.1). Contact angle indicates the 
hydrophobicity level of the membrane surface. The larger the contact angle, the more 
hydrophobic the membrane surface is. The contact angle of the virgin membrane (before 
compaction) is 40 (on Y-axis). This value seems to increase considerably to around 80 after 
compaction and filtration at 5 bar (point I), even if there is no evidence of the presence of a 
fouling layer. Verliefde et al. [58] found that after compaction in ultrapure water, contact 
angles of some polyamide membranes increase from 48 to 80. Higher is the initial 
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hydrophilicity of the membrane, the more significant the increase in contact angle due to 
compaction is. Then, similarly to Verliefde et al. work, contact angle increase after 
filtration at 5 bar can be mainly attributed to the effect of membrane compaction.  
From Fig.III-30, it can be observed that the contact angle decreases with the percentage 
of calcium and phosphate on membrane surface, in particular when the scaling is 
homogeneous (fouling type 3). It seems that scaling modifies the hydrophobicity of the 
membrane to a more hydrophilic surface. 
 
 
Fig.III-30 Contact angles of the membrane surface after filtration of MBR effluent as a function of the 
percentage of Ca and P detected on fouled membrane surface (from EDX analysis, table III-6 in section 
III.B.4.1). 3 regions can be defined corresponding to: Unfouled membrane; fouling type 2: membrane fouled 
by inhomogeneous scaling and colloidal silica and organics layer; fouling type 3: membrane fouled with 
homogenous scaling and colloidal silica and organics fouling. B, D…I is the serial name of filtrations. 
 
   Fig.III-31 exhibits rejections of ciprofloxacin, ifosfamide and cyclophosphamide for 
each filtration according to different fouling types and the corresponding contact angle. 
Generally, the rejection of pharmaceuticals decreases with the increase of hydrophobicity 
(contact angle). The relatively less hydrophilic pharmaceutical (cyclophosphamide, log P = 
0.76) shows a more significant reduction in rejection when the contact angle increases. In 
contrast, the rejection of CIP, which is more hydrophilic, decreases less (log P = 0.28).  
Considering the influence of fouling types, when the membrane is unfouled or suffers 
from an inhomogeneous scaling and fouling by colloidal organic matters, the pseudo 
stable flux is greater. The rejection of pharmaceuticals is lower and differs according to 
pharmaceuticals properties. More precisely, the rejection of pharmaceuticals seems to be 
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correlated with their hydrophobicity. The pharmaceuticals rejection follows the order: 
 
R(CIP) >R(IFO) > R(CYP) 
 
The higher value of log P indicates that the molecule is more hydrophobic: 
 
log P (CIP) < log P (IFO) < log P (CYP) 
 
The low rejection of cyclophosphamide can be due to hydrophobic interactions 
between membrane surface and compounds.  
 
 
Fig.III-31 Rejection values of pharmaceuticals:  and  ciprofloxacin rejection in MBR effluent and 
ultrapure water,  ifosfamide, cyclophosphamide; the tendency of contact angle as a function of the 
pseudo stable flux for different fouling conditions: Unfouled membrane; fouling type 2: membrane fouled 
with inhomogeneous scaling and colloidal silica and organics fouling; fouling type 3: membrane fouled with 
homogenous scaling and colloidal silica and organics fouling.  
 
These interactions decrease when the membrane surface is less hydrophobic (smaller 
contact angle), resulting in a significant increase of the rejection of hydrophobic 
pharmaceuticals in fouling type 2 region. 
When a homogeneous scaling occurs on the membrane surface (fouling type 3), a 
low pseudo stable flux is observed. In this case, rejections of pharmaceuticals are around 
100% independently of pharmaceuticals or matrix properties. Previous studies show that 
the fouling layer can reduce the membrane pore size [47,55] by pore blocking which can 
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increase the pharmaceutical rejection by size exclusion. This is also in accordance with 
the increase of ions rejection (both cations and anions) for this type of fouling (section 
III.C.1). As a consequence with fouling type 3, the contribution of hydrophobic 
interactions is totally screened, size exclusion becoming the principal rejection 
phenomenon. 
III.C.2.2 Effects of water matrix  
When the membrane is unfouled, the rejection of pharmaceuticals in MBR effluent 
is not only related to the interactions with the virgin membrane but is also influenced by 
water matrix characteristics. Previous studies reported that pH, ionic strength and the 
hardness of the water matrix can impact MWCO of membrane by modifying the 
electrostatic interactions within the membrane pores [9,34,59–62]. Relatively alkaline pH 
of MBR effluent (MBR effluent, pH 7-8, conductivity 600-700 µs cm-1; ultrapure water, 
pH 5-6, conductivity 0.18 µs cm-1) can increase the electrostatic repulsions within the 
membrane pores and enlarge the pore size, while the higher ionic strength can reduce the 
electrostatic repulsions in membrane pores and induce a decrease in apparent pore radius. 
Due to these competitive effects, the membrane MWCO following contact with MBR 
effluent can be different from the one of the virgin membrane (in ultrapure water). The 
increase of flux at the beginning of the MBR effluent filtration by comparison to pure 
water filtration (Chapter III.B) seems to confirm an enlargement of membrane pore. A 
rather lower rejection of pharmaceuticals is then expected when the membrane is 
unfouled during filtration of MBR effluent compared to results obtained in pure water. As 
shown on Fig.III-31, the rejection of CIP in MBR effluent is considerably lower than the 
one in ultrapure water, when the membrane is unfouled.  
When severe fouling is established, there is a predominant effect of pore blocking on 
the pharmaceuticals rejection which is higher than in pure water. This last case is 
observed for fouling type 3. 
For moderate fouling, combined impact of MBR matrix which reduces 
pharmaceuticals rejection and of fouling layer which increases it can contribute to 
intermediate rejection behavior. 
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III.C.2 Conclusion 
   With the unfouled membrane and membrane fouled with homogenous colloidal 
organics and silica the rejection of ions and pharmaceuticals is predominantly governed 
by electrostatic repulsions and hydrophobic interactions respectively. The rejection of 
both ions and pharmaceuticals with membrane fouled by colloidal silica and organics and 
homogenous scaling is governed by size exclusion. When the fouling layer is not settled, 
the apparent MWCO of the membrane is enlarged in MBR effluent compared to ultrapure 
water; then pharmaceuticals, usually retained by NE70, can pass through. In contrast, 
when fouling is established, this effect of water matrix is screened by pore blocking. 
The combined effect of the matrix and fouling layer on the pharmaceuticals rejection 
results in various rejection behaviors of pharmaceuticals depending on the type and extent 
of the fouling.  
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III. Conclusion 
The aim of this chapter was to investigate the main parameters which can influence 
the productivity and the selectivity of nanofiltration as primary step of tertiary treatment. 
It has been possible to estimate a critical flux in the case of the filtration of the MBR 
effluent complex matrix from the square wave method. The ideal productivity could be 
obtained with an initial flux lower than the critical flux to avoid the fouling. Two limiting 
fluxes are observed. One of them is around the estimated critical flux while the other is 
well below due to the presence of scaling. A working diagram reporting permeate flux 
versus applied pressure has been divided in three regions: un-fouling region, region of 
colloidal silica and organics fouling and region of scaling. The productivity is ideal in the 
un-fouling region, acceptable in the region of organics fouling while low in the region of 
scaling. Maintaining the pH of filtrated solution at 6 is verified to be a solution to avoid 
the scaling. 
Rejection of pharmaceutical are various due to the combined effect of water matrix, 
membrane properties and fouling mechanisms. The presence of homogeneous scaling on 
membrane surface can induce the rather low flux while lead to the excellent rejection of 
pharmaceuticals.  
Regarding association of productivity and selectivity with fouling types, in a 
continuous process, the filtration retentate characteristics can differ over time, impacting 
the performance of electrochemical oxidation considered as second step of the tertiary 
treatment. The efficiency of EO to eliminate pharmaceuticals in the nanofiltration 
retentate will be studied in section IV and V with the concentrates collected after the 
various filtrations. Then the operating conditions offering the best compromise for the 
coupling process will be discussed to improve the global efficiency of the treatment. 
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Chapter IV Elimination of pharmaceuticals by electrochemical oxidation
This chapter investigates the removal of pharmaceuticals by electrochemical oxidation. 
In this chapter, the impact of the composition of the solution (organic and inorganic 
components) is studied. For that, the interaction between pharmaceuticals, the chemical 
reactions between pharmaceuticals and electrogenerated oxidants or byproducts is studied.   
This chapter has two parts: the section IV.A is devoted to the elimination of 
pharmaceuticals in synthetic solutions and in section IV.B. The study is performed in NF 
retentate.  
IV.A Electrochemical oxidation in synthetic solution 
    This section investigates the removal of pharmaceuticals containing in the synthetic 
solutions by electrochemistry. The influence of factors on electroxidation are studied such 
as the applied current intensity, the presence of salts and common organic waste, the 
competition and interaction between pharmaceuticals on the degradation of 
pharmaceuticals. Finally, a numerical model for the degradation of pharmaceutical during 
electrolysis is also proposed in this chapter. 
IV.A.1 Study of ciprofloxacin as molecule model 
The first part of this study is devoted to the electrochemical study of the oxidation by 
cyclic voltammetry. Then galvanostatic electrolyses are performed. Ciprofloxacin (CIP) 
degradation and mineralization rate are followed. 
IV.A.1.1 Electrochemical study of ciprofloxacin   
The electrochemical behavior of CIP in sulfuric acid solution is studied by cyclic 
voltammetry. Fig.IV-1 presents the cyclic voltammograms obtained on BDD in the 
electrolyte (H2SO4 0.1M) with and without CIP (0.068mM). The voltammogram of H2SO4 
(0.1M) shows the oxidation of water at 1.25 V/SCE (corresponding to 0.95 mA cm-2). 
According to BDD’s electrochemical properties, ·OH is expected to be produced from 
water discharge as Eq. IV.1-1.  
  
E0 = 2.74 V / SHE [1] (Eq.IV.1-1) 
 
2H O OH H e
    
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In presence of CIP an oxidation peak was observed before the water discharge at 
1V / SCE, the current intensity of the oxidation wave has a peak value of 2.27 mA cm-2. 
This wave is an irreversible direct electrons transfer between CIP and BDD anode. 
 
 
Fig.IV-1 Cyclic voltammetry of CIP 0.068 mM in 0.1M H2SO4 .Working electrode: BDD (0.196 cm2), 
Counter electrode: Pt, Reference electrode: SCE. Scan rate: 100 mVs-1, ω = 800 rpm. 
 
Montes et al. [2] observed the similar behavior with BDD electrode in 
Britton-Robinson solution (pH = 10), the oxidation current of CIP started to increase at 
approximately +0.85 V/ref and reached a plateau value between +0.95 and +1.10 V/ref.  
The mechanism of CIP oxidation involving two-electrons was proposed by Fotouhi and 
Alahyari with multi-wall carbon nanotubes film-modified glassy carbon electrode [3] 
(see Fig.IV-2).  
 
 Fig.IV-2 electrochemical reaction of CIP 
 
    In parallel hydroxyl radical produced during water discharge. Hydroxyl radical, a 
strong oxidant, act as a for oxygen transfer. 
Thus, CIP can be oxidized by BDD anode with two pathways: direct electron transfer 
and oxygen transfer via ·OH.  
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IV.A.1.2 Galvanostatic electrolysis of CIP solution 
Galvanostatic electrolyses are performed in synthetic solutions containing CIP.   
Fig.IV-2 shows that the concentration of CIP decays with (a) EO time and (b) electrical 
charge. CIP degradation follows a pseudo-first order kinetic and the observed rate constant 
(kobs) is determined as 0.0287 min-1 (inset panel). 97 % of CIP removal was reached after 
120 min of electrolysis with a charge consumption of 0.2A h L-1.  The total removal of CIP 
was obtained after 180 min. 
 
(a) (b) 
Fig.IV-2 CIP concentration decay with (a) EO time and (b) electrical charge during 300min electrolysis of 1L 
CIP solution in K2SO4 0.1 M at pH = 3.7. [CIP]0 = 20.64 mg L-1 (0.0623 mM), I = 0.1A (i = 1.45 mA/cm2,  
i0lim = 1.29 mA/cm2), flow rate = 366 L h-1, T = 30 °C. Inset panel: pseudo –first order kinetic analysis of CIP      
The removal of TOC is shown in Fig.IV-3 (a) during electrolysis of CIP solution. 84% 
of TOC was removed after 300 min (0.5Ah L-1) of electrolysis.  
(a) (b) 
Fig.IV-3 (a) TOC degradation (b) Normalization of carbon of CIP and carbon of TOC during electrolysis of 
1L CIP solution in K2SO4 0.1 M at pH = 3.7. [CIP]0 = 20.64 mg L-1 (0.0623 mM), I = 0.1A (i =  1.45 mA/cm2,  
i°lim = 1.29 mA/cm2), flow rate = 366 L h-1, T = 30 °C.  
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    Fig.IV-3(b) presents a comparison between TOC and carbons calculated from the 
remaining CIP concentration (1 mol of CIP corresponds to 17 mol of carbons). The 
difference of the carbons of CIP and carbons of TOC represents the intermediates of CIP 
degradation. Fig.IV-3 (b) highlights that CIP was completely removed after 180 min, the 
remaining TOC is 46%, which corresponds to the intermediate compounds from CIP 
oxidation. The complete mineralization takes more time and energy due to the mass 
transfer limitation. Moreover, some generated carboxylic acids have low reaction rate with 
•OH compared with aromatics [4].   
FigIV-4 plots the COD decay with time during electrolysis. The graph compares the 
experimental value and theoretical COD decay which can be calculated with Eq.I-24 (see 
chapter I) in the case of mass transfer controlled regime. A good agreement between 
experimental COD and theoretical values are observed. 100% of COD was removed after 
300 min of electrolysis (0.5 Ah L-1). 
 
 
Fig.IV-4 COD decay with time during electrolysis of 1L CIP solution in K2SO4 0.1 M at pH = 3.7. 
[COD]0 = 28 mg L-1, I = 0.1A (i =  1.45 mA cm-2,  i0lim = 1.29 mA cm-2), flow rate = 366 L h-1, T = 30 °C  
 
The concentration of NO3- and NH4+ during electrolysis of CIP solution was present 
on Fig.IV-5. During degradation of CIP, NO3- and NH4+ appear after 10 min electrolysis 
corresponding to 20 % CIP degradation. After 300 min of electrolysis, removal of organic 
nitrogen reaches 62 %. The nitrogen in CIP structure is conversed to NO3- and NH4+with a 
ratio of 1:3.  
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.  
Fig.IV-5 Nitrogen concentration of CIP, and the concentration of NO3- and NH4+ during electrolysis 1L of 
synthetic CIP solution: [CIP]0 = 0.069 mM in K2SO4 0.02 mM; I = 0.1A (Ilim  = 0.08A), flow rate = 366 L 
h-1, T = 30 °C.    
IV.A.1.3 Conclusion 
This section is devoted to the electroxidation of CIP chosen as molecule model of 
pharmaceuticals. The oxidation has occurred by direct electron transfer and via ·OH 
(oxygen transfer). Its degradation follows pseudo-first-order kinetics. COD decayed with a 
good agreement between experimental and theoretical value under mass transfer controlled. 
The mineralization degree of CIP solution (TOCfinal/TOC0) reached 84% after 300 min of 
electrolysis. 
 
IV.A.2 Influence of the applied current on CIP mineralization 
This section investigates the influence of the applied current on the rate of CIP 
degradation rate, TOC and COD removal. The galvanostatic electrolyses are conducted at 
various applied current intensities corresponding to different regimes: I < Ilim0, I > Ilim0, 
I >> Ilim0. The initial limiting current intensities are calculated with initial COD values, 
according to BDD’s electrochemical properties (Eq.I-24). The operating conditions for 
each electrolysis are presented in table VI-1. 
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Table IV-1 Applied current and initial operating conditions for each electrolysis with BDD anode in K2SO4 
0.1 M, T = 30 °C, flow rate = 366 L h-1, [COD]°≈ 35 mg/L, [TOC]°≈10-11mg/L 
 [CIP]0  
(mM) 
Current 
intensity 
I (A) 
Current 
density  
i (mA cm-2)
i0lim  
(mA cm-2) 
I/I0lim 
 
 
 
I < I0lim 
0.0522 0.03 0.43 0. 93 0.5 
0.0523 0.05 0.72 0.93 0.8 
 
I > I0lim 
0.0622 0.1 1.45 1.10 1.3 
0.0561 0.5 7.25 1.00 7.2 
I >> I0lim 0.0568 1.5 21.74 1.00 21.7 
IV.A.2.1 Influence of applied current on CIP degradation rate  
Figure IV-6 presents temporal profile of CIP concentration using different current 
intensities and the degradation rate of CIP. It was observed generally that CIP degrades fast 
with an increasing applied current. The influence of applied current density on CIP 
degradation rate differs from current regimes. 
(i) I < Ilim0 
As expected, it can be observed that the higher current intensity is the faster the 
removal of CIP, when the applied current intensity is lower than the initial limiting 
current intensity. 
(ii) I > Ilim0 
Fig.IV-6 (b) presents that for both current intensities (I = 0.1 A and I = 0.5A), CIP 
concentration decreases with the same rate and 100% of CIP was removed after 180 min 
of electrolysis. In this case, the applied current is higher than the initial limiting current 
intensity, and then the process is mass transfer controlled. The removal rate of CIP does 
not depend on the applied current.  
(iii) I >> Ilim0 
  The observed degradation rate of CIP at 1.5 A is much higher than the case I = 0.1 
or 0.5A. CIP was degraded completely around 100 min. These results can be explained as 
follows: besides the oxidation of organics, the generation of oxygen happens at the same 
time as Eq. IV-2 to Eq. IV-4 [5]. 
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         k = 5.2×109 M-1s-1 (Eq. IV-2) 
 
k = 2.7×107 M-1s-1 (Eq. IV-3) 
 
k = 1×1010 M-1s-1 (Eq. IV-4) 
 
Herein, the applied current intensity is much higher than the limiting current 
intensity. The current used for oxygen generation (Iapplied - Ilim ) is more significant than 
the case I = 0.1 and 0.5A and more oxygen bubbles were generated close to the electrode. 
The formation of bubbles in the hydrodynamic system able to enhance mass coefficient 
was reported by Vogt [6]. Consequently, the mass transfer coefficient increases locally. In 
the case of mass transfer control, the increasing mass transfer coefficient can lead to the 
faster degradation rate. Flox et al. [5] reported that the electrogenerated oxygen bubbles 
can accelerated the degradation rate of phenol with BDD anode. To prove this hypothesis, 
the influence of the current on COD variation will be investigated on section IV.1.2.2.  
  
2 2OH OH H O
  
2 2 2H O OH H O O H
     
2O OH O OH
    
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(a)  I < Ilim0 
 
(b)   I > Ilim0 
 
(c)   I >> Ilim0  
 
Fig.IV-6 The concentration of CIP decays with EO time (I) and the observed degradation rate (II) during 
electrolysis of 1L CIP solution in K2SO4 0.1 M at pH = 3.7 with various current (a, b, c). Flow rate = 366 L h-1, 
T = 30 °C. The ratio of I/Ilim and initial concentration of CIP see table VI-1. 
 
More obviously, Fig.IV-7 illustrates CIP degradation rate versus the applied current 
intensity. I < Ilim0, the degradation of CIP depends on I, forI > Ilim0, the influence of current 
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intensity becomes more important at very high values, when the production of dioxygen 
becomes majority. 
 
Fig.IV-7 CIP observed degradation rate versus applied current density. Operating conditions: see Fig.IV-5.  
IV.A.2.2 Influence of applied current on COD decay 
    Figure IV-8 presents COD decay using various applied current intensities. In Fig 
IV-8(a), in the case of I < Ilim0 according to BDD’s electrochemical properties, the COD 
follows a linear relationship as function of electroxidation time (Eq.I-20); then after critical 
time  (Eq.I-22), the applied current is higher than the limiting current, the COD decreases 
exponentially (Eq.I-24) as shown on the Fig IV-8 (b) and (c). Fig.IV-8 (b) describes the 
case of the kinetic regime under diffusion limitation. A good agreement between theoretical 
and experimental values is observed in the graph (a and b). 
When the applied current is much higher than the initial limiting current (graph c), the 
experimental COD values decrease faster than the theoretical ones during the first 50 min 
and then raises until the end of experiment.  
(i) t ≤ 50 min 
To explain these deviations, it can be taken account that during the electrolysis, the 
current exceeded than the limiting current (Iapplied - Ilim ) leads to the evolution of oxygen at 
the anode, as pointed out on section IV.1.2.1. Consequently, the rate of the gas evolution 
close to the electrode has a great effect on the mass transfer since a release of bubbles 
increase the mass transfer coefficient. Previous studies in our laboratory were performed to 
evaluate the mass transfer coefficient taking account the generation of bubbles [5,7]. Annex 
IV-1 presents all the calculations for the corrected COD decay which corresponds to the 
dashed line on FigIV-8 (c). 
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Fig.IV-8 COD decay with time during electrolysis of 1L CIP solution in K2SO4 0.1 M at pH = 3.7 with 
various current, flow rate = 366 L h-1, T = 30 °C.  
(a) I < Ilim0, [COD]0 = 35 mg L-1, I = 0.03A (i = 0.064 mA cm-2, i/ilim0 = 0.5);  
(b) I > Ilim0, [COD]0 = 28 mg L-1, I = 0.1A  (i = 1.45 mA cm-2,  i/ilim0 = 1.3);  
(c) I >> Ilim0, [COD]0 = 37 mg L-1, I = 1.5 A (i = 1.45 mA cm-2, i/ilim0 = 21.7) 
  
0
10
20
30
40
0 50 100 150 200 250 300 350
CO
D 
(m
g L
-1 )
EO time (min)
experimental value
theoretical value
0
10
20
30
40
0 50 100 150 200 250 300 350
CO
D (
mg
 L-
1 )
EO time (min)
experimental value
theoretical value
0
5
10
15
20
25
30
35
40
0 50 100 150 200 250 300 350
CO
D 
(m
g L
-1 )
EO Time (min)
experimental value
theoretical value
modification with bubbles effect
Critical time
i < ilim i > ilim
(a) 
(b) 
(c) 
 153 
Chapter IV Elimination of pharmaceuticals by electrochemical oxidation
 (ii) t ≥ 100 min: the experimental COD values increase continuously.  
In parallel the increase of COD, the analysis of sample shows the decrease of TOC after 
100 min (see Fig.IV-9). 
 
 
Fig.IV-9 COD and TOC variation with time during electrolysis of 1L CIP solution in K2SO4 0.1 M at pH = 3.7 
with applied current I = 1.5A (I = 207 A m-2), flow rate = 366 L h-1, T = 30 °C 
 
 
Thus, this unexpected increase of COD does not depend on the concentration of 
organics The depletion of organic leads a higher surplus of hydroxyl radicals which are 
very reactive and  form H2O2 [8] (Eq. IV-2). The hydrogen peroxide can be oxidized by 
dichromate in the COD test tube to produce Cr3+. The reactions are presented on eq.IV.1-5 
and IV.1-6 [9]. 
 
(Eq. IV-5) 
 
 
(Eq. IV-6) 
 
To verify this hypothesis, H2O2 solutions at various concentrations were prepared and 
measurements of COD were carried out. Fig.IV-10 shows the obtained results. A linear 
relationship was observed and the concentration of H2O2 can be evaluated from the COD 
value. Around 1.5 mM of H2O2 remained after at 255 min of electrolysis with an applied 
current intensity of 1.5A, considering that the COD related to 0.03 mM at 255 min is 
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negligible.     
 
Fig.IV-10 Correlation of concentrations between H2O2 and COD  
IV.A.2.3 Influence of applied current on TOC mineralization 
    Table IV-2 presents the TOC values at initial and 240 min using various current 
intensities. One can clearly distinguish three “groups” corresponding to 3 regimes: I < Ilim0: 
TOCt = 240/TOC0 = 66%, I > Ilim0: TOCt = 240/TOC0 = 75 %, I >> Ilim0: TOCt = 240/TOC0 = 
97%, respectively. The decay of TOC with electrolysis time for each electrolysis are 
shown in Annex IV-2. 
 
Table IV-2 The TOC values at initial and 240 min during electrolysis of 1L CIP solution in K2SO4 0.1 M at pH 
= 3.7 with various current, flow rate = 366 L h-1, T = 30 °C  
 I < Ilim
0 I > Ilim0     I >> Ilim0 
I = 0.03 A I = 0.05A I = 0.1 A I = 0.5 A I = 1.5 A 
TOC0 10.5 9.4 10.4 10.0 11.0 
TOCt = 240 3.3 3.2 2.7 2.2 0.35 
TOCt = 240/TOC0 67% 66% 74% 78% 97% 
 
IV.A.2.4 Influence of applied current on intermediates production and mineralization 
The amounts of intermediates produced during CIP degradation can be estimated by 
the difference between carbons from CIP and TOC, Δ, in the solution (as defined 
previously in section IV.A.1.2). As shown on Fig.IV-11, the amounts of intermediates 
products increase from the beginning of electrolysis, then reached a maximum value and 
y = 15.949x - 5.0353
R² = 0.9942
-10
0
10
20
30
40
50
60
70
80
90
100
0 2 4 6 8
CO
D (
mg
 L-
1 )
H2O2 (mM)
 155 
Chapter IV Elimination of pharmaceuticals by electrochemical oxidation
began to decline after complete removal of CIP.  
 
Fig.IV-11 Estimation of Δ and its variation during electrolysis of 1L CIP solution in K2SO4 0.1 M at pH = 3.7 
at 0.1 A, flow rate = 366 L h-1, T = 30 °C. 
    The carbons from CIP and total organic carbon are compared at various applied current 
in Annex IV-3, separately. At initial state, the total organic carbon corresponds to the initial 
carbons coming from CIP. 
The variation of Δ with time is shown in Fig.IV-12. With each applied current the 
maximum amounts of intermediates is quite the same. The higher the current is, the shorter 
is the range of time where intermediates present. 
 
Fig.IV-12 The variation of Δ (the amounts of intermediates) during electrolysis of 1L CIP solution in K2SO4 
0.1 M at pH = 3.7 at various applied current (0.05 - 0.1 A), flow rate = 366 L h-1, T = 30 °C. 
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For a given operating condition, the total amounts of intermediates produced during 
the mineralization of CIP can be calculated as the differences between the carbons 
concentration of CIP and total organic carbons as the shadow part of Fig.IV-13. 
 
 
Fig.IV-13 Calculation of total amounts of intermediates during electrolysis 
    
 The total amounts of intermediates during electrolysis can be calculated with Eq.IV.1-7. 
The duration for the calculation was 300 minutes. The function of CarbonsTOC(t) and 
CarbonsCIP(t) was simulated with RSQ function (R2) higher than 92%. 
 
 
(Eq.IV.1-7) 
 
To understand the effect of current to total amount of intermediates, the total amount 
of intermediates for each applied current were calculated according to Eq.IV.1-7, 
integrating from t (0, 300). The raw data of CarbonsTOC(t) and CarbonsCIP(t) is shown on 
Annex 3.  
Fig.IV-14 plots the variation of total amounts of intermediates produced during 
mineralization of CIP at various applied current. I < Ilim0, the amount of by-products 
decreases sharply with the increasing current; while in the case I > Ilim0, the total amounts of 
by-products is the same for an increasing current intensity in the range of 0.1 - 0.5A and a 
slightly decrease is observed at 1.5A. 
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Fig.IV-14 The variation of total amounts of intermediates produced during electrolysis of 1L CIP solution 
with various applied current in K2SO4 0.1 M at pH = 3.7, flow rate = 366 L h-1, T = 30 °C. 
 
An example of the calculation of energy consumption and mineralization rate in the 
synthetic solution is shown in Annex IV-4. The current intensity close to the limiting 
current can be the best compromise of less energy consumption and high mineralization 
rate. 
IV.A.2.5 Conclusion 
The increase of the current density accelerates CIP degradation, COD removal and 
TOC mineralization. Some effects have been evidenced like electrogeneration of oxygen 
bubbles and hydrogen peroxide which have a great impact on the COD removal. 
The total amounts of intermediates are inversely proportional to applied currents: 
I < Ilim0, it decreases sharply with an increasing current, while in the case of I > Ilim0, it is 
stable or decreases slightly.  
 
IV.A.3 Removal of common organic waste and the other 
pharmaceuticals  
In hospital wastewater, micropollutants are corresponding to a few percentages of the 
organics. The common organic waste is present in higher concentration than the 
micropollutants in wastewater. Urea is the major organic in fresh human urine and can be 
reached a concentration close to 25g L-1[10–12], while the concentration of 
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pharmaceuticals are in the range of 1 mg L-1[13]. In this section, urea is studied as a 
common organic waste present in hospital wastewater at higher concentration than 
pharmaceuticals in wastewater. Salbutamol and sulfamethoxazole with high risk level to 
environment are selected for this study because both are usually present in hospital 
wastewater [14]. 
 This section investigates the electrooxidation of urea and others pharmaceuticals: 
salbutamol (SALBU) and sulfamethoxazole (SMX) in single organic synthetic solution. 
The object is to understand their electrochemical oxidation behavior with BDD anode.  
IV.A.3.1 Removal of urea as a common organic waste  
The electrochemical behavior of urea was reported by Hernández et al. [15] with 
BDD anode. Figure IV-15 presents the cyclic voltammograms of electrolyte (NaClO4 1M) 
contained 0, 0.1 and 1M of urea. In presence of urea no oxidation peak was observed 
before the water discharge, which indicated that no direct electron transfer occurs during 
the oxidation of urea. The increasing current density at 1.5V with urea concentration is 
observed in the region of water oxidation where the formation of hydroxyl radicals occurs. 
Thus, the oxidation of urea occurred via ·OH. 
 
Fig.IV-15 Cyclic voltammetry in 1 M NaClO4 with different urea concentrations, working electrode: 
BDD (50 cm2), Reference electrode: SCE. Scan rate: 30 mv s-1[13].  
IV.A.3.1.1 Electrolysis of Urea solution 
Galvanostatic electrolyses were performed at 30 °C on solutions containing urea 
(0.63 M) at 0.5 A. Samples were taken regularly for analysis by UV spectroscopy for urea 
concentration and TOC. In this study, COD cannot be measured accurately with the 
standard method. Indeed, in spite of its strong oxidizing power, some nitrogenous organic 
compounds cannot be completely oxidized by dichromate solution [16,17].  
Figure IV-16 shows the concentration of urea and TOC with electroxidation time. The 
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initial urea concentration was 0.63 mM and the applied current was 0.5 A. In this case, the 
process is limited by mass transfer (I > Ilim0). It was observed that the concentration of urea 
and TOC decreased sharply with the electroxidation time. The observed degradation rate of 
urea is 0.0152 min-1, which is slower than CIP (0.0254 min-1) at the same current intensity. 
After two hours, removal of urea and TOC reached 93% and 74%, respectively. Then TOC 
and urea concentration stabilized. This stabilization can be due to the low concentration of 
urea and the transfer limitation, in addition the kinetic of the reaction between hydroxyl 
radical and urea is low (7.9 ×105 M-1 s-1) [18]. It was also reported that urea is refractory 
to ozone treatment [19]. Nevertheless, urea is biodegradable and can be degraded into NH3 
and CO2 through the hydrolysis process controlled by the enzyme ureases [20] which are 
found in numerous bacteria, fungi, algae, plants and some invertebrates, as well as in soils, 
as a soil enzyme [21].  
The amounts of intermediates can be characterized by the difference between the TOC 
and carbons from urea. Herein, urea is a molecule containing one carbon, so the molar 
concentration of urea is the molar concentration of carbon. From Fig.IV-15, the temporal 
curves of TOC and urea are quite close, which indicate few intermediates are observed 
during the electrochemical oxidation of urea with BDD anode. It can be explained as 
following: for the degradation of urea, the first step is the ·OH attack at –NH2 moiety. 
This pathway is very slow and the determined-step for urea degradation [22]. It can be 
proposed that once the first step happens, urea degrade and the intermediates are 
mineralized in a short time. 
 
Fig.IV-16 Concentration of urea and TOC decayed with EO time and during electrolysis of 1L urea solution 
in K2SO4 0.1 M at pH = 3.7. [Urea]0 = 0.63 mM (38.1 mg L-1), [TOC]0 = 0.6 mM (7.12 mg L-1), I = 0.5A 
(Ilim0 = 0.17A,), flow rate = 366 L h-1, T = 30 °C. Insert panel: the observed degradation rate of urea. 
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IV.A.3.1.2 Oxidation pathway of urea 
 
Figure IV-17 shows the variation of the concentration of NH4+, NO3-, and urea. NH4+ 
and NO3- are the producted by urea oxidation. NO3- is the main form of nitrogen product at 
the beginning of electrolysis. The concentration of it reached a maximum value as 0.94 mM 
at 120 min when the urea concentration reached a minimum value. NH4+ appeared after 20 
min of electrolysis and then remained constant until the end (0.14 mM). The total of 
nitrogen from NH4+, NO3-, and urea at 300 min reached 94 % of the initial nitrogen from 
urea. 
 
 
Fig.IV-17 Concentration of nitrogen in form of NH4+, NO3-, urea and total nitrogen in the solution during 
electrolysis of 1L urea solution in K2SO4 0.1 M at pH = 3.7-7 (pH increase during electrolysis). The dashed 
line is the initial concentration of nitrogen in the solution (from urea). [Urea]0 = 0.63 mM (38.1mg L-1), 
I = 0.5A (I0lim = 0.17A, oxidation product is nitrate), flow rate = 366 L h-1, T = 30 °C. 
 
The mechanism of urea mineralization can be discussed, according to the final 
products:  NH4+ and NO3- . The carbon atom in the urea structure has +4 oxidation states 
(and no extractable C-H bond is present), •OH attack is forced at the -NH2 moiety. This 
first pathway is very slow and determines the slow rate of urea disappearance [22]. It 
leads, probably, to the transformation of an amino group into a nitrous group, followed by 
the detachment of nitrite ions, rapidly oxidized to nitrate [22–24,24,25]. Calza et al. 
suggested that the product of NH4+ (or NH3·H2O depending on the pH) was probably 
formed by the • OH attack on the carbon atom after the attack on the N atom. Then the 
production of carbamic acid allowed NH3 discharged or in the form of NH3·H2O and NH4+ 
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depending on the solution) (Fig.IV-18). 
 
 
Fig.IV-18 Chemical reaction of  carbamic acid with hydroxyl radicals [22] 
 
In the present, the ratio [NH4+] / [NO3-] is 1:7, from which it can be inferred that the 
• OH mainly attack the N atom rather than C atom. From table IV-3, noting that the first 2 
min 0.014 mM urea in the solution is removed and 0.027 mM NO3- is produced, it seems 
to be that the entire nitrogen from urea is converted to NO3- at first. The basic pathway 
proposes that the two -NH2 moiety were attacked by •OH and transformed into a nitrous 
group, followed by the detachment of nitrite ions, rapidly oxidized to nitrate, as discussed 
above. After 20 min of electrolysis, NH4+ is present which intimates that the pathway of 
•OH attack on the carbon atom after the attack on the N atom occurs. At this time, the N 
from urea reacts and the concentration of NO3- + NH4+ diverges, which indicates there is 
another reaction probably the formation of carbamic acid allowing producing NH4+..  
Table IV-3 Concentration of urea,NO3- and NH4+during electrolysis  (Operating conditions: see 
Fig.IV-16) 
EO time 
(min) 
Urea reacted 
(mM) 
N(Urea reacted) 
(mM) 
NO3- produced 
(mM) 
NH4+ produced 
(mM) 
NO3- + NH4+ 
(mM) 
2 0.014 0.028 0.027 0 0.027 
20 0.207 0.413 0.277 0.100 0.376 
120 0.589 1.179 0.899 0.147 1.046 
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Thus, the pathways proposed is shown in Fig.IV-19. 
  
Fig.IV-19 Pathways proposed for urea oxidation, step (b) according to Fig.IV-18 
From the pathway of urea electroxidation, two -NH2 moieties in urea molecule 
structure can be attacked by •OH and transformed into a nitrous group in one step leading 
a low production of intermediates. In the case of photocatalysis , the oxidation of organic 
nitrogen follows two step: attack on one -NH2 moiety and production of nitrous group and 
carbamic acid  which are oxidized to NH3+ and CO2 in a second step[22,24].  
IV.A.3.2 Mineralization of Salbutamol and sulfamethoxazole 
The electroxidation of two other pharmaceuticals salbutamol (SALBU) and 
sulfamethoxazole (SMX) is studied in this section. Electrolyzes were performed in single 
organic system and the results were compared with ciprofloxacin in the same operating 
conditions. 
The electrochemical behavior of SALBU and SMX were studied by Karuwan et al. 
[26] and Boudreau et al. [27]. 
 
Fig.IV-20 (I) Background (BG) and signal (S) voltammograms obtained from1 mM SALBU solution at pH 
8.3, Working electrode: BDD , Reference electrode: SCE. Scan rate: 100 mv s-1 [26]. (II) Linear 
voltammetry of SMX  in 0.05 M Na2SO4 Working electrode: Si/BDD (1 cm2), Reference electrode: NHE. 
Scan rate: 50 mV s-1. (A) 1 mM; (B) 0.5mM; (C) 0.25 mM [27]. 
(b) 
I II 
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From the cyclic voltammograms of SALBU (Fig.IV-20 (I)), an oxidation peak is 
observed before water discharge, an irreversible direct electron transfer has occured. The 
authors also observed the electrode fouling on the BDD surface. It suggests to be due to the 
electrochemical oxidation of salbutamol which undergoes electron transfer gives phenolic 
radical which may combine and form a dimer [26,28,29]. The electrochemical reaction 
between SALBU and anode and the mechanism of fouling was proposed in Fig.IV-21. 
 
Fig.IV-21 The proposed electrochemical reaction of SALBU by electron transfer [26,28]. 
Fig.IV-20 (II) presents the cyclic voltammetry of SMX in 0.05 M Na2SO4 at different 
SMX concentrations [27]. The oxidation peak can be seen at +0.85 V and the current 
increases with the SMX concentration. The oxidation of SMX also has two pathways: 
direct electron exchange and reaction with hydroxyl radical. The author also observed the 
deposition of a polymeric film on the anode before the water discharge. Direct oxidation 
of SMX to the corresponding azo compound had previously been observed at carbon 
anodes, through a series of direct one electron oxidations [30].  
    The electrooxidation behavior of salbutamol and sulfamethoxazole during 
galvanostatic electrolyses of solution containing a single organic has been investigated.  
Fig.IV-22 shows the degradation of salbutamol, sulfamethoxazole and ciprofloxacin 
during 300 min of electrolysis.  
 
Fig.IV-22 Comparison of the degradation of salbutamol, sulfamethoxazole, ciprofloxacin  decay 
with EO time. 1L synthetic solution in K2SO4 0.02 M. [SALBU]0 = 0.0671mM, [SMX]0 = 0.0596 mM,  
[CIP]0 = 0.0695 mM, I = 0.5A ( I > Ilim), Flow rate = 366 L h-1, T = 30 °C. Inset panel: the observed 
degradation rate of SALBU, SMX and CIP. 
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The removal of the three molecules follows a pseudo first order kinetic. It can be 
observed that CIP, SMX and SALBU degradation rate is almost the same (0.0203 min-1, 
0.0208 and 0.0168 min-1, respectively) with a slightly difference with SALBU. The 
complete removal of them is observed at around 250 min (2.08 Ah L-1). 
Fig.IV-23 plots the normalized concentration of TOC of salbutamol, 
sulfamethoxazole and ciprofloxacin with EO time. TOC from SALBU decreases as the 
same rate as TOC from CIP, while TOC from SMX seems to decrease faster. The 
mineralization degree (TOCfinal / TOC0) was 80% after 300 min electrolysis. The difference 
can be due to the fact that SMX contains only 10 carbons in the molecular structure (in 
comparison with CIP (17)). The amount of intermediates produced during electroxidation 
of SALBU and SMX is discussed in Annex IV-5. One can note that the amounts of 
intermediates depend on the carbon number of the organic molecule. 
     
Fig.IV-23 Normalized concentration of TOC, salbutamol, sulfamethoxazole and ciprofloxacin with EO time. 
Operating conditions see Fig.IV-26. [TOC (SALBU)]0 = 11.4 mg L-1, [TOC (SMX)]0 = 7.5 mg L-1,  [TOC 
(CIP)]0 = 10.1 mg L-1.   
IV.A.3.3 Conclusion 
Urea as the common waste organic was mineralized using BDD anode. 94% of urea 
was removed after 180 min electrochemical oxidation. The oxidation of both -NH2 
moieties of urea molecule can be attacked by •OH and transformed into a nitrous group in 
one step. Both of salbutamol and sulfamethoxazole can be oxidized through direct 
electron transfer with BDD anode and reaction with •OH. The degradation of SMX , 
SALBU and CIP almost follows the same rate.. In section IV.4.3, the competition between 
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these pharmaceuticals will be studied. 
IV.A.4 Influence of the matrix on the pharmaceutical removal 
The hospital wastewaters contain basic components like salts and common organic 
compounds such as urea and micropollutants (like pharmaceuticals and hormones) [31]. 
This part is devoted to the influence of these components on the performance of the 
electrochemical oxidation of pharmaceuticals. The electrolyses were carried out in 
synthetic solutions containing: salts and pharmaceutical; ciprofloxacin and urea or two 
pharmaceuticals.  
The objective is to clarify the influence of components on the mineralization of 
pharmaceuticals in the wastewater and in view to the application of the process in real 
wastewater. 
IV.A.4.1 Influence of salts to electrolysis of pharmaceuticals  
    The presence of salts in wastewater allows increasing the conductivity and acts as 
electrolyte. Moreover, some salts are electroactive and can generate mediators which can 
react with pharmaceuticals ,  Fig.IV-24 [32].   
 
Fig.IV-24 Scheme of the electrochemical process for the removal of organic compounds by indirect 
oxidation [32]  
Thanks to the electrochemical properties of BDD allowing the generation of ·OH 
at the anode surface, strong oxidants such as peroxo and oxo compounds, metal ions, 
ozone, and chlorine species can be electrogenerated [33–35]. 
IV.A.4.1.1Presence of sulfates  
 
To show the role of sulfate species on the removal of pharmaceuticals, the 
electrochemical oxidations of CIP, SMX, SALBU were performed in K2SO4 0.02M (pH = 
6.4) and K2SO4 0.1M (pH = 3.7 adjusted with H2SO4 0.1 M solution). The main form of 
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sulfate in K2SO4 solution is SO42-.The concentration of undissociated H2SO4 is negligible 
and the concentration of HSO4- can be calculated with the dissociation constant (1×10-2) 
of Eq.IV.1-8 [36]. 
(Eq.IV.1-8) 
The concentrations of HSO4- and SO42- in both solutions are given in Table IV-4. 
Table IV-4 Concentration of SO42-, HSO4- and the pharmaceuticals in the synthetic solutions at initial time 
Concentration (mol 
L-1)  
K2SO4 0.1M pH = 3.7 K2SO4 0.02M pH = 6.4 (initial) 
[SO42-] 9.8×10-2 2×10-2 
[HSO4-] 1.9×10-3 8×10-7 
[SALBU] 6.77×10-5 6.71×10-5 
[SMX] 6.23×10-5 6.95×10-5 
[CIP] 6.23×10-5 6.95×10-5 
 
Fig.IV-25 presents the degradation of SALBU, SMX and CIP in K2SO4 0.1M and 
0.02M during electrolysis. Fig.IV-25 (a) shows the same degradation rates are observed in 
both electrolytes. There is no influence of sulfate on the SALBU removal.Fig.IV-25 (b) 
shows that the degradation rate of SMX is slightly higher in K2SO4 0.1M. Fig.IV-25 (c) 
shows that CIP degradation is obviously faster in K2SO4 0.1 M solution: the total removal 
of CIP is obtained in 180 min (in comparison with 250 min in K2SO4 0.02 M solution, 
inset panel). The higher concentration of K2SO4 leads to faster CIP degradation. 
 Murugananthan et al. [37] observed that the effective mineralization of ketoprofen 
can only be achieved when the supporting electrolyte is Na2SO4, comparing to NaNO3, 
NaCl and explained this phenomenon to the generation of S2O82- and SO4·- from SO42- 
with a BDD anode. SO4·- is a strong oxidant for wastewater treatment  with high 
potential (E0 = 2.43V [38]) [39,40]. Only HSO4- and undissociated H2SO4 react 
with ·OH radicals to form sulfate radical [41]. In the present experimental conditions, 
the generation of SO4-· and S2O82- is shown on Eq.IV.1-9 and Eq.IV.1-10. 
 
k = 6.9×105 M-1s-1 (Eq.IV.1-9) 
 
Radical SO4-·may product S2O82- by recombination [42]. 
 
k = 7.6×108 M-1s-1[42] (Eq.IV.1-10) 
2
4 2 4 3HSO H O SO H O
    
4 4 2HSO OH SO H O
    
2
4 4 2 8SO SO S O
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However, S2O82- is a weaker oxidant than ·OH and SO4-·[6]–[8].. Thus, the impact of 
sulfate to pharmaceutical oxidation is mainly due to the radical SO4• -formation. 
  
 
 
Fig.IV-25 The normalized concentration of pharmaceuticals during electrolyses: (a) SALBU, I = 0.5A 
(b) SMX, I = 0.5 A (c) CIP, I = 0.1A in K2SO4 0.1M, pH = 3.7,  K2SO4 0.02M, pH = 6.4-4, flow 
rate = 366 L h-1, T = 30 °C. Inset: the observed degradation rate of pharmaceuticals.  
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Table IV-4 shows that in case of K2SO4 0.1M, pH = 3.7, the concentration of HSO4- 
is 2000 times higher than in K2SO4 0.02 M, pH = 6.4. Thus, the SO4·- was produced in 
K2SO4 0.1M solution, while in K2SO4 0.02M solution, the production of the SO4·- was 
negligible. 
The different behaviors of the degradation SALBU, SMX and CIP in Fig.IV-25 
highlights the selectivity of SO4·- . It was reported that sulfate radical is more selective 
than ·OH due the different radical reaction mechanisms [40,43,44]. Herein, SALBU 
degraded with the same rate in both in K2SO4 0.1M and K2SO4 0.02M solutions, 
indicating that SALBU is inert to react with SO4·-. For SMX and CIP, the reaction 
between SO4·- and them occurs and the rate constants equals 1.61×1010 [45] and 1.2×109 
M-1 S-1[46], respectively. Thus, the additional reaction between SMX, CIP and SO4·- (in 
the K2SO4 0.1 M) leads to a faster degradation of them. 
Moreover, the removal of TOC and COD depends on the electrolyte. Fig.IV-26 (a) 
shows the TOC decrease which is faster after 80 min in K2SO4 0.1M. 84 % of TOC removal 
is reached after 300 min of electrolysis and only 71 % in K2SO4 0.02 M solution. The 
presence of SO4·- plays a role after 80 min which corresponds to 81% of CIP removal. 
These results indicates that SO4·- reacts with some intermediates which are produced 
during electrochemical oxidation of CIP. The similar behavior is observed for the removal 
of COD Fig.IV-26 (b). 
 
Fig.IV-26 The normalized variation of TOC (a) and COD (b) during electrolysis of 1L of CIP solution.
K2SO4 0.1M, pH = 3.7, [TOC]0 = 10.40 mg L-1  K2SO4 0.02M, pH = 6.4-4, [TOC]0 = 11.17 mg L-1 I = 
0.1A, flow rate = 366 L h-1, T = 30 °C.  
IV.A.4.1.2 Presence of chlorides  
Chloride ion is a common salt in wastewater. Numerous studies highlight that the 
presence of chloride allows accelerating the removal of organic by means of the chemical 
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reaction via electrogenerated active chlorine which is able to degrade organic pollutants 
[47–49]. However, the undesired organochloride compounds can be formed. The objective 
of this section is to study the influence of the presence of chloride ions on the removal of 
pharmaceuticals. 
Considering the production of hydroxyl radicals by water discharge on BDD, the 
reactions involving hydroxyl radical should be taken account besides the direct electron 
transfer reactions. Numerous reactions involving chlorine occur via electron transfer and 
chemical reaction with hydroxyl radical [50–56]. Fig.IV-27 exhibits the possible pathway 
during electroxidation of Cl-. 
 
Fig.IV-27 Oxidation Pathways of Cl- 
    In table IV-5, the corresponding reactions are listed. One can remark that the 
perchlorate can be formed during an ultimate step, which is undesired due to that 
perchlorate due to health risks[4,57].  
 
Table IV-5 Reactions of chlorine species corresponding to Fig.IV-26 during electrolysis 
 Reaction  Ref. 
a  
 
E0 = 1.36V [50], 
[58] 
b  kFor = 4.3 × 109 M−1 s−1 [59] 
c  
 
 
E0 = 0.46V 
[50] 
d  (alkaline solution) [52] 
e  k = 9 × 109 M−1 s−1 
k >1× 109 M−1 s−1 
[51] 
f  (alkaline solution) [52] 
g  k = 6 × 109 M−1 s−1 
k = 4 × 109 M−1 s−1 
[51] 
h  
 
 [56] 
22 2Cl Cl e  
2 2 2Cl H O HOCl Cl H O
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Cl OH ClOH   
22 36 3 2 4 6 3 / 2 6OCl H O ClO Cl H O e         
22 36 3 2 4 12 3 / 2 6HOCl H O ClO Cl H O e         
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IV.A.4.1.2.1 Electrochemical oxidation of CIP solution in presence and absence of 
chloride 
 
Electrolyzes were carried out with CIP solutions with and without chloride ions in the 
regime of mass transfer control. The range of Cl- concentration was chosen according to the 
concentration range in NF retentate (chapter V). 
Fig.IV-28 shows the decay of COD in the presence and absence of Cl-. The decay of 
COD follows the theoretical value (Eq. I-24) in both cases. The decay rate of COD does 
not changed significantly in the presence of Cl-.  
 
 
Fig.IV-28 COD decay in K2SO4 0.02M,  K2SO4 0.02M+2.25mM KCl during electrolysis of 1L CIP 
solution, I = 0.1A, (1.45 mA cm-2). : theoretical COD value. [COD]0 = 35 mg L-1 , flow rate = 366 L h-1, 
T = 30 °C. 
 
Figure IV-29 (a) shows the degradation of CIP in presence or absence of chlorides at 
0.1A. The remarkable acceleration for CIP degradation is observed in presence of Cl-: the 
complete removal of CIP is reached at 80 min in presence of Cl- while 240 min in absence 
of Cl-. Moreover, it can be observed in Fig.IV-29 (b) that the removal of TOC is faster in 
presence of Cl-: after 300 min of electrolysis 90 % of TOC is removed, while in the 
absence of Cl- , the removal is only 70 %. The faster degradation in presence of Cl- can be 
attributed to the additional oxidation reaction with the electrogenerated active chlorine 
(eq. a, e in Table IV-5) which can react with CIP and intermediates. Malpass et al. [49] 
reported that the removal of atrazine with NaCl as supporting electrolyte is quite faster 
than with Na2SO4 and NaNO3 using DSA electrodes. The same trend was obtained in the 
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work of degradation of 17β- estradiol on BDD anode [60].  
 
 
 
Fig.IV-29 Variation of CIP (a) and TOC (b) in K2SO4 0.02M, K2SO4 0.02M + 2.25mM KCl, during 
electrolysis of 1L CIP solution, [CIP]0 = 22.30 mg L-1 (0.068 mM), [TOC0] = 11.17 mg L-1, I = 0.1A (1.45 
mA cm-2), flow rate = 366 L h-1, T = 30 °C 
 
Moreover, it is possible to generate sulfate radicals (oxidants) via the 
electrogenerated chloride radical (Cl·). Ferro et al. [58] discussed on a mechanism 
pathway for the formation of Cl2 from 2Cl·and Brito et al. also suggested  a direct 
oxidation of chloride with BDD anode (probably Cl− → Cl·) [61] as Eq.IV.1-11. On the 
anode surface, the reaction between Cl· and SO42- which can form SO4·- are reported 
by Das et al. [62] as the Eq.IV.1-12. 
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(Eq.IV.1-11) 
 
 k = 2.5×108 M-1s-1[62]  (Eq.IV.1-12) 
 
    Then the SO4·- generated in the presence of chloride and sulfate accelerates the 
degradation of CIP and some byproducts. 
Fig.IV-30 shows the CIP degradation with the electrical charge in presence of 
chloride at 0.1A and 3A. It can be observed that at low current intensity (0.1A), the 
chloride concentration decrease when 90 % of CIP is removed.  
Conversely, at higher current intensity (3A), chloride is oxidized from the beginning 
of the electrolysis. In addition, at 0.1 A, the complete removal of CIP occurs with a charge 
consumption of 0.13 Ah L-1 when 1.6 % of Cl- is oxidized. At 3A, 100 % of CIP removal 
is reached for 0.25 Ah L-1 and 14 % Cl- is oxidized. At high current intensity, more 
electrical charge is spent for oxidation of Cl- during CIP removal.    
 
Fig.IV-30 CIP decay with electrical charge in K2SO4 0.02M + 2.25 mM KCl I = 0.1A (1.45 mA cm-2), 
I = 3 A (43.47 mA cm-2) during electrolysis of 1L CIP solution, [CIP]0 = 22.3 mg L-1, flow  rate = 366 L 
h-1, T = 30 °C. full symbols:  and  represent [CIP]; empty symbols:  and  represent [Cl-]. 
The TOC measurement shows that only 41 % has been removed at 3A after 300 min 
whereas 90% reached at 0.1 A for the same duration (Annex IV-6). The incomplete TOC 
removal in the presence of chloride were also reported by Murugananthan et al. in the 
case of mineralization of bisphenol A, atenolol and ketoprofen with BDD anode 
[37,63,64]. In these studies the poor mineralization efficiency was observed in the 
presence of Cl-, which may be attributed to the possible formation of chlorinated 
compounds in higher current intensity (3A). 
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In conclusion, the use of a very high current intensity ( ூூ°೗೔೘	> 30) generates oxidation 
of Cl-. The incomplete mineralization and formation of undesired organochlorine 
compounds may occur in these conditions. The next part is devoted to analyse the 
electrogenerated chlorine species.  
IV.A.4.1.2.3 Chlorine species conversion and AOX  
To understand the role of Cl- and intermediate compounds, analysis of the species and 
ions during electrolysis were performed.  
Figure IV-31 shows the chlorine species conversion during electrolysis of CIP 
(2.25mM) in presence of Cl- at 0.1A and 3A.  
 
 
 
Fig.IV-31 Chlorine transformation in K2SO4 0.02M + 2.25mM KCl (a) I = 0.1A (1.45 mA cm-2), 
(b) I = 3A (43.48 mA cm-2) during electrolysis of 1L CIP solution, flow rate = 366 L h-1, T = 30 °C. The 
dashed line is the total concentration of chlorine in the solution. 
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The formation of hypochlorite species (HClO and ClO-) occurs during electrolysis in 
both case at 0.1A and 3A. When the current intensity is 0.1A, Cl- is oxidized in 
hypochlorite (the sum of the concentration of Cl- and ClO- equals the initial concentration 
of Cl-). In the case of higher current intensity (3A), ClO- and ClO4- are formed from the 
beginning of electrolysis. The concentration of ClO- reaches a maximum value of 0.42 
mM at 20 min, then decreases to 0.05mM at 120 min and disappears at the end of 
electrolysis. The concentration of ClO3- presented during the electrolysis at 3A is lower 
than the detection limit of ionic chromatography (< 1ppm). After 300 min of electrolysis, 
90% of chloride is converted into perchlorate which is the only ionic chlorine species in the 
solution at 3A.  
From Fig.IV-27, it can be noted that electrogenerated oxygen species play an 
important role for the generation of ClO4- [53,54,65].  
 
(Eq. IV.1-13) 
     In the case of a high applied current intensity, large amounts of electrogenerated 
oxygen species (mainly·OH) are produced, which allows the reaction of the 
intermediate species with oxygen species and forming ClO4-. Jung et al also found the 
electrogeneration rate of ClO4- depended on the concentration of oxygen species (·OH, 
H2O2, O3). A faster generation rate of ClO4- was observed at higher concentration of 
oxygen species [53]. The non-observation of intermediates species ClO2- and ClO3- are 
owing to their short-live and instability in this operating condition, even the oxidation of 
ClO3- to ClO4- is slow and the rate-determining step [4,56]. Brito et al. has also observed 
that ClO4- formed with higher current intensity and ClO2- and ClO3- were present before 
the formation of ClO4-[61]. 
Fig.IV-32 shows the formation of hypochlorite as a function of electrical charge 
during electrolysis at 0.1 and 3A. At the beginning, the ClO- concentration varies with the 
electrical charge with the same rate in both cases (3A and 0.1A). After 0.25 Ah L-1, the 
concentration of ClO- continues to increase at 0.1 A, while it begins to decrease until zero 
at 3 A. The production of ClO- at beginning does not depend on the current intensity. The 
disappearance of ClO- for high current (3A) can be explained by its oxidation by oxygen 
transfer.  
 
2 3 4Cl OCl ClO ClO ClO
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Fig.IV-32 Formation of hypochlorite versus the electrical charge in K2SO4 0.02M + 2.25mM KCl  I = 
0.1A (1.45 mA cm-2),  I = 3A (43.48 mA cm-2) during electrolysis of  CIP solution (1L), flow rate = 366 
L h-1, T = 30 °C.  
 
These reactions occur mainly on the electrode surface but also in the bulk. Castagna 
et al. [66] reported the reaction between ClO- and H2O2 as Eq.IV.1-14 
       
(Eq.IV.1-14) 
    The risk to form organochloride product which are toxic for environment and human 
health seems to exist in particular at high current intensity. Adsorbable Organic Halogen 
(AOX, II.4.7) were analyzed in the samples after electrolysis. Results are summarized in 
Table IV-6 
 
Table IV-6 Concentration of AOX at initial time and after 300 min of electrolysis of 1L of K2SO4 0.02M + 
2.25mM KCl containing CIP  at 0.1 and 3A , flow rate = 366 L h-1, T = 30 °C. 
Current intensity 
(A) 
EO time 
(min) 
Q  
(Ah L-1)
Initial Cl- concentration 
(mg L-1) 
AOX 
(µM Cl) 
TOC 
(mg L-1) 
0 0 0         77.0 < LD 11.2 
3 300 15 76.5 130 6.8 
0.1 300 0.5 78.5 10 1.1 
 
Table IV-6 highlights that at 3 A, the amount of AOX at the end of electrolysis is 13 
times higher than at 0.1 A. The significant formation of AOX at 3A explains the low 
removal of TOC (39%) at the end of electrolysis. The formation of AOX is due to 
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reactions between organic compounds and electrogenerated active chlorine species (e.g., 
Cl2, OCl, HOCl) and chlorine radicals (Cl •, ClOX •). At higher current intensity (3A) the 
amount of these electrogenerated compounds is very important. Consequently, increase 
the risk of the AOX formation.  
In the case of the study on the treatment by other electrodes, Chaplin reported that 
BDD surface has surface radical sites (for example C-O· and C· radical sites), which 
can act as stabilized adsorption sites for ClOx· radicals on BDD surface [4]. Bagastyo et 
al. [67] found that the production of haloacetic acids (HAAs) and halomethanes (THMs) 
are more important using BDD electrode than Ti/Pt-IrO2 and Ti/SnO2-Sb: for BDD, the 
formation of HAAs and THMs reached 62.4 and 9.1 μM, respectively at the end of the 
experiment (Q = 5.6 Ah L-1). In the case of Ti/SnO2-Sb, 34.2 μM of HAAs and 8.9 μM, of 
THMs were formed after 5.6 Ah L-1, while 27.4 μM of HAAs and 5.6 μM of THMs were 
measured for the Ti/Pt-IrO2 anode.  
In this study, the TOC value (Annex IV-6) which probably corresponds to the AOX 
keeps stable between 120 min (6 Ah L-1) and 300 min (5 Ah L-1). The decrease of TOC is 
not observed even for an enhancement of 15 Ah L-1(300min). The AOX persist during 
electrooxidation, although Chaplin [4] suggest that halogenated organic compounds can 
be totally oxidized after elimination of halogen ions or compounds.  
Thus, the choice of appropriate current intensity is important to limit the formation 
of refractory and toxicity AOX for application of electrochemical oxidation with BDD to 
treat the wastewater in presence of chlorine. 
IV.A.4.1.3 Conclusion  
The salts in the wastewater can acts as inorganic oxidants. The species and amount 
of these inorganic oxidants can be important. On one hand, such oxidants allow 
increasing the removal of organics (case of sulfate). On the other hand, the presence of 
chlorides can be the source of halogenated compounds in particular at high current 
density. This study highlighted that the choice of operating conditions determines the 
efficiency and viability of the process. 
IV.A.4.2 Removal of pharmaceuticals in presence of urea 
    This section investigates the interaction and competition of pharmaceuticals during 
the electrolysis of a solution containing pharmaceuticals and a common organic. Urea 
was chosen as model of common organic. Electrolyzes were carried out in synthetic 
 177 
Chapter IV Elimination of pharmaceuticals by electrochemical oxidation
solution containing CIP and urea with different concentrations under galvanostatic 
conditions. The applied current intensities were higher than the limiting current. 
Fig.IV-33 shows the variation of urea and CIP concentrations with EO time in the 
case of mono component solutions (CIP or urea) and bi-component solutions (CIP and 
urea). The analysis of these data allows estimating the constant rate kobs for each case, 
these values are reported in the Fig.IV-34. It can be observed that the degradation of CIP 
follows the same rate in a single solution and in the presence of urea when the ratio 
[CIP]0:[urea]0 = 1:2. Surprisingly, CIP degrades faster in presence of higher urea 
concentration. One can note that during the first 10 min the degradation of CIP follows 
the same rate, after that the rate is faster in the case of higher concentration of urea 
([CIP]0:[urea]0 = 1:11). It can be assumed that by-products generated from the urea 
oxidation can react with CIP. Considering the degradation of urea, it appears the same rate 
in all solutions and the concentration is stabilized after 120 min.   
Fig.IV-33 CIP (a) and urea (b) concentration versus time during electrolyses: CIP solution (a) [CIP]0 = 
0.061mM, urea solution (b) [urea]0 = 0.63 mM; CIP and urea solution [CIP]0:[urea]0 = 1:2, [CIP]0 = 0.042 
mM, [urea]0 = 0.09 mM ;  CIP and urea solution [CIP]0:[urea]0 = 1:11, [CIP]0 = 0.053 mM, [urea]0 = 0.61 
mM. I = 0.5A (I > Ilim0), flow rate = 366 L h-1, electrolyte: K2SO4 0.1 M, T = 30 °C.   
 
Fig.IV-34 The observed degradation constant rates, kobs, of CIP and urea (obtained in 80 min) in 4 
electrolyzes: CIP solution and urea solution, CIP and urea solution [CIP]0:[urea]0 = 1:2; CIP and urea 
solution [CIP]0:[urea]0  = 1:11.Operating condition see Fig.IV-45. 
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Fig.IV-35 presents the TOC decay with time at different ratio of concentration: 
[CIP]0:[urea]0 = 1:2 and [CIP]0:[urea]0 = 1:11. Whatever the initial TOC value, the TOC 
value reaches 4 mg L-1 after 120 min. Then 95% of TOC is mineralized after 300 min, 
while in the case of [CIP]0:[urea]0 = 1:2, less removal of TOC is obtain as 90%. The TOC 
decay confirms the role of some productions from the oxidation of urea in CIP 
degradation.This value is stabilized because of the depletion of organic matter and then 
the limitation of mass transfer. 
 
 
Fig.IV-35 The variation of TOＣduring 300 min electrolyzes of CIP and urea solutions in K2SO4 0.1M, pH 
= 3.7, I = 0.5A, flow rate = 366 L h-1, T= 30 °C. 
 
The oxidation pathway of urea was discussed in section IV.1.3.1.2. The final products 
are NO3- and NH4+. The presence of them does not impact on the degradation of 
pharmaceuticals (Annex IV-8, degradation of CIP in K2SO4 0.1M + 2.5mM NH4+ and 
degradation of SMX in K2SO4 0.1M + 2.5mM NO3-). 
For a better understanding of the mechanism of interaction CIP/Urea, the 
concentration of nitrogen compounds has been followed. Fig.IV-36 presents nitrogen 
conversion during 300min of electrolysis of CIP and urea solution when the ratio of CIP 
and urea is [CIP]0:[urea]0 = 1:2 and 1:11. For both ratio, all the nitrogen are converted into 
NH4+ and NO3- at the end of electrolysis.  
  (a) For [CIP]0:[urea]0 = 1:2, the final ratio of [NH4+]/[NO3-] is around 1:1. Considering 
the molecular structure, the nitrogen from CIP and urea is almost the same amount 
(N(CIP):N(Urea) = 3:4 ≈ 1 :1). As discussed on section IV.1.1.2 and IV.1.3.1.2, the 
nitrogen of urea is probably mainly converted into NO3- and the one of CIP into NH4+. It 
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explains why the observed [NH4+]/[NO3-] is around 1:1.  
 
Fig.IV-36 Conversion of nitrogen during 300 min of electrolyses of 1L synthetic solutions containing CIP 
and urea with different ratio and K2SO4 0.1 M at pH = 3.7. I =0.5A, flow rate= 366 Lh-1, T = 30 °C. : 
concentration of N from CIP and urea, : concentration of NO3-, : concentration of NH4+ : the sum of 
concentration of N from CIP, urea, NO3- and NH4+.  
(a) [CIP]0:[urea]0 = 1:2, [CIP]0 = 0.045 mM, [urea]0 = 0.094 mM;   
(b) [CIP]0:[urea]0 = 1:11, [CIP]0 = 0.053 mM, [urea]0 = 0.606 mM. 
 
     (b) In the case of [CIP]0: [urea]0 = 1:11, considering the initial ratio of 
N(CIP):N(Urea)  = 3:22 and 90% of nitrogen comes from urea. The NH4+ and NO3- 
produced from CIP are negligible in this case. The final ratio of [NH4+]/ [NO3-] is around 
1:2. This value is different as the one obtained in the case of electrolysis of urea solution 
([NH4+]/ [NO3-] = 1:7). According to the oxidation pathway of urea (section IV.1.3.1.2), 
NH4+ is released from the carbamic acid (key intermediates from urea oxidation), which 
indicates that in the case of [CIP]0:[urea]0 = 1:11 more carbamic acid is produced. 
Nevertheless, to prove the influence of carbamic acid on the oxidation rate of CIP, further 
studies are needed.  
    Although the completely removal of urea is not efficient by electrochemical 
oxidation, the urea is nontoxic and has shown grade biodegradability [20]. The target of 
electrochemical oxidation here is to mineralize the bio-refractory pharmaceuticals and it 
seems the presence of urea in higher concentration ([CIP]0:[urea]0 = 1:2 or 
[CIP]0:[urea]0 = 1:11) does not prevent the degradation of CIP but render it faster. These 
results promote the feasibility and efficiency of electrooxidation of pharmaceuticals in 
wastewater on BDD. 
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IV.A.4.3 Competition and interaction between pharmaceuticals during 
electrochemical oxidation 
This section investigates the competition and interaction of pharmaceuticals during 
the electrochemical oxidation process. Two interactions will be treated here: (i) 
ciprofloxacin (CIP) and sulfamethoxazole (SMX); (ii) CIP and salbutamol (SALBU). In 
each case, the applied current intensity is higher than the limiting current intensity under 
galvanostatic.  
    
(i) Competition and interaction between CIP and SMX 
    The electrolysis was performed with the solution containing CIP and SMX. After 
300 min (2.5 Ah L-1) of electrolysis, an excellent removal of TOC (92%) is obtained 
(Annex-9). Fig.IV-37 shows the variation of CIP and SMX concentrations during 
electrolysis. The degradation of CIP and SMX follows a pseudo first order kinetic. It can be 
observed that both pharmaceuticals almost are degraded at quite the same rate;  there is a 
slight difference at the beginning of electrolysis, probably due to the competition of them in 
the reaction with ·OH. The rate constants between CIP and ·OH, 2.15 ×1010 [68], is 
higher than the rate constant of SMX with ·OH,  7.02 × 109 [45]. This difference favors 
faster degradation rate of CIP. 
A very good agreement between experimental and theoretical COD (Eq. IV-24) 
value is presented in the inset panel.  
 
Fig.IV-37 CIP  and SMX  variation with EO time during 300 min electrolysis of 1L solution in K2SO4 
0.02 M at pH = 3. [CIP]0 = 0.072 mM, [SMX]0 = 0.0572 mM. I = 0.5A (i = 7.25 mA cm-2, i > i°lim ), flow rate 
= 366 L h-1, T = 30 °C. Inset panel: theoretical and experimental decay of COD. 
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(ii) Competition and interaction between CIP and SALBU 
Fig.IV-38 presents the degradation of CIP and SALBU during electrolysis of 
solution containing both pharmaceuticals.  
 
Fig.IV-38 CIP  and SALBU  removal with EO time during 300 min electrolysis of 1L solution in 
K2SO4 0.1 M at pH = 3. [CIP]0 = 0.052 mM, [SALBU]0 = 0.049 mM. I = 0.5A (I > Ilim0), flow rate = 366  L 
h-1, T = 30 °C. Inset panel: theoretical and experimental decay of COD.  
    It can be observed that during the first 50 min, CIP seems to decrease slightly faster 
than SALBU and then both degrade at the same rate. Complete removal is obtained in 
around 200 min for both. In addition, 90% of TOC are mineralized after 300 min 
(2.5 Ah L-1) (Annex IV-9). The inset panel shows the corresponding COD decay during 
300 min of electrolysis. After 100 min, the experimental COD becomes slower than the 
theoretical ones.  
Fig.IV-39 plots the removal of CIP and SALBU with EO time in the case of mono 
component solutions (CIP or SALBU) and bi-component solutions 
([CIP]0: [SALBU]0 = 1:1).  
Fig.IV-39 Degradation of CIP (a) and SALBU (b) with time during 3 electrolyzes: CIP solution (a) 
[CIP]0 = 0.061mM, SALBU solution (b) [SALBU]0 = 0.067 mM; CIP and SALBU mixture solution 
[CIP]0:[SALBU]0 = 1:1, [CIP]0 = 0.049 mM, [SALBU]0 = 0.052 mM I = 0.5A (I > Ilim0), 
flow rate = 366 L h-1, electrolyte: K2SO4 0.1 M, T = 30 °C.   
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  It can be observed clearly (Fig.IV-39 (a)) that during the first 10 min, CIP degrades 
with the same rate with or without SALBU and then the degradation of CIP in the 
multi-component solution is slower. In the case of SALBU there is no difference 
(Fig.IV-39 (b)). 
    Fig.IV-40 presents the constant rates of CIP, SALBU and SMX removal in mono 
component and mixture solutions. In SALBU and CIP mixture solution, it can be noticed 
clearly that the degradation rate of CIP in mixture solutions is lower; it seems that the 
presence of SALBU hinders the degradation of CIP. However, in SMX and CIP mixture 
solution, this phenomenon is not observed. 
 
 
Fig.IV-40 (a) observed degradation rates of CIP and SALBU for 3 electrolyzes: CIP solution 
([CIP]0 = 0.059 mM ) SALBU solution ([SALBU]0 = 0.066 mM), CIP and SALBU mixture solution in 
K2SO4 0.1 M, I = 0.5A (I > Ilim0). Operating condtions: see Fig.IV-37 (b) Observed degradation rates of CIP 
and SMX for 3 electrolyses: CIP solution ([CIP]0 = 0.0561 mM) , SMX solution ([SMX]0 = 0.057 mM), 
CIP and SMX mixture solution in K2SO4 0.02 M, I = 0.5A (I > Ilim0).Operating conditions: see Fig.IV-36.   
     
    Thus, during electrochemical oxidation of pharmaceuticals in multicomponent 
solutions (CIP and SMX; CIP and SALBU), the interaction and the competition can 
induce different impacts on the degradation of pharmaceuticals, depending on the 
pharmaceuticals’ properties. In the case of electrolysis of CIP and SMX solution, CIP 
decreases slightly faster than SMX; it is probably due to the higher kinetic constant of 
CIP with·OH. The degradation of CIP and SMX occurs almost at the same rate in mono 
component and mixture solutions. The experimental values of COD vary with a good 
agreement with theoretical value, which confirmed the applicability of this model for 
multiple pharmaceuticals systems. 
    Conversely, the presence of SALBU slows down the CIP oxidation. Different 
hypothesis can be formulated: SALBU or intermediates can compete for the reaction with 
hydroxyl radical. Another hypothesis is that. a part of SALBU can be oxidized by direct 
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electron exchange on BDD, which undergoes the formation of a dimer [26,28,29], as 
discussed in section IV.1.3.2. This formation on the electrode surface can hinder the 
oxidation of CIP.  
IV.A.5 Modelling of anodic degradation for organic with BDD anode 
Fig.IV-41 shows a general scheme of the possible pathway during electroxidation of 
electroactive organic with BDD anode. The oxidation can occur at the anode surface by 
direct electron transfer (1) or by oxygen transfer (3) (reaction with·OH generated by 
water discharge (2)). Because of the weak interaction between BDD surface and hydroxyl 
radical, ·OH can be considered as quasi free on the surface [69]. If the amount of 
available·OH is enough, complete mineralization can be reached (7). Otherwise, it is 
possible to generate organic radicals (5) with chain reactions [70].. 
The oxidation via direct electron exchange occurs only on the anode surface, and the 
reaction with·OH happens in a narrow zone adjacent to the electrode surface (< 1.0 µm), 
while the chain reaction between organic radical and oxygen can occurs from the anode 
surface to the bulk depending on the duration life of the species. 
 
 
Fig.IV-41 Oxidation pathway of organic in BDD system: (1) direct electron exchange, (2) electrogeneration 
of ·OH, (3) generation of oxygen (4) formation of organic radicals via reaction between organics and 
hydroxyl radicals, (5) reaction between O2 and organic radical, (6) reaction between peroxy radicals and 
organics in the solution, (7) complete mineralization 
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IV.A.5.1Model description 
The direct electroxidation can be written as  
  
(Eq.IV.1-15) 
The corresponding initial limiting current density depends on the mass transfer coefficient 
kd (m s-1): 
 
(Eq.IV.1-16) 
Where ݅௟௜௠,௡௘ష଴  is initial limiting current density of directly electron transfer (A m-2), 
n is the number of electrons exchanged, F is Faraday constant as (96485 C mol-1) and [C]0 
is the initial concentration of electroactive species in the solution (mol m-3). 
When the current density is lower than the ݅௟௜௠,௡௘ష  the oxidation process is 
controlled by electron transfer. 
When the applied current density is higher than	݅௟௜௠,௡௘ష, the oxidation of water 
occurs and reactive oxygen species can be generated. Free hydroxyl radicals allow 
mineralizing organic compound. The equivalent number of exchanged electrons can be 
calculated with Eq.IV.1-17:  
 
(Eq.IV.1-17) 
 
km is the constante rate of mineralization. 
The equivalent number of exchanged electrons γ can be written as: 
 
(Eq.IV.1-18) 
 
The limiting current density corresponding to the total mineralization of the organics 
(ilim0,·OH, A m-2) is a function of γ, kd and [C0].  
 
(Eq.IV.1-19) 
 
Depending on the value of the initial concentration of organics and the applied current 
intensity, three different regimes can be considered. 
red ox ne 
0
0lim, [ ]dnei nFk C 
2 2(2 ) (4 2 ) (4 2 )kmx y zC H O x z H O xCO x y z H x y z e        
4 2x y z   
0
lim, OH 0(4 2 ) [ ]di x y z Fk C   
 185 
Chapter IV Elimination of pharmaceuticals by electrochemical oxidation
(a) i ≤ ilim,ne-0 
(b) ilim,ne-0< i < ilim,·OH0,  
(c) i > ilim0,·OH  
This model is based on the mass balance (Section I.3.3) by which molecule disappearance 
can be expressed as 
 
(Eq.IV.1-20) 
 
V is the reservoir volume (volume of the solution), A is the electrode surface (m2), Γ is 
the reaction rate of organic on the electrode. 
 
(a) i ≤ ilim,ne-0 
In this regime, only direct electron exchange occurs, the reaction rate of organic is the 
direct electrochemical reaction rate by electrons transfer (Γe-) which depends on the 
applied current density i: 
 
(Eq.IV.1-16) 
Then Eq.IV.1-22 can be written as: 
(Eq.IV.1-22) 
 
The integration of Eq.IV.1-22 gives the expression of the temporal concentration,  
 
(Eq.IV.1-23) 
 
To calculate Γe-, for a constant current density equals to the limiting current density 
ilim,ne- corresponding to the part of the current density used to oxidized organic molecule. 
 
(Eq.IV.1-24) 
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In this case, the concentration profile of the organic specie becomes: 
 
(Eq.IV.1-25) 
 
(b) ilim,ne-0< i < ilim,·OH0 
For a current density higher than the limiting current density, the oxidation of water 
occurs. Then the rate of oxidation of organic is expressed as the sum of the rate of 
electron transfer and the rate of reaction with·OH (Γ·R)  
 
(Eq.IV.1-26) 
 
The oxidation of organic can be expressed as 
  
(Eq.IV.1-27) 
 
Here, the i·OH (part of current density used to generate·OH) is calculated with the 
difference between the applied current density and ilim,ne-: 
 
(Eq.IV.1-28) 
 
The ·OH chain reaction rate depends on the generation rate of hydroxyl radicals. As 
shown on Eq.IV.1-17, mineralization of one mol CxHyOz consumes γ mol of·OH. The 
reaction rate of organic with·OH radical chain reactions (Γ·R) can be written as 
Eq.IV.1-29.   
                                    
(Eq.IV.1-29) 
 
Combining Eq.IV.1-27 and Eq.IV.1-29, it can be obtained: 
 
(Eq.IV.1-30)          
 
In the case of n <<γ, it can be considered that the main part of the applied current 
density is used to produce·OH, i = i·OH. 
Integration of Eq.IV.1-27, t = 0, Ct = 0 = C0, the temporal variation of C in the range 
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(ilim,ne-0< i < ilim,·OH0):  
 
(Eq.IV.1-31) 
 
where K depends on the initial organic concentration, electrons number for mineralization 
of organics (i·OH = iapplied).                                                    
                                                           
 (Eq.IV.1-32)            
 
    This behavior persists until a critical time (tcr), at which the applied current density (i) 
equals the limiting current density for mineralization.  
A characteristic parameter α is defined as   
 
(Eq.IV.1-33)            
 
The concentration of organic on critical time is [C]cr defined by Eq. IV.1-34                              
(Eq.IV.1-34)            
 
 
 
Substituting Eq.IV.1-34 to Eq.IV.1-31, the critical time can be calculated as  
  
(Eq.IV.1-35)            
 
 
As the electrons number of direct exchange is far less than the electrons number of 
mineralization (n << γ), the function can be simplified: 
 
                (Eq.IV.1-36) 
 
                                             
(c) i > ilim,·OH 0 
In the case of applied current density higher than the limiting current density for the 
complete mineralization i > ilim,•OH0. The reaction with radicals is described by 
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pseudo-first-order kinetics. The reaction of organic for·OH radical chain reactions is 
written as  
 
(Eq.IV.1-37)   
 
km is constante rate of mineralization in s-1 (see Eq.IV.1-16). 
Combining Eq.IV.1-24, and Eq.IV.1-37, then Eq.IV.1-27 is written as Eq.IV.1-36:  
 
(Eq.IV.1-38)                
 
 
In the case of i > i0lim, the variation of organic concentration with time can be 
calculated with Eq.IV.1-39, 
 
(Eq.IV.1-39)    
                 
IV.A.5.2 Comparison of model and experimental values    
 
When i > ilim, ·OH, ·OH which is quasi free on the electrode surface can react 
massively on organics. In this case, the oxidation is not selective and km does not depend on 
the nature of organic, the rate of oxidation depends on the hydrodynamic conditions. To 
determine km, experimental data from the electrolysis of urea is used, because urea don’t 
have the direct electron transfer with BDD. In that case	 ௜௜೗೔೘,൉ೀಹ  = 2.9, then concentration 
of urea follows an exponential relation as Eq.IV.1-40 
 
(Eq.IV.1-40)                
 
km can be evaluated by the liner relationship between -lnC(t)/C0 ~ t (Fig.IV-42) 
 
(Eq.IV.1-41)                
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The linear relationship allows to estimate km = 2.54 ×10-4 s-1 
 
Fig.IV-42 Variation of -lnC(t)/C0 with electroxidation time during electrolysis of 1L of urea solution in 
K2SO4 0.1 M at pH = 3.7. [Urea]0 = 0.63 mM (38.1 mg L-1, i = 7.24 mA cm-1 (ilim, ·OH = 2.46 mA cm-1), flow 
rate = 366 L h-1, T = 30 °C. 
 
    Three pharmaceuticals: CIP, SMX and SALBU are selected to test the model. Cyclic 
voltammograms have shown that these three pharmaceuticals can be degraded by both 
direct electrons exchange with electrode and chemical reaction with·OH. Table IV-7 
gives the number of exchanged e- and the equivalent e- for complete mineralization.   
 
Table IV-7 Electrons numbers of CIP, SMX, SALBU for direct oxidation, n and for mineralization, γ 
Pharmaceuticals CIP SMX SALBU 
n 2 1 1 
γ 78 71 73 
 
    The mineralization of CIP by radical chain reactions is presented in Eq.IV.1-42. The 
nitrogen is calculated as that one-third into NO3- and two-third into NH4+, according the 
experimental nitrogen conversion of CIP (section IV.1.1.2). The value of γ is 78.     
 
(Eq.IV.1-42)            
 
For SMX and SALBU, the nitrogen is considered to be converted into NO3- (in ionic 
chromatograph, just NO3- is observed); the corresponding reaction of mineralization is 
shown in Eq.IV.1-43 and Eq.IV.1-44. The values of γ are presented on table IV-6. 
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(Eq.IV.1-43)                
 
(Eq.IV.1-44)                
 
Then the initial limiting current for mineralization (i0lim,·OH) by electron exchange 
and·OH radical chain reactions is calculated with Eq.IV.1-35.  
 
(a) Simulation at i0lim,ne- < i < i0lim,·OH  
    Table IV-8 summarizes the operating conditions during electrolyses of CIP solution and 
the calculated limiting current densities (i0lim,ne-, i0lim,·OH), the critical time considering to i 
= ilim,·OH (Eq.IV.1-33)  
 
Table IV-8   Applied current density, initial limiting current and the calculated critical time for the 
electrolyses on the range ilim,ne-0 < i < ilim,·OH0  
Applied current density 
(mA cm-2) 
[CIP]0 
(mM) 
ilim,ne-0 
(mA cm-2) 
ilim,·OH0  
(mA cm-2) 
α tcr 
(min) 
0.43 0.052 0.023 0.90 0.47 45 
0.72 0.052 0.023 0.90 0.8 34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
10 11 3 3 2 2 3 4C H N O 30 10 3 71 71S H O CO NO SO H e        
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Fig.IV-43 presents the experimental values obtained during electrolysis in the case of 
i0lim,ne- < i < i0lim,·OH at 0.43 mA cm-2 and simulated values according to Eq.IV.1-31 and 
Eq.IV.1-39 (separated by critical time). A good agreement between experimental and 
model is observed. Fig.IV-44 shows the simulation using another current density 
0.72 mA cm-2 (tcr = 34 min). Also, a good accordance is observed.   
 
Fig.IV-43 Normalized CIP concentration with electroxidation time (symbol: experimental) comparing with 
the model:  continuous line : ilim,ne- < i < i0lim,·OH (calculated by Eq.IV.1-31) and  dashed line : i > 
ilim,·OH0 (calculated by Eq.IV.1-39). The applied current density is 0.43 mA cm-2 in K2SO4 0.1 M at pH = 3.7. 
[CIP]0 = 0.052 mM, flow rate = 366 L h-1, T = 30 °C.      
 
Fig.IV-44 Normalized CIP concentration with electroxidation time (symbol: experimental) with 
electroxidation time comparing with the model: ilim,ne- < i < i0lim,·OH(calculated by Eq.IV.1-31), continuous 
line ; i > i0lim,·OH (calculated by Eq.IV.1-39), dashed line . The applied current density is 0.72 mA cm-2 
in K2SO4 0.1 M at pH = 3.7. [CIP]0 = 0.052 mM, flow rate = 366 L h-1, T = 30 °C.      
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(b) Simulation at i = 7.24 mA cm-2 in the region i > i0lim,·OH 
In the case of i > i0lim,·OH, electrolyses were carried out with two pharmaceuticals CIP 
and SMX at 7.24 mA cm-2 which corresponds to the range of  i > i0lim,·OH. Table IV-9 
shows the limiting current densities and applied current densities for each electrolysis.     
 
Table IV-9 Limiting current densities and applied current densities in electrolyses of Fig. IV-44 (i > i0lim,·OH) 
Molecule Initial concentration 
(mM) 
I0lim,ne- 
(mA cm-2) 
I0lim,·OH 
(mA cm-2)
Applied current density
i (mA cm-2) 
CIP 0.059 0.026 1.02 7.24 
SMX 0.053 0.012 0.95 7.24 
 
For each electrolysis, Fig.IV-45 compares the experimental value and model 
calculated from Eq.IV.1-39 at i > i0lim,·OH. Once again, an excellent accordance is obtained 
for both CIP and SMX in the case of i > i0lim,·OH. 
 
 
Fig.IV-45 Comparison of normalized experimental concentration of CIP  and SMX  during electrolysis 
and model: continuous line  i > ilim,·OH0 (calculated by Eq.IV.1-39); dashed line  i = ilim,ne-0 
( Eq.IV.1-24). The applied current density is 7.24 mA cm-2 in K2SO4 0.1 M at pH = 3.7. [CIP]0 = 0.059 mM, 
[SMX]0 = 0.053 Mm, flow rate = 366 L h-1, T = 30 °C.    
      
(c) Effect of presence of SO42- on the removal of organics 
Previously (section IV.A.4.1.1), the role of electrolyte, in particular the sulfate 
anions which can form SO4·- via chemical reaction with·OH, was evidenced for the 
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removal of organics.  
km, which is evaluated by the urea degradation from Eq.IV.1-41, was observed from 
electrolysis performed in K2SO4 0.1M. In this case, km can be presented as the sum of k·OH 
and kSO4·- : 
(Eq.IV.1-44)            
 
where, km is the constant rate of mineralization involving the reaction ·OH and SO4·- 
radicals; k·OH, the reaction rate with·OH ; kSO4·- is the reaction rate with SO4·-. 
As discussed on section IV.A.4.1.1 (Table IV-4), the amounts of SO4·- can be 5 times 
lower in K2SO4 0.02 M solution, than in K2SO4 0.1M (pH = 3). One can consider that the 
reaction of SO4·- is not significant in the case of K2SO4 0.02 M. The value of kSO4·- can 
be evaluated by comparing the degradation of SMX in K2SO4 0.1M, pH = 3 and K2SO4 
0.02 M.  
This value of k·OH and kSO4·- can be evaluated by comparing the degradation of SMX 
in K2SO4 0.1M, pH = 3 and K2SO4 0.02 M. 
    In K2SO4, pH = 3, the degradation of SMX can be written as Eq.IV.1-45 
 
(Eq.IV.1-45)            
 
    In K2SO4 0.02 M, the degradation of SMX can be written as Eq.IV.1-46 
 
(Eq.IV.1-46)            
 
 
From the different linear relationship of -lnC(t)/C0 ~ t, the kSO4·- are evaluated. 
    Fig.IV-46 shows linear relationship of -lnC(t)/C0 ~ t with different slop values during 
electroxidation of SMX in K2SO4 0.1M and K2SO4 0.02 M.  
 
4m OH SO
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C V 
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Fig.IV-46 Variation of -lnC(t)/C0 with electroxidation time during electrolysis of 1L of SMX solution in 
K2SO4 0.1 M at pH = 3.7 ([SMX]0 = 0.053 mM) and K2SO4 0.02 M solution ([SMX]0 = 0.059 mM). i = 7.24 
mA cm-1 (ilim,·OH ≈ 1 mA cm-1), flow rate = 366 L h-1, T = 30 °C. 
The calculated value of k·OH and kSO4·- are presented in table IV-10  
 
Table IV-10 Values of k·OH and k kSO4·- (Fig.IV-45) 
 Slope (s-1) k·OH (s-1) kSO4·- (s-1) 
K2SO4 0.02 M 3.47×10-4 3.47×10-4 0 
K2SO4 0.1M 4.29×10-4 3.47×10-4 8.2×10-5 
     
    The electrolyses were carried out with solution of CIP or SALBU. The degradation of 
SALBU is not impacted by the presence of SO4·- (section IV.1.4.1). The experimental 
conditions of electrolyses of different pharmaceuticals in K2SO4 0.1 and 0.02 M are 
presented on Table IV-11.   
Table IV-11 The limiting current densities and applied current densities during electrolyses (i > ilim,·OH0) 
 C0  
(mM) 
ilim,·OH0  
(mA cm-2) 
i 
 (mA cm-2) 
k·OH 
(S-1) 
Electrolyte 
CIP 0.069 1.19 1.45 1.72×10-4 K2SO4 0.02 M 
SMX 0.059 1.08 7.24 1.72×10-4 K2SO4 0.02 M 
SALBU 0.068 1.23 7.24 1.72×10-4 K2SO4 0.02 M 
SALBU 0.067 1.22 7.24 1.72×10-4 K2SO4 0.1 M 
 
Fig.IV-46 shows experimental data and the model using m OHk k  and 
(Eq.IV.1-37) with k·OH = 3.47×10-4 s-1 and kSO4·-= 8.2×10-5 s-1 for 
y = 4.29E-04x
R² = 9.99E-01
y = 3.47E-04x
R² = 1.00E+00
0
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electrolysis at ilim,·OH. This figure evidences that in the case of electrolysis carried out in 
K2SO4 (0.02 M), a good agreement with the model obtained with k·OH.This model seems to 
confirm that SALBU doesn’t react with sulfate radical and the role of SO42- during 
electrolysis. 
 
Fig.IV-46 Experimental and numerical data obtained for electrolysis of: CIP , SMX  and SALBU  in 
K2SO4 0.02M and SALB U  in K2SO4 0.1M at i > ilim,·OH0:  continuous line  (Eq.IV.1-39 with km = 
k ·OH = 2.54×10-4), dashed line  (Eq.IV.1-39with ), flow rate = 366 L h-1, T = 30 °C.        
(d) Effect of oxygen bubbles 
When the i >> i0lim,·OH, electrogenerated oxygen bubbles can be considered to 
enhance the mass transfer coefficient and then accelerate the degradation of organics as 
discussed in IV.1.2.2. The electrolysis of CIP solution at high current density (i >> i0lim,·OH) 
was performed. The applied current density and mass transfer coefficients: hydrodynamic 
(kdh) and global (kd including the hydrodynamic and bubble effects) are presented on table 
IV-12 (the calculation follows Annex IV-1). 
 
Table IV-12 the parameter for the electrolysis of CIP with high current density 
[CIP] 
(mg L-1) 
iapplied  
(A m-2) 
ilim  
(A m-2) 
io2  
(A m-2) 
kdh  
(m s-1) 
kd  
(m s-1) 
km 
(s-1) 
20.4 217 10 207 2.31×10-5 4.33×10-5 2.54×10-4
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Fig IV-48 shows the good agreement between experimental and model using a 
global mass transfer coefficient including the effect of electrogenerated bubbles.  
 
 
Fig.IV-48 Experimental and numerical data obtained for electrolysis of CIP in K2SO4 0.1M, i =  21.7 mA 
cm-2  i >> ilim,·OH0: continuous line  (Eq.IV.1-37 with kd = 4.33×10-5 m s-1), dashed line  (Eq.IV.1-37 
with kdh = 2.31×10-5 m s-1), flow rate = 366 L h-1, T = 30 °C.      
 
Thus, the experimental validation of the model at several conditions with one or 
three pharmaceuticals shows excellent agreement in the investigated cases.  
 
IV.A.6 Conclusion: 
A complete study was performed on the treatment of solutions containing 
ciprofloxacin by electroxidation using BDD anode. The complete mineralization can be 
reached and the experimental COD values are in accordance with the COD model. At low 
current density (I < I0lim), the amount of intermediates decreases sharply with the 
increasing current density; while in the case of I > Ilim0, the total amount of intermediates 
doesn’t change significantly..  
The salts present in the wastewater can play a significant role in the process. Since, 
strong oxidants (SO4·-,ClO- and ClO·) can be generated at the anode and react chemically 
with the organic matter. On the other hand, some undesired products can be generated by 
reaction with hydroxyl radicals such ClO4- and AOX in presence of Cl-. The study on the 
operating conditions evidenced that the current density must be chosen carefully.. 
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Rather than a hindering effect, the presence of urea even at higher concentration can 
accelerate the degradation of pharmaceuticals.  
In the case of synthetic solutions which contain two pharmaceuticals, the interaction 
and the competition can induce different impacts on the degradation of pharmaceuticals. . 
A model allowing predicting the variation of organic concentration is developed. The 
effects of electrolyte and the electrogenerated oxygen bubbles are also taken into account. 
The numerical model was validated by experimental data obtained with electrolysis of 3 
pharmaceuticals at different operating conditions. In all investigated cases, the comparison 
of model with experimental dates shows a good agreement.  
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IV.B Electrochemical oxidation of pharmaceuticals in 
wastewater   
This chapter investigates the elimination of pharmaceuticals in the NF retentate 
which is the concentrated solution of MBR effluents from hospital wastewater. The 
objective is to identify the feasibility and the impact of the real media (hospital 
wastewater) on the electrochemical process. Table VI-13 presents physico-chemical 
characteristics and composition of this wastewater matrix. Around 50 pharmaceuticals are 
analysed in the MBR permeate from hospital and concentrated in NF retentate [71].  
 
Table VI-13 Physico-chemical characteristics and composition of the wastewater matrix (NF retentate of MBR 
effluents) 
Property Value Ions Concentration 
pH 7.84 Na+ (mg L-1) 161 
COD (mg L-1) 86 K+ (mg L-1) 34 
BOD5 (mg L-1) 0 Mg2+ (mg L-1) 9 
TOC (mg L-1) 40 Ca2+ (mg L-1) 70 
UV254 1.13 Cl- (mg L-1) 70 
HCO3- (mg L-1) 63 NO3- (mg L-1) 152 
Conductivity (mS cm-1) 1.17 SO42- (mg L-1) 110 
  PO43- * (mg L-1) 13 
Concentration of target pharmaceuticals (µg L-1) 
Ciprofloxacin  81 
Cyclophosphamide  22 
Ifosfamide  4 
*Due to the analysis method, all phosphate species H3PO4, H2PO4-, HPO42- and PO43- in the solution were 
measured in the form of PO43-. 
VI.B.1. Elimination of pharmaceuticals and AOX 
Fig.IV-49 shows the decay of COD with EO time during electrolysis of NF retentate. 
It appears that a very good agreement is obtained between experimental and theoretical 
values (I-24). Moreover, COD decay after 120 min of electrolysis is slightly faster than 
the theoretical ones. It can be suggested that an additional phenomenon occurs during the 
electrochemical oxidation. In wastewater, there are a large amount of salts, as shown on 
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table IV-13, which can not only act as electrolyte support but also react with ·OH to 
generate strong oxidants. The results shown in paragraph IV.A.4.1 evidenced that SO4·- 
and ClO- can be electrogenerated from sulphate and chloride, respectively. These oxidants 
react chemically with organics. For electrochemical treatment of landfill leachate using a 
BDD anode, Anglada et al. [72] reported that the evolution of COD follows the 
theoretical value at the current densities of 300 and 400 A m-2, while at higher current 
densities (600, 900 and 1200 A m-2), the oxidation rate of COD is higher than the 
theoretical one. These authors owe these phenomena to the strong influence of the 
indirect electrochemical oxidation due to electrogenerated oxidants from salts present in 
the electrolyte support.  
 
 
Fig.IV-49 The decay of experimental and theoretical COD with EO time during 360 min electrolysis of 1L 
NF retentate. [COD]0 = 81 mg L-1, I = 0.3A (i = 4.34 mA cm-2, ilim = 2.25 mA cm-2), pH = 7.8, flow rate = 
366 L h-1, T = 30 °C 
 
Fig. IV-50 presents the degradation of CIP with EO time during 360 min electrolysis of 
1L NF retentate. The complete removal of CIP is obtained after 80 min (0.4 Ah L-1). It 
can be observed that during the first 15 min CIP decreases faster with a higher 
degradation rate, then the degradation rate decreases. The change of degradation rate is 
possibly induced by the production of several kinds of intermediates which can compete 
with CIP for the oxidation and slow down the observed CIP degradation rate in the 
complex matrix. Nevertheless, the degradation rate of CIP in the NF retentate matrix 
(0.091 min-1for the first 15 min and then 0.034 min-1) is higher than the case of in 
synthetic solution in the same current density range: 0.028 min-1 at 0.5A (section 
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IV.A.2.1). The faster degradation of CIP in the NF retentate can be attributed to the 
influence of electrogenerated inorganic oxidants and some intermediates from organics 
oxidation. As discussed on section IV.A.4.1, the oxidants (SO4·- and hypochlorite) 
electrogenerated from sulphate and chloride can accelerate the degradation of CIP; the 
presence of urea was also observed to lead to a faster degradation of CIP. 
 
 
Fig.IV-50 Decay of CIP with EO time during 360 min electrolysis of 1L NF retentate. [CIP]0 = 76 μg L-1 
(0.23 μM), I = 0.3A (i = 4.34 mA cm-2, ilim = 2.25 mA cm-2), pH = 7.8, flow rate = 366 L h-1, T = 30 °C. 
Inset: The observed degradation rate of CIP. 
 
Table IV-14 shows the concentration of target pharmaceuticals, TOC and AOX at 
initial time and after 360 minutes of electrolysis of 1 L NF retentate. Target 
pharmaceuticals: ciprofloxacin, cyclophosphamide and ifosfamide are totally removed 
after electrolysis. Final TOC reaches 3 mg L-1 and AOX also decreases from 2300µg Cl 
L-1 to 450 µg Cl L-1.  
Table VI-14 Concentrations of selected pharmaceuticals, TOC and AOX at initial time and after 360 
minutes of electrolysis of 1 L NF retentate, operating conditions: see Fig.IV-49 
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VI.B.2 Conversion of ions (in particular Cl-) during electrolysis 
The presence of Cl- in the process has to be studied carefully in particular because of 
the possible formation of toxic by-product such as ClO4-. Fig.IV-51 presents the 
conversion of chlorine species during 360 min electrolysis of 1L NF retentate. It appears 
that the concentration of Cl- declines with time and ClO-, ClO3- and ClO4- are formed 
(concentration of ClO3- is lower than the quantification limits <1 mg L-1). As we can see, 
the sum of ionic chlorine species (Cl- + ClO- + ClO4-) is higher than the initial 
concentration of ionic chlorine (only Cl-). 
 
Fig.IV-51 Variation of concentrations of chlorine species: (a) Cl- ( ); Cl- + ClO- + ClO4- ( ); (b) ClO- ( ), 
ClO3- ( ) ClO4- ( ) with EO time during 360 min electrolysis of 1L NF retentate with different pH: pH  
7.8, The dashed line is the initial chloride concentration. [Cl-]0 = 67 mg L-1, operating conditions: see 
Fig.IV-49 
 
Table IV-15 presents the concentration of chlorine species at initial time and after 
electrolysis. The part exceeding the initial value is probably due to the release of chlorine 
during the oxidation of organics which contain chlorine atoms. 
 
Table VI-15 Concentrations of chlorine species at initial time and after 360 minutes of electrolysis of 1 L 
NF retentate. Operating conditions: see Fig.IV-50 
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The generation of undesired perchlorate ClO4-, it appears after 180 min. After 360 
min of electrolysis, the concentration of ClO4- is 3 mg L-1. Based on these findings, tests 
of ecotoxicity and AOX measurements have been implemented for the study on the 
coupling of nanofiltration and electroxidation in chapter V. 
    In order to investigate the conversion of organic nitrogen, sulphate and phosphate 
from the pharmaceuticals and organic waste and evolution of the other ions, the ionic 
concentrations were analysed. Fig.IV-52 shows the variation of ionic concentrations with 
time during 360 min electrolysis of 1L NF retentate. Two kinds of tendencies are 
observed. 
It appears that the concentration of NO3- and SO42- slightly increase during the 
process and stabilizes at around 180 min. (The increasing amount of NO3- and SO42- are 
17 mg L-1 and 9 mg L-1, respectively). This increasing concentrations can be explained by 
the degradation of organics which contains S or/and N. This fact has been already 
observed during oxidation of urea and salbutamol (N in the molecular structures) and 
sulfamethoxazole (S and N in molecular structure) in synthetic solution. 
 
 
Fig.IV-52 Evolution of the concentration of   NO3- ,  SO42- ,  Ca2+,  Mg2+,  PO43- and 
HCO3- with EO time during 360 min electrolysis of 1L NF retentate, pH = 7.8. [NO3-]0 = 147.2 mg L-1, 
[SO42-]0 = 106.7 mg L-1, [Ca2+]0 = 69.8 mg L-1, [Mg2+]0 = 8.8 mg L-1, [PO43-]0 = 10.8 mg L-1, [IC]0 = 62.8 
mg L-1, operating conditions: see Fig.IV-49. 
 
For the variation of the concentrations of Mg2+, PO43-, Ca2+and HCO3-, one can 
observe the decrease of them with electrooxidation time. The decline of the 
concentrations of Ca2+ and inorganic carbon (mainly HCO3-) is significant from 69.8 mg 
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L-1 to 30.8 mg L-1 and from 62.8 mg L-1 to 23.3 mg L-1. Then the concentrations of Mg2+, 
PO43- decrease from 8.8 mg L-1 to 2.7 mg L-1 and from 10.8 mg L-1 to 0 mg L-1, 
respectively. The disappearance of them is probably due to the scaling which occurs on 
the electrolysis cell.  
Van Hege [73] also observed the decrease of concentrations of Mg2+ and Ca2+ in the 
solution during electrooxidation of reverse osmosis membrane concentrates with BDD 
anode.  
The principle of the electrochemical scaling is the following: 
 
During water electrolysis, dissolved oxygen is reduced on the cathode in a large 
potential range: 
   
(Eq.IV.2-1) 
 
(Eq.IV.2-2) 
 
The generation of hydroxyl ions (Eq.IV.2-1 and Eq.IV.2-2) disturbs the 
calco-carbonic equilibrium of the solution with an increasing pH at the cathode surface. 
Hydrocarbonate ions (HCO3-) are converted to carbonate ions: 
 
(Eq.IV.2-3) 
 
Carbonate ions may react with calcium ion to for calcium carbonate on the cathode 
surface. 
 
(Eq.IV.2-4) 
 
The scaling of calcium carbonate was observed during electrochemical water 
softening[74,75]. 
In the same way, the precipitation of Mg(OH)2 happens at the cathodes [76]. 
 
(Eq.IV.2-5) 
 
To verify this hypothesis, the electrochemical cell was washed with pure water and 
2 22 4 4O H O e OH   
2 2
12 2H O e H OH
   
2 2
3 3Ca CO CaCO
   
2
2( )Mg OH Mg OH   
2
3 3 2HCO OH CO H O
    
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then with 0.7 L of H2SO4 0.1M solution. The acidic solution was recirculated in the 
system for 1 h and the concentration of ions in the solution was measured before and after 
washing. It appears that the concentrations of Mg2+, PO43-, Ca2+ increased in the solution 
after recirculation. Table VI-16 summarizes the different masses of Mg2+, PO43-, Ca2+and 
inorganic carbon , the mass loss during 360 min of electrolysis and the mass recovered 
after 1 hour of recirculation of acidic solution.. It can be observed that there is a good 
correlation between the increasing mass of Mg2+, PO43-, Ca2+ in H2SO4 0.1 M after 
recirculation and the disappearance of these ions during the electrolysis of NF retentate, 
except inorganic carbon evolving as CO2 in acidic solution.  
 
Table VI-16 The different mass of Mg2+, PO43-, Ca2+and inorganic carbon from the beginning and after 360 
minutes of electrolysis and the mass of them in the H2SO4 0.1 M solution after 1 h recirculation. Operating 
conditions: see Fig.IV-66 
Mass (mg)  Mass t=0 Mass t=360 (mass)t=0 – (mass)t=360 mass washed out 
PO43- 10.8 0 10.8 8.3 
Mg2+ 8.8 2.7 6.1 7.3 
Ca2+ 69.8 30.8 39 31.4 
Inorganic carbon 62.8 23.3 39.5 - 
 
    Even the scaling occurred during the electrolysis, the increasing of cell potential was 
not observed during the electrolysis. The deposit should be porous and doesn’t hinder the 
electron transfer. However, the long-term effect should be taken care considering the life 
of electrodes. This phenomenon is well known in the case of water treatment. The good 
correlation between the disappearance mass of Mg2+, PO43-, Ca2+ indicates that 
recirculation with acidic solution can be an effective method to deal with the scaling on 
the cell. The regularly recirculation with acidic solution in the electrolysis system can be 
the proposal strategy to protect the electrode which works in the NF retentate matrix. 
Another treatment consists to apply regularly a reverse polarity at electrodes to dissolve 
the scaling deposit. 
VI.B.3 Electrolysis of NF concentrate in acid condition 
Then the electrolysis was performed in NF retentate after adjusting pH to 3.7 (with 
H2SO4 0.1M). The COD decay is slightly faster at acidic pH (Annex IV-10). Moreover, it 
seems that the oxidation of Cl- and formation of ClO- and ClO4- are more significant in 
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acid conditions (Annex IV-10). The risk of formation of toxic compounds increases at pH 
3, besides ClO4-. Considering this point, the conversion of chlorine species during 
electrolysis of NF retentate in acidic condition should be studied. 
The concentration of HCO3- in acidic NF retentate (14.0 mg L-1, pH = 3.7) is less 
important than in the NF retentate (62.8 mg L-1, pH = 7.8) at the beginning of electrolysis, 
because of the formation of CO2 from HCO3- at lower pH. After electrolysis, only the 
concentration of HCO3- and Mg2+ decreases slightly from 14 mg L-1 to 0.3 mg L-1 and 
from 10.6 mg L-1 to 3.4 mg L-1, respectively. The concentrations of Ca2+and PO43- are 
stable. These results confirms that at pH = 3.7 the problem of scaling for the process is 
less important.  
 
Table IV-17 Concentrations of Ca2+, Mg2+, PO43- and inorganic carbon before and after 360 min electrolysis 
of 1L NF retentate. I = 0.3A (i = 4.34 mA cm-2, ilim = 2.25 mA cm-2), pH = 3.7 (with 0.5 mmol H2SO4 
addition), flow rate = 366 L h-1, T = 30 °C 
Concentration  (mg L-1)  Concentration t = 0 Concentration t = 360 min
Ca2+ 71.4 72.1 
Mg2+ 10.6 3.4 
PO43- 11.0 11.3 
HCO3- 14.0 0.3 
 
VI.B.4 Conclusion 
The electroxidation of NF retentate from MBR effluent of hospital wastewater was 
studied. At the end of electrolysis, the experimental COD decay is faster than the 
theoretical one, probably due to additional chemical oxidation with electrogenerated 
oxidants. The targeted pharmaceuticals: ciprofloxacin, cyclophosphamide and ifosfamide 
are completely removed after electrolysis. The degradation rate of CIP is higher than in 
the synthetic solution, which are also owing to the additional chemical oxidation by the 
electrogeneration oxidants. A good removal of TOC and AOX are also observed.  
The scaling (in the electrolysis cell) which containing Ca2+, Mg2+, PO43- and 
inorganic carbon is due to the locational increase of pH at cathode. The cell potential did 
not increase during electrolysis, while considering the lifetime of electrode and long-time 
effect, the regularly recirculation with acidic solution in the electrolysis system can be the 
proposal strategy to remove scaling in the electrolysis cell. The electrolysis in acidic 
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solution shows slightly higher decay rate of COD and the mainly part of scaling can be 
avoided. However, that more Cl- is oxidized in the acidic condition and more production 
of undesired ClO4- is the disadvantage factor to carry out electrolysis in acidic condition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 207 
Chapter IV Elimination of pharmaceuticals by electrochemical oxidation
IV. Conclusion  
A complete study was performed on the treatment of solutions containing 
ciprofloxacin by electroxidation using BDD anode. The influence of operating conditions 
and the competition between components oxidation in the reactor are studied. Rather than a 
hindering effect, the presence of ions and common organics in the concentrate can 
accelerate the degradation of pharmaceuticals. In particular, the formation of 
organohalogens due to the presence of chloride can be controlled thanks to the choice of 
appropriate operating conditions. A model giving the temporal variation of 
pharmaceuticals concentration is established. One objective is to access to the best 
compromise between mineralization of pharmaceuticals and energy consumption.  
Based on the study in synthetic solution, the electrochemical oxidation shows an 
excellent elimination of pharmaceuticals and AOX in the NF retentate. The targeted 
pharmaceuticals: ciprofloxacin, cyclophosphamide and ifosfamide are completely 
removed after electrolysis. The degradation rate of CIP is higher than in the synthetic 
solution, due to additional chemical oxidation with electrogenerated oxidants. In the 
presence of Ca2+, Mg2+, PO43- and inorganic carbon, the scaling can be avoid at low pH. . 
By contrast, at low pH the production of undesired ClO4- is more important.  
In conclusion, this work has evidenced promising results on the removal of 
pharmaceuticals by electrochemical process using a BBD anode both in synthetic 
solutions or real wastewater. The next chapter is devoted to its implementation in the 
coupling with the nanofiltration. 
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Chapter V Treatment efficiency and toxicity removal of combining EO and NF process
 
This chapter is devoted to the performances and efficiency of the coupling NF and EO 
process. The process efficiency will be assessing in terms of removal of targeted 
pharmaceuticals, final toxicity and energy consumption. The operating conditions for each 
process are chosen on the basis of the studies carried out in Chapters III and IV. 
V.1 Working diagram  
    Hospital wastewater after MBR treatment is firstly treated by NF and the obtained 
concentrate corresponding to a volume reduction factor of 5 is treated by electrochemical 
oxidation. The permeate analysis allows to qualify the selectivity of the process when the 
productivity is evaluated through the permeate flux.  
    Regarding the productivity, a working diagram can be established from the results 
obtained in chapter III.B. This diagram represented in Fig V-1 plots permeate fluxes vs 
applied pressures. Different zones are defined which give the productivity of the process 
and the related fouling types depending on the operating conditions of the filtration.  
 
 
Fig.V-1 NF working diagram between applied pressures and permeate fluxes. Full line is the average pure 
water permeability; dashed line is the threshold permeability. 
 
In Region A the applied pressure is lower than the critical one, thus an increasing 
applied pressure results in higher productivity.  
For pressures higher than the critical value, the flux is controlled by fouling mechanism: 
Region B: colloidal silica and organics fouling or Region C combination of organics 
fouling and scaling. The study in Chapter III.B demonstrates that the occurrence of scaling 
is highly related to the pH of the MBR effluent matrix, associated to the effect of salts 
concentration. When the pH of filtrated solution is higher than 7.2, fouling involves a 
scaling phenomenon. Unfortunately, the pH of MBR effluents in most cases is alkaline as 
A CB
0
20
40
60
80
100
120
0 10 20 30 40
J (
L h
-1 m
-2 )
Pressure (bar)
Region of colloidal 
organic fouling Region of scaling
 216 
Chapter V Treatment efficiency and toxicity removal of combining EO and NF process 
this corresponds to optimal conditions for bacterial viability and oxidation efficiency [1]. 
Consequently, without adjusting pH, the working diagram of nanofiltration is limited to 
regions A and C. 
The impact of fouling types and water matrix are discussed in chapter III.C. Fig.V-2 
summarizes the rejection of targeted pharmaceuticals in working each region of NF. The 
complete removal (in the range of 94 % to 99 %) is reached in region C; while in region A, 
lower rejection is observed. Certainly, considering the variability of MBR effluent 
composition, there are some intermediate cases with an inhomogeneous scaling. These 
intermediate cases lead to an intermediate rejection rate (lower than in the case of 
homogenous scaling and higher than in unfouled conditions). 
 
 
Fig.V-2 Rejection rate of 3 targeted pharmaceuticals, R, in different working regions of NF 
 
Thus, salts, organics and pharmaceuticals concentrations in NF retentate depends on 
the initial MBR effluent composition and the NF working regions. This concentrate 
composition can impact the performances of the electrochemical oxidation.  Two extreme 
cases will be studied for the coupling: regions A and C with a special focus on region C. 
In the case of the maximum of selectivity, electrolysis was carried out on NF retentate 
coming from region C. The results shown in chapter IV.B highlighted a complete 
disappearance of CIP in 80 minutes (operating conditions: BDD anode, area 69 cm2, I = 0.3 
A, Ilim = 0.18 A). Duration of 6 h is needed to obtain an EO effluent free from targeted 
pharmaceuticals with a nearly total disappearance of TOC (92.5 %).  
    A specific study including ecotoxicity measurements is developed in the next 
paragraph to qualify the performances of the coupling process. 
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V.2 Removal of toxicity by combining process 
    The toxicity in terms of androgenic, estrogenic and pregnane X receptor (PXR)-like 
(xenobiotic response) activity was measured at the inlet and outlet of each process (NF 
retentate and permeate were collected after a volume reduction factor of 5). 
 
 
 
 
 
 
Fig.V-3 Biological toxic equivalents in terms of androgenic (a) estrogenic (b) and PXR-like activity (c) of 
MBR effluent, NF permeate, NF retentate and after EO. 
 
Regarding the results on androgenic activity, the combining process shows an excellent 
efficiency; the effluents from both NF and EO are free of toxicity in spite of an important 
biological toxic equivalent in the NF retentate.  
Regarding the results on estrogenic activity, the removal by NF process of toxic 
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compounds is not efficient. Nevertheless, EO exhibits a good performance to eliminate this 
kind of toxicity. Considering that the NF permeate could still pose the threats to the 
environment, in this case the choice of the membrane should be considered to reach a better 
rejection of compounds responsible for this toxicity. 
In the case of PXR-like activity, NF permeate doesn’t exhibit any toxicity, while the 
electrochemical oxidation increases the toxicity of the NF retentate. This case needs a 
special attention: in section IV.A.4.1.2, the possible formation of ClO4- and AOX during 
electrochemical oxidation has been evidenced. AOX compounds enhance the biological 
toxic equivalents in terms of PXR-like activity [1-2]. In the study of Chapter IV it was 
evidenced and underlined that at high current intensity the amount of the electro generated 
halogen organic compounds can be very important. To check this result, the PXR-like 
activity was measured after EO at lower current intensity (I= 0.2 A instead of 0.3A) with 
various duration of treatment. 
In parallel, regarding to the possible impacts of water matrix, the electrooxidation of 
NF concentrate obtained after filtration in Region A is studied. Results are shown in 
Fig.V-4.  
Regarding the results obtained with NF retentate of region C, in comparison with 0.3 A, 
the decrease of toxicity in PXR-like activity is observed at 0.2 A. It seems that at an 
appropriate applied current density (close to the limiting current), the electrochemical 
oxidation shows a good performance for the removal of this kind of toxic compounds. 
In working Region A, the NF process shows weakness in the selectivity, a 
non-negligible toxicity in terms of PXR-like activity is evidenced in the permeate. 
Nevertheless, the PXR-like activity in NF retentate decreases significantly after EO, even 
at higher current intensity (0.3 A).  
 
 
Fig.V-4 Biological toxic equivalents in terms of PXR-like activity of MBR effluent, NF permeate, NF 
retentate and after EO for two NF working conditions: regions A and C. 
 
The comparison of results from EO treatment of NF retentate of regions A and C at 
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0.3 A evidences a great difference. This difference can be attributed to the composition of 
the concentrate. Table V-1 presents the concentrations of Cl- and ClO4- in NF retentate and 
EO effluent. The formation of ClO4- is likely independent on the chloride concentration in 
this range, but is highly related to the applied current intensity as it was shown previously. 
Moreover, the concentration of ClO4- is the same in the EO effluents after 6 h of EO at 0.3 A 
for both NF retentate. Because the concentration of perchlorate is the same and the 
PXR-like activity is 6 times higher in the region C, one can conclude that in this range of 
concentration there is no correlation between the presence of ClO4- and the response in 
PXR-like activity.   
 
Table V-1 Concentration of Cl- in the NF retentate and concentration of ClO4- after EO 
Concentration  
(mg L-1) 
[Cl-]  
in NF retentate 
[ClO4-]  
T = 1 h 
[ClO4-]  
T = 5 h 
[ClO4-]  
T = 6 h 
Region A, I = 0.3 A 47.2 ± 0.7 <LD 2.6 ±1 3.8 ± 1 
Region C, I = 0.2 A 67.8 ± 1 <LD <LD  
Region C, I = 0.3 A 68.3 ± 1 <LD 2.2 ± 1 3.4 ± 1 
 
Fig.V-5 presents the measurements of AOX in NF concentrate and after EO treatment 
at various current intensities and durations. The concentration of AOX present in the 
retentate decreases after EO in all conditions. Concentration of AOX after 6 h of EO at 0.3 
A is higher when the electroxidation is performed with the NF retentate from region C than 
from region A, which is in accordance with the tendency shown with the measurements of 
PXR-like activity.  
 
Fig.V-5 Concentration of AOX in various NF concentrate and EO effluent 
 
To explain that the PXR-like activity after EO at 0.3A is very high although the 
concentration of AOX is lower in the EO effluent than the NF retentate, one can make the 
following assumption: it is possible that the toxicity depends on the AOX forms, some 
compounds which are more toxic are produced at this current density range.  
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Lower toxicity and AOX concentration after 6 h of EO at 0.3 A is obtained when the Cl- 
concentration is lower (retentate from region A). 
The production of AOX depends on the applied current intensity during the 
electrochemical treatment of NF retentate from region C, higher removal efficiency is 
obtained at lower applied current intensity (0.2 A) after 5 hours of EO. As discussed 
above, it is possible to form some toxic by-products in the case of electrolysis at higher 
applied current intensity (0.3A) during 6 hours of electrolysis. Pérez et al. [2] observed 
that more trihalomethanes were formed at higher current and that the concentration of 
them increase during electroxidation of reverse osmosis concentrates generated in tertiary 
water treatment using BDD anode (surface area of 70 cm2). More precisely 200, 80, 50 μg 
L-1 of trihalomethanes were formed at current densities of 200,100 and 50 A m-2 after 6 
hours of electroxidation, respectively.  
  
Table V-2 shows almost the same removal of target pharmaceuticals, TOC and COD 
using two applied current intensities, both higher than the limiting current density 
(calculated from COD, Eq.I-12). This result evidences that the lower current intensity close 
to Ilim can be the best choice to remove the targeted pharmaceuticals, TOC and COD. 
Moreover it reduces the risk of formation of ClO4- and toxic by-products.  
 
Table V-2 Removal of CIP, TOC, COD and electrical charge at two current intensities for electroxidation of 
NF concentrate in Region C 
Applied 
current   
I (A) 
EO time 
(min) 
Ilim 
(A) 
Electrical 
charge  
(Ah L-1) 
CIP 
(mg L-1) 
COD 
(mg L-1) 
TOC 
(mg L-1) 
0.2 300 0.18 1 100% 100% 91.0 % 
0.3 300 0.18 1.8 100% 100% 91.5% 
 
The low concentration of Cl- in the NF retentate obtained in Region A allows 
avoiding the formation of toxic by-products during the electrochemical process. Even if 
the retentate from Region C contains more chlorides ions than on Region A, it is possible 
by controlling and using the appropriate current intensity to reduce the formation of toxic 
by-products.   
As a conclusion, the coupling NF and EO process shows excellent elimination of 
toxicity in terms of androgenic and PXR-like activity in appropriate operating conditions. 
Regarding the androgenic activity, results suggest that the selected membrane is not 
adapted to remove it, another NF membrane type could be considered to improve the 
efficiency of the process.  
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V.3 Energy consumptions  
Fig.IV-6 presents the energy consumption for the removal of the targeted 
pharmaceutical (CIP), COD and AOX during electrolysis of NF concentrate in working 
region A and C. In all cases the targeted pharmaceutical (CIP) has totally disappeared. It 
can be observed that the lowest efficiency of CIP removal is obtained during 
electrooxidation of NF retentate obtained in region A: removal of 48 μg of CIP in 1L 
solution needs 2.8 Watts. In contrast, the same energy consumption used for the 
electrochemical treatment of NF retentate from region C can remove around 70 μg of CIP 
in 1L.  
         
 
                 
 
Fig.V-6 Removal of CIP (blue), COD (green) and AOX (red) in the NF retentate obtained in  Region A at 
I = 0.3 A,  Region C,  at I = 0.3 A and  Region C at 0.2 A vs. energy consumption.  
 
Due to the low salt rejection in region A, the conductivity of NF retentate is lower, 
which increases the cell voltage. Moreover, the low rejection of pharmaceuticals in Region 
A leads to high concentration of pharmaceuticals in permeate.  
Thanks to the higher conductivity of NF retentate in region C, the AOX and COD removal 
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consumes less energy during electrooxidation. Expectedly, the one with lower applied 
current can reach best removal with lower energy consumption. In this case, 80 mg of COD 
can be removed with 4.4 W in 1 L solution.  
 
V.4 Discussion and conclusion  
According to the working diagram of NF, in the working region A, it is possible to 
reach the high NF productivity of 100 L h-1 m-2 with a low concentration of Cl- in the 
retentate for avoiding the formation of organochlorides during the EO process. However, 
in these conditions the quality of the permeate is unsatisfactory in terms of toxicity and 
pose threats for the environment. In addition, because the conductivity of retentate is low, 
it results in a low energy efficiency in the following EO step. Thus, for these reasons, the 
region A doesn’t correspond to the best operating conditions for the coupling process. The 
working region C can then be the best compromise. 
The study carried out on chapter IV evidences that the applied current intensity is the 
key factor. When the applied current is close to the limiting current intensity, the 
efficiency is high and the concentration of organochlorides which can be formed during 
the electroxidation of organics in presence of chloride ions is negligible. Nevertheless, 
during EO process the depletion of organics concentration leads to increase of  ூூ೗೔೘. One 
solution is to adapt the value of the applied current intensity during the process. Previous 
study in chapter IV has shown that in all the cases the experimental values were in a good 
agreement with the COD model.  
Another possibility is to adapt the geometry of electrochemical cell (by increasing the 
ratio electrode surface/reactor volume) to insert it in a continuous mode combined with 
feed-and-bleed continuous NF process and to control the range of COD concentration at 
the inlet of the electrochemical reactor. 
To summarize, the best compromise for the NF operating conditions without 
adjusting pH, taking into account the toxicity criteria and energy consumption of the EO 
step, is situated in the working region C. In the case of wastewater containing chlorides, it 
will be necessary and safe to use an appropriate current intensity for EO. 
After optimization, MBR effluent (7 L) which contents 8-36 μg L-1 of target 
pharmaceuticals and 3 μg SR-EQ L-1 of xenobiotic response was treated by coupling 
process. NF retentate was conducted in region C and the EO was performed at 0.2 A for 
300 min. The flow diagram is shown in Fig.V-7. The coupling of NF and EO shows 
excellent efficiency for removal of target pharmaceuticals and toxicity. Xenobiotic 
response was completely removed by NF and the removal rate of pharmaceuticals was 
superior to 88 %. Xenobiotic response concentration of target pharmaceuticals which 
were concentrated in NF retentate were eliminated by EO. The final solution of EO was 
without pharmaceuticals and the toxicity decreased drastically. It can believed that after 
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treatment, high quality water obtained by NF permeate and EO effluent can be discharged 
without detrimental effect on environment. 
 
 
Fig.V-7 Example of tertiary treatment combining nanofiltration and electrochemical oxidation for 
elimination of pharmaceuticals and toxicity from MBR effluent, NF in region C, EO duration 300 min, I= 
0.2 A (Ilim = 1.8 A), T = 30 °C, flow rate = 366 L h -1. 
 
The comparison of the quality of effluent after treatment by the coupling process 
(NF permeate and after EO) with the irrigation water standards confirms the possibility of 
reuse of the treated water (See Annex V -1). Other reuse types can also be considered.  
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 Conclusions
 
Conclusions 
 
Numerous studies have demonstrated the occurrence of pharmaceuticals in the aquatic 
environment. The reason is these molecules are incompletely eliminated in wastewater 
treatment plants even if a membrane bioreactor (MBR) process is used. Considering their 
potential long-term toxicity towards exposed organisms, tertiary treatments are required to 
prevent the release of pharmaceuticals in aquatic ecosystems. Nanofiltration and 
electrochemical oxidation were proved to be promising processes for the separation and 
elimination of micropollutants. A tertiary treatment combining these two processes is 
proposed in this Thesis for the elimination of pharmaceuticals in hospital wastewaters after 
MBR. 
The objective of this thesis was to investigate main parameters which influence the 
productivity and selectivity during NF in one hand, and the efficiency and safety of EO in the 
other hand, in order to be able to propose appropriate operating conditions to enhance the 
coupling efficiency in an economically viable and environmentally sustainable way. 
NF and EO process were first studied separately in order to determine the effect of 
operating conditions and matrix on both processes.  
In the first part, the critical flux and limiting flux which relate to the NF productivity 
were studied. The square wave filtration method, developed in previous studies to determine 
the critical flux during the filtration of a synthetic solution, has been implemented in the 
present work to estimate the critical flux during NF of MBR effluent matrix. The ideal 
productivity could be obtained with an initial flux lower than the critical flux to avoid 
irreversible fouling. For fluxes beyond this critical value, two limiting fluxes were observed. 
One of them was around the estimated critical flux while the other was well below due to the 
presence of scaling. Due to the low productivity when scaling occurs, a method predicting 
scaling by estimation of a threshold permeability before scaling was investigated.  
A working diagram reporting the permeate flux versus applied pressure has been 
established and divided in three regions: un-fouling region, region of colloidal silica and 
organics fouling and region of scaling. This working diagram allows identifying the fouling 
type according to flux behaviors versus the pressure. Thanks to a set of independent 
filtrations using real water matrix with variabilities, effects of the matrix on the fouling 
mechanisms were studied. The appearance of either limiting flux values mentioned before 
was demonstrated to be dependent of water matrix characteristics, mainly organics and salts 
concentrations and pH. Maintaining the pH of filtrated solution at 6 is proposed and verified 
to be a solution to avoid the scaling.  
In a second step, rejections of salts and pharmaceuticals were studied to determine the 
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influence of the water matrix and fouling types on the selectivity, beside other significant 
factors such as membrane material and structure and pharmaceuticals properties. With the 
unfouled membrane or in presence of a moderate organics fouling, rejection of ions and 
pharmaceuticals is predominantly governed by electrostatic repulsions and hydrophobic 
interactions respectively. With membrane fouled by scaling, the rejection of both ions and 
pharmaceuticals is governed by size exclusion leading to the excellent rate of removal.  
 
In the second part, the electrochemical oxidation of pharmaceuticals was studied in 
synthetic solutions and NF retentate. The first aim was to determine how operating 
conditions and simultaneous presence of organics and inorganics affect the mineralization 
efficiency of pharmaceuticals with a specific focus on the formation of by-products in the 
presence of chloride ions. The strategy proposed was to, first, study the process using a 
synthetic solution to simplify the number of parameters, and then after that, study the process 
under real matrix condition (NF retentate).  
Thus, a complete study was performed on the treatment of synthetic solutions 
containing ciprofloxacin by electrochemical oxidation using BDD anode. At low current 
density (I < I0lim), the amount of intermediates decreases sharply with increasing the current 
density; while in the case of I > I0lim, the total amount of intermediates doesn’t change 
significantly. Using a current intensity slightly higher than limiting current can be the best 
compromise between the mineralization rate and energy consumption.  
Salts present in the wastewater can play a significant role in the process. Since, strong 
oxidants (SO4•-, ClO- and ClO•) can be generated at the anode and react chemically with the 
organic matter. On the other hand, some undesired products can be generated by reaction 
with hydroxyl radicals such as ClO4- and AOX in the presence of Cl-. The generation of 
ClO4- and AOX is facilitated at very high current density. The study on the influence of 
operating conditions evidenced that the current density must be chosen carefully.  
Rather than a hindering effect, the presence of urea even at higher concentration can 
accelerate the degradation of pharmaceuticals. In the case of synthetic solutions which 
contain two pharmaceuticals, the interaction and competition can induce different impacts on 
the degradation of pharmaceuticals.  
A model allowing predicting the variation of organic concentrations was developed and 
effects of salts and electrogenerated oxygen bubbles are also taken into account.  
Considering the electrochemical oxidation of NF retentate in MBR effluent matrix, 
targeted pharmaceuticals were completely removed after electrolysis. The degradation rate of 
CIP was higher than in the synthetic solution, probably due to additional chemical oxidation 
with electrogeneration oxidants. A good removal of TOC, COD and AOX were also 
observed. The scaling (in the electrolysis cell) was observed due to the increase of the local 
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pH at cathode. The cell potential did not increase during electrolysis, while considering the 
lifetime of electrode and long-time effect, the regularly recirculation with acidic solution in 
the electrolysis system can be the proposal strategy to remove scaling.  
 
In a last step, the efficiency of the coupling process was studied through the global 
elimination of pharmaceuticals from the influent and the removal of the related toxicity 
which can be more appropriate in term of evaluation of the efficiency of the process with 
environmental perspective.  
Based on the working diagram of NF, filtration conditions corresponding to the un-
fouling region insure higher productivity while low rejections in that case can lead to higher 
pharmaceuticals and toxic compounds concentrations in the permeate. In this case, NF 
permeate continues to pose threats on the environment, in addition to the production of a 
lower concentrated NF retentate which results in a lower energy efficiency for the removal of 
pharmaceuticals in the following EO step.  
Operating EO in a current intensity higher while close to the limiting current is the best 
operating condition to obtain higher efficiency and avoid the production of toxic by-products. 
Considering the removal of toxicity, EO is confirmed to be an efficient and safe method if an 
appropriate operating current density is selected.  
After optimization of operating conditions, the efficiency of the coupling process for the 
total removal of target pharmaceuticals has been demonstrated through the elimination of 
androgenic activators and PXR-like activators. It was still observed some estrogenic 
activators attributed to the fact that corresponding compounds were certainly not totally 
rejected by the membrane. 
 
As further developments of this thesis, several possibilities are proposed. 
Concerning the NF, there is still an open question: how to obtain great productivity and high 
selectivity at the same time. The first track to be investigated is the technical and economic 
feasibility of a regulation of the feed pH, according to its impact factor on fouling and 
pharmaceuticals rejection. It can be conclude from the present study that filtration operated at 
a flux lower than the critical flux with adjusting pH to 6 could lead to (i) high productivity 
due to the absence of irreversible fouling especially scaling; (ii) acceptable rejection of 
pharmaceuticals due to the control of the enlargement of pore size attributed in alkaline water 
matrix to electrostatic repulsions within the membrane pores. 
Expectedly, the adjustment of the pH during NF could be accompanied by higher cost 
and difficulty of application. This must be balanced with the lower productivity and cost of 
fouling removal without adjusting the pH.  
To manage the EO process in an environmental and economic sustainable way, the 
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present work has evidenced that the choice of the applied current is the key factor. The 
objective is to control the formation of halogenated organics besides operating current. It 
already determined that the current density closed to the liming current density can be the 
best operating condition to obtain the great process efficiency and avoid formation of AOX. 
However, Ilim depends on the COD which changes during EO experiments. The next step of 
this study will be the design of the coupling process. Some tracks of reflexion have been 
proposed such as: 
 
(i) Adapt the applied current during the EO time; this study has evidenced that the 
implementation is possible thanks to the excellent adequacy between COD 
model and experiments.  
(ii) Adapt the geometry of the electrochemical cell to maintain the COD 
concentration at the inlet of the electrochemical cell in a continuous mode. For 
that a study is required to develop a new reactor with a high conversion rate per 
pass. 
(iii) Another way is to design the EO to only increase the biodegradability of 
effluents (without mineralization) with a recirculation in the MBR. In this case, 
the material of anode doesn’t need the same oxygen overpotential as the one of 
BDD. The potential of the cell would be lower. The use of a carbon felt which 
gives a high active surface can be used. In this way refractory compounds are 
modified by electrooxidation into more biodegradable compounds. 
 
At the end of this manuscript, it could be affirmed that this Thesis, providing a better 
understanding on the effects of the complex MBR effluent matrix on the behaviors of both 
NF and EO, paves the way for the application of NF and EO coupling process for the 
elimination of pharmaceuticals. From this knowledge, appropriate operating conditions can 
be achieved. Thus, the study can be used as a reference for industrial applications of this 
tertiary treatment process and for further developments in coupling treatment process. 
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Annex IV-1: Electrogenerated bubbles enhance the mass transfer coefficient 
 
Breck [6] showed that the mass transfer coefficient the global mass transfer 
coefficient (kd) is the sum of two contributions, the flow rate of reaction system (kdh) and 
the convection due to bubbles (kdb).  
  
(Eq.IV.1-5) 
 
Nevertheless, Vogt [4] tested and proposed a more precise correlation given by 
Eq.IV.1-6, which takes into account the influence of the flow rate on the bubble radius 
before dropping out :  
 
           
(Eq.IV.1-6) 
 
Where kd is the global mass transfer coefficient, kdh and kdb is mass transfer 
coefficient contributed by flow rate of reaction system and the part from bubbles, 
respectively. 
kdb depends on the gas flow production [4]: 
 
           
(Eq.IV.1-7) 
 
In this equation, B is a constant related to the bubbles (shape, diameter, surface tesion); 
its value is estimated with experimental data, D is the gas diffusion coefficient in liquid 
phase,      (m2 s-1) is the volumetric rate of gas evolution and S (m2) area of the flow cross 
section. The constant value m is function of the gas nature. The average value for dioxygen 
in acid media is m = 0.5 [6], [7].  
 
The gas flow production,       is a function of applied current density 
which produces oxygen, iO2 (A m-2), and the molar volume of oxygen, Vmol in m3 
mol-1 
(Eq.IV.1-8) 
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Previous studies carried out in the LGC have been determined the constant B in the 
same system and operating conditions [3], [8]; B*D0.5 was tested as 4.3×10-3, iO2 = 207 A 
m-2. Then, kdb can be calculated as 2.4×10-3 m s-1 and the mass transfer coefficient in this 
case kd was 3.5 ×10-3 m s-1.  
In fact, the impact of current to mass transfer coefficient was merely observed at high 
applied current. Weiss [5] calculated the relationship of applied current and mass transfer 
coefficient (Fig.IV-9).  
 
Fig.1 the relationship of applied current and mass transfer coefficient [5] 
 
That is the reason why the CIP degradation rate was quit the same with current 0.1 and 
0.5 A (I0 > Ilim0, I/I lim0 = 7.2), but raised significant when the current increasing to 1.5A(I >> 
I lim0, I/Ilim0 = 21.7) on the section IV.1.2.1: at 0.5 the current consumed to produce oxygen 
(iapplied - ilim0) is 62 A m-2 and the mass transfer coefficient was negligible; at 1.5A  this 
value can be 207 A m-2 and the contribution of oxygen bubbles to mass transfer coefficient 
was significant from the Fig.IV-9.  
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Annex IV-2: TOC decayed with time during electrolysis of 1L CIP solution with various 
applied current density 
 
Fig. 2 presents the evolution of TOC with EO time as various applied current intensity. 
It was observed that the removal of TOC became faster at a higher applied current. Value 
decreased slightly and was even stable at the first 10 min in the case I < Ilim0. As we 
discussion on section IV.1.2.1.1, CIP can be oxidized by BDD anode with two pathways: 
directly electrons transfer and oxygen transfer via ·OH. That directly electrons transfer 
between CIP and anode just can degrade CIP molecule instead of releasing carbon dioxide 
to reduce organic carbon in the solution. TOC mineralization merely could happen in the 
case oxidation via ·OH. On the other hand, the reaction between CIP and anode, CIP 
and ·OH happened and the competed at the same time. When the applied current lower than 
the limiting current (charge controlled), the oxidation is not completely. The slow decline 
of TOC at the beginning of electrolysis was due to that the main reaction was directly 
electrons transfer between CIP and anode. Until the part of current which produce ·OH 
increased and took the dominant role in the electrolysis, TOC mineralize can be in a faster 
rate. 
TOC decayed with almost the same rate, when the applied current increased from 
0.1A to 0.5A, whereas a faster TOC mineralization was obtained when the current became 
to 21 times of limiting current (I >> Ilim0). This phenomenon was owing to that the effect of 
electrogeneration bubble on mass transfer coefficient was more significant at a very high 
applied current as discussion above. 
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Fig.2 TOC decayed with time during electrolysis of 1L CIP solution in K2SO4 0.1 M at pH = 3.7 with 
various current, flow rate = 366 L h-1, T = 30 °C. [TOC]0 shown on table IV-2, Ilim ≈ 0.08A 
(a) I < Ilim0, I = 0.03A and I = 0.05A 
(b) I > Ilim0,    I = 0.1A and I = 0.5 A 
(c) I >> Ilim0,  I = 1.5 A 
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Annex IV-3: the carbons from CIP and total organic carbon are compared at various 
applied current 
 
I < Ilim 
I = 0.03A I = 0.05A 
I > Ilim 
I = 0.1A I = 0.5A 
I >> Ilim    
I = 1.5A  
 
Fig. 3 Comparing the comparing of carbons from CIP and total organic carbons during electrolysis of 1L 
CIP solution in K2SO4 0.1 M at pH = 3.7 at various applied current, flow rate = 366 L h-1, T = 30 °C. 
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Annex IV-4：An example of the calculation of energy consumption and mineralization 
rate in the synthetic solution 
    Fig.4 presents the time and corresponding energy for complete CIP and 80% of TOC 
removal with various applied currents. From the figure, the time for 80 % TOC removal 
shorten 30 % from 400 to 280 min decreased with the applied current 0.03, 0.05 and 0.1 A, 
and then the decline became slower when the applied current exceeded limiting current. 
The removal time was 270 min and 130 min when the applied current increases to 0.5 and 
1.5 A, respectively. The removal time of CIP was observed as similar phenomenon. When 
the applied current rose from 0.03 A to 0.1A the removal time decreased from 190 min to 
150 min, whereas the removal time keep stable at 140 min with the current increasing from 
0.1A to 0.5A. Then a slight decline was occurred to 85 min when the applied current was 
1.5 A. 
Considering energy consumption, energy consumption for 70 % TOC removal at 
applied current of 0.03, 0.05, 0.1, 0.5 and 1.5 A were 0.2, 1.2, 1.8, 9.5 and 19.3 Wh L-1, 
respectively. Comparing the applied current 0.03 and 0.1A, the energy consumption rose 
from 0.18 to 1.43 Wh L-1 and TOC removal time shortened 37%. On the other hand, in 
the range of 0.1 A to 1.5 A, a large amount energy consumption earned a slightly removal 
time decline.  
 
                                                               
Fig.IV-4Time (solid points) and corresponding energy consumption (hollow points) for 100% CIP (a), 80% 
TOC removal(b) during electrolysis of 1L CIP solution with various applied current in K2SO4 0.1 M at 
pH = 3.7, flow rate = 366 L h-1, T = 30 °C 
 
One can be abstracted from Fig.4 that the limiting current intensity could be a 
“critical current intensity”: when the current intensity lower than the limiting current 
intensity, increasing current shortens the removal time and the energy consumption 
slightly increases; when the current intensity exceeds limiting current intensity, the 
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increasing current leads to higher energy consumption with insignificant removal time 
shortened for both CIP and TOC. Table.1 presents the values of removal time shorten, 
energy consumption increased and also energy consumption for shortening every minutes 
for the 80 % TOC and completely CIP  removal in two current range: 0.03 to 0.1 A (I≤ 
Ilim0), 0.1 to 1.5 A (I > Ilim0). It can be noticed that the special energy consumption for 
shorten 1 min for TOC removal was 0.013 WhL-1 in the range of 0.03 to 0.18A, and the 
almost 10 times energy consumption was required at current range 0.1 to 1.5 A (I > Ilim0). 
It is the same tendency in the case of completely CIP removal.  
 
Table.1Comparison of the shorten of time and corresponding energy consumption in two current range for 
80 % TOC and completely CIP removal 
TOC CIP 
Current range 0.03 to 0.1 A 0.1 to 1.5A 0.03 to 0.1 A 0.1 to 1.5A
Time shortened   min 120 144 37 63 
Energy consumption increased  WhL-1 1.6 17.5 0.9 11.4 
Energy consumption for every min 
(WhL-1) min-1 0.013 0.12 0.024 0.18 
 
Thus, the current intensity which value close to the limiting current can be the best 
compromise of less energy consumption and better mineralization rate. 
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Annex IV-5: The discussion of the amounts of intermediaries produced during 
electrooxidation of SALBU and SMX in comparing with CIP 
 
To discussion the amounts of intermediaries produced during electrooxidation of 
SALBU and SMX, we also introduce the concept of Δ as the different of carbons of TOC 
and carbons of molecule (SALBU or SMX or CIP, identified on section IV.1.2.4). 
Comparing with CIP, it can be observed from the Fig.IV-28 that Δ of SALBU and CIP reach 
a peak value at the same time around 80 min of electrolysis and the maximum Δ of CIP is 
higher than SALBU. The total amount of intermediates produced during electrolysis can be 
characterized by the intermediates surface (
0
t
dt ). From the figure it can be observed that 
the amount of intermediaries of CIP produced during electrolysis is more than SALBU and 
SMX, which can be expected due to CIP is a more complex molecule and containing 
more carbons than the others. The amounts of intermediaries of SALBU and SMX are 
almost the same at the first 1 h. It can be infer that probably, the amounts of 
intermediaries produced during electrolysis of pharmaceuticals depend on the carbons 
number of molecule in the same operating condition. 
 
 
Fig. 5 The variation of Δ of SALBU, SMX and CIP with EO time during 300 min electrolysis. Operating 
condition see Fig.IV-26. 
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Annex IV-6: TOC decay in presence of Cl- with current intensities as 0.1A and 3A 
 
 
Fig.6 TOC decayed in K2SO4 0.02M+2.25mM KCl, I = 0.1A (1.45 mA cm-2),  I = 3 A (43.47 mA 
cm-2). [TOC]0 = 11 mg L-1, during electrolysis of 1L CIP solution, flow  rate = 366 L h-1, T = 30 °C. 
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Annex IV-7  
Fig.7 shows the degradations of CIP and urea with EO time in synthetic solutions 
containing both molecules with different ratios: [CIP]0:[urea]0 = 1:2 and [CIP]0:[urea]0 = 
1:11. For the ration of [CIP]0:[urea]0 = 1:2 (Figure IV-44 (a)), it can be observed that the 
completely removal of CIP is reached after 180 min of electrolysis, while the 
concentration of urea seems to be stabilized at 0.009 mM. This stabilization was already 
observed during electrolysis of urea solution. For the ration of [CIP]0:[urea]0 = 1:11 
(Fig.8 (a)), the degradation of CIP is surprisingly rapider than the case the concentration 
of urea as double of CIP as shown on Fig. 8 (b): the completely removal of CIP is 
obtained only after 100 min of electrolysis.  
 
 
 
Fig. 7: The evolution of the concentrations of CIP and urea during 300 min electrolyses of 1L in 
synthetic solutions containing CIP and urea with different ratio and K2SO4 0.1 M at pH = 3.7. I = 0.5A, 
flow rate = 366 L h-1, T = 30 °C. Inset: the kinetics analysis of CIP and urea. 
(a) [CIP]0:[urea]0 = 1:2, [CIP]0 = 0.045 mM, [urea]0 = 0.094 mM;  
(b) [CIP]0:[urea]0 = 1:11, [CIP]0 = 0.053 mM, [urea]0 = 0.606 mM.  
0
0.03
0.06
0.09
0
0.015
0.03
0.045
0 100 200 300
[U
rea
] (m
M)
[C
IP]
 (m
M)
EO time (min)
0
1
2
0 50 100
lnC
/C
0
EO time (min)
0
0.2
0.4
0.6
0
0.02
0.04
0.06
0 50 100 150 200 250 300
[U
rea
] (m
M)
 
[C
IP]
 (m
M)
EO time (min)
0
1
2
3
4
0 50 100
lnC
/C0
EO time (min)
(b) 
(a) 
 239 
Annex IV-8 Degradation of pharmaceutical in presence of NH4+ and NO3- 
 
Fig.8 (a) CIP degraded with I = 0.1 A in K2SO4 
0.02M,  I = 0.5 A in K2SO4 
0.1M + 2.5mM NH4+ during electrolysis of 1L CIP 
solution, [CIP]0 = 0.069 mM, flow rate = 366 L h-1, 
T = 30 °C.  
Fig.8 (b) SMX degraded with I = 0.5 A in 
K2SO4 0.02M, KNO3 0.02M during electrolysis 
of 1L SMX solution, [SMX0 = 0.060 mM, flow rate 
= 366 L h-1, T = 30 °C 
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Annex IV-9: Decay of TOC during electrooxidation of CIP and SALBU 
 
 
 
Fig.9 Decay of TOC in CIP and SALBU solution I = 0.5A (I > Ilim0), [TOC]0 = 25.4 mg L-1, 
flow rate = 366 L h-1, electrolyte: K2SO4 0.1 M, T = 30 °C.   
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Annex IV-10: Influence pH on the decay of COD and conversation of Cl- during 
electrooxidation of NF concentrate 
 
Influence pH on the decay of COD 
    The influence of pH on the decay of COD was also studied. Fig.IV-10 shows the 
decay of COD with time in the cases of pH = 3.7 and pH = 7.8 during 360 min electrolysis 
of 1L NF concentrate. It can be observed that the decay of COD in pH = 3.7 is faster than 
the case of pH = 7.8 and simulation value. This phnonena is probably due to that the 
addition electrogenneration oxidants besides·OH is easier to be generated or stabilized in 
acidic solution and then the additional chemical oxidation is more significant. For example, 
as we disscussed, the SO4·- is easier to be generated in acidic solution due to higher 
concentration of HSO4- in acidic solution.  
 
 
Fig.IV-10 The decay of COD with time in different pH:  pH =3.7, pH = 7.8 and  simulated value 
during 360 min electrolysis of 1L NF concentrate. [COD]0 ≈ 81 mg L-1, I = 0.3A (i = 4.34 mA cm-2, 
ilim = 2.25 mA cm-2), flow rate = 366 L h-1, T = 30 °C 
 
The influence pH on the conversation of chlorine species 
The conversation of chlorine species are studied with different pH by measurement 
of the concentration of ionic chlorine species. 
Fig.IV-11 presents the conversation of chlorine species during 360 min electrolysis 
of 1L NF retentate. It appears that the concentration of Cl- declines with the 
electrooxidation time and ClO- and ClO4- are formed. As we can see from Fig. IV-11 (a), 
the sum of ionic chlorine species (Cl- + ClO- + ClO4-) is higher than the initial 
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concentration of ionic chlorine (only Cl-). The exceed part is proposed to be the oxidation 
productions of organics which contain chlorine. The amounts of them are the same in 
both cases of pH = 7.8 and 3.7. The decrease of concentration of Cl- is related to the pH 
of solution: in the case of pH = 3, the concentration of Cl- decreases faster than the other.  
 
  
 
 
Fig.IV-11 The evolution of the concentration of chlorine species: (a) Cl- ( , ); Cl- + ClO- + ClO4-   ( , ); 
(b) ClO- ( , ), ClO4- ( , ) with EO time during 360 min electrolysis of 1L NF retentate with different 
pH: pH = 7.8, blank symbols; pH = 3 (with 0.5 mmol H2SO4 addition), hollow symbols. The dished line 
is the initial chloride concentration. [Cl-]0 = 67 mg L-1, I = 0.3A (i = 4.34 mA cm-2, ilim = 2.25 mA cm-2), 
flow rate = 366 L h-1, T = 30 °C. 
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Fig.IV-11 (b) compares the formation of ClO- and ClO4- in two pH. It can be 
observed that the formation of ClO- is also faster at pH = 3.7. To the generation of 
undesired ClO4-, it begin to release in the solution at 120 min in the case of pH = 3, while 
it appears latter at 180 min at pH = 7.8 during electrolysis. Considering the amount of 
formation, more ClO4- is formed at the same electro oxidation time (also the same charge 
consumption) in acidic case. After 360 min of electrolysis, the concentration of ClO4- is 
4.8 mg L-1 in acidic condition, while the concentration is 3 mg L-1 at pH = 7.8.      
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Annex V-1: Water quality of effluence from coupling process 
 
Table V-1 Quality of the effluent treated by the coupling process (NF permeate and after EO) Comparison 
with Irrigation water standards 
< LD*: due to the entrapped phosphate into the scaling in the electrolysis cell.  
NDa:   No standard;   
NDAb: No data;   
 
 
 
 
 Feed NF permeate EO effluent Irrigation 
water 
standard
Region 
A 
Region 
B 
Region 
A 
Region B 
I = 0.3A I = 0.2 A 
Conductivity 
(µS cm-1) 
- - - 504 1061 0-3000 
pH - - - 7.38 7.33 7.35 6.00-8.50
Na+ (mg L-1) 68.6 67.3 67.3 75.3 162.4 145.5 0-920 
K+   (mg L-1) 21.5 16.6 16.6 19.17 35.3 33.2 0-2.0 
Mg2+ (mg L-1) 3.8 1.71 4.2 1.5 2.7 3.23 0-400 
Ca2+  (mg L-1) 32.7 17.4 37 28.3 30.9 33.6 0-60.00 
NH4+-N(mgL-1) - - - - -  0-5.00 
Cl- (mg L-1) 46.5 37.6 52.6 15.45 29.8 50.7 0-1065 
ClO- (mg L-1) - - - 67.4 94.5 34.5 NDa 
ClO4- (mg L-1) - - -   - NDa 
NO3- (mg L-1) 1.0 0.56 1.2 25.4 164.5 155.0 0-10.0 
SO42- (mg L-1) 30.0 5.30 12.8 56.2 9.0 81.7 0-960 
PO43- (mg L-1) 9.0 2.7 4.7 0.49 < LD* < LD* 0-2.00 
HCO3- (mg L-1) 63.2 65.4 48.1 23.5 23.3 21 0-610 
COD (mg L-1) 30 4 9 0 0 0 NDa 
TOC (mg L-1) 10.23 0.97 5.49 1.7 2.9 3.6 NDa 
AOX(µg Cl L-1) 380 NDAb NDAb 1610 450 190 NDa 
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Tertiary treatment combining nanofiltration and electrochemical oxidation for 
the elimination of pharmaceuticals in wastewater  
The coupling of nanofiltration and electrochemical oxidation is studied for the tertiary treatment of hospital 
wastewater after membrane bioreactor treatment. The effectiveness of nanofiltration is greatly affected by 
membrane fouling. In order to ensure sustainable flux and high performances during nanofiltration step, 
fouling mechanisms are investigated. The critical flux and the limiting flux are determined and associated 
with the combined effect of the organic colloidal fouling and the scaling. Impact of the fouling layer and of 
the presence of organic matters in the matrix on pharmaceuticals rejection is also investigated. NF retentate 
is then treated by electrochemical oxidation on BDD anode. The influence of operating conditions and the 
competition between components oxidation in the reactor are studied. Rather than a hindering effect, the 
presence of ions and common organics in the concentrate can accelerate the degradation of pharmaceuticals. 
In particular, the formation of organohalogens due to the presence of chloride can be controlled thanks to 
the choice of appropriate operating conditions. A model for the degradation of pharmaceuticals over 
electrooxidation time is established. One objective is to access to the best compromise between 
mineralization of pharmaceuticals and energy consumption. After optimization of the operating conditions 
of both processes, their coupling is confirmed to be efficient for the elimination of pharmaceuticals and the 
reduction of the toxicity of the effluent, allowing to consider its release into the environment or its reuse. 
 
Keywords: Pharmaceutical Elimination, Nanofiltration, Electrochemical Oxidation, Critical Flux, Fouling 
Mechanism, Toxicity Removal 
 
Traitement tertiaire couplant nanofiltration et oxydation électrochimique pour 
l’Élimination des produits pharmaceutiques présents dans les eaux usées  
Le couplage de la nanofiltration et de l’oxydation électrochimique est étudié pour le traitement tertiaire des 
eaux usées de l'hôpital après leur traitement par bioréacteur à membrane. L'efficacité de la nanofiltration est 
fortement influencée par le colmatage. Afin d'assurer des flux durables et des performances élevées lors de 
l’étape de nanofiltration, les mécanismes de colmatage sont étudiés. Les flux critique et limite sont 
déterminés et liés à l’effet combiné du colmatage colloïdal organique et du dépôt inorganique. L’impact de 
la couche de colmatage et de la présence de matières organiques dans la matrice sur la rétention des 
produits pharmaceutiques est également évalué. Le rétentat de la nanofiltration est ensuite traité par 
oxydation électrochimique sur une anode BDD. L'influence des conditions opératoires et la compétition 
lors de l’oxydation des constituants au sein du réacteur sont évaluées. Au lieu d’être rédhibitoire au bon 
fonctionnement du procédé, la présence des ions et des composés organiques dans le concentrat peut 
accélérer la dégradation des produits pharmaceutiques. En particulier, la formation de composés 
organohalogénés due à la présence de chlorure peut être contrôlée par le choix de conditions opératoires 
appropriées. Un modèle décrivant la dégradation des produits pharmaceutiques en fonction du temps 
d’électrooxydation est établi. Un des objectifs est d'accéder au meilleur compromis entre la minéralisation 
des produits pharmaceutiques et la consommation d'énergie. Après optimisation des conditions opératoires 
des 2 procédés, il est démontré que leur couplage est efficace pour l'élimination de produits 
pharmaceutiques et la diminution de la toxicité de l'effluent, permettant d’envisager son rejet dans 
l'environnement ou sa réutilisation.  
 
Mots-clés : Élimination de produits pharmaceutiques, Nanofiltration, oxydation électrochimique, Flux 
critique, mécanismes colmatage, élimination toxicité  
